interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
6919 |
6. Filter based on genotype QC (FinnGen only) |
6733 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Interstitial lung disease endpoints
based on the number of shared cases.
Similar with more cases:
- Other interstitial pulmonary diseases
- Interstitial lung disease
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
- Diseases of the respiratory system
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 6733 | 2689 | 4044 |
| Unadjusted period prevalence (%) | 1.50 | 0.95 | 1.85 |
| Median age at first event (years) | 70.27 | 67.99 | 71.78 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6919
- Matched controls
- 69190
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
318.8
1073
3119
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.6
317.5
834
2017
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
22.8
307.7
359
166
356
Kela drug reimbursment
Nintedanib and pirfenidone
6978.7
307.7
645
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
9.9
307.7
2358
3449
R06.0
ICD-10 Finland
Dyspnoea
3.1
307.7
3144
14541
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
24.6
307.7
2590
1644
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.0
307.7
1028
1964
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
29.8
307.7
286
100
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.5
307.7
900
2239
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.7
307.7
1586
4146
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
15.9
307.7
1081
795
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.5
307.7
2571
5072
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
70.9
307.7
253
37
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
307.7
646
*
H02AB06
ATC
prednisolone; systemic
5.1
307.7
5199
25808
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
7283.5
307.7
3713
11
TGC00
NOMESCO Finland
Bronchial lavation
30.5
307.7
1556
653
L04AX05
ATC
pirfenidone; oral
+∞
307.7
420
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
16384.0
307.7
1983
*
R03AC02
ATC
salbutamol; inhalant
2.7
307.7
4359
26987
L04AA06
ATC
mycophenolic acid; systemic
14.0
307.7
529
408
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
307.7
5048
28958
J96.1
ICD-10 Finland
Chronic respiratory failure
8.2
307.7
597
792
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
9.3
307.7
715
845
GD1AD
NOMESCO Finland
Thorax CT examination
6.8
307.7
1466
2628
L04AX01
ATC
azathioprine; systemic
7.4
307.7
746
1113
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.9
307.7
3722
15782
L01EX09
ATC
nintedanib; oral
3429.4
307.7
337
*
XG410
NOMESCO Finland
Flow-volume spirometry
7.9
307.7
917
1306
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
9686.7
307.7
3273
6
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
294.9
3299
18493
P01BA02
ATC
hydroxychloroquine; oral
3.9
287.4
951
2722
Z94.2
ICD-10 Finland
Lung transplant status
77.7
284.3
152
20
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
268.1
1253
4467
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
4.3
260.9
721
1805
J01MA14
ATC
moxifloxacin; systemic
3.3
246.1
1089
3745
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.0
244.8
447
783
GX1K5
NOMESCO Finland
Diffusion capacity
17.1
244.5
203
122
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.0
244.3
749
2022
GX1D5
NOMESCO Finland
Flow volume spirometry
33.4
225.5
144
44
L01XE31
ATC
[U] nintedanib
+∞
216.8
207
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
20.2
216.5
166
84
R03BB04
ATC
tiotropium bromide; inhalant
2.7
204.6
1271
5242
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
1903.6
201.9
195
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
195.0
1870
9435
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
10.9
192.5
209
198
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.3
189.4
521
1292
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
7.4
168.4
249
349
C03CA01
ATC
furosemide; systemic
2.0
167.9
3221
20961
A02BC02
ATC
pantoprazole; systemic
2.2
167.4
5185
40001
M05BA04
ATC
alendronic acid; oral
2.8
165.9
976
3885
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
9.1
164.5
203
229
48499
ICD-8 Finland
Acute interstitial pneumonia
+∞
164.2
157
*
L04AX03
ATC
methotrexate; systemic
2.9
163.3
883
3361
R05
ICD-10 Finland
Cough
2.2
153.9
1805
9751
J47
ICD-10 Finland
Bronchiectasis
5.3
152.7
313
608
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.2
152.0
662
2226
L04AA13
ATC
[U] leflunomide
5.3
150.1
310
606
WX721
NOMESCO Finland
Oxygen concentrator therapy
21.7
146.8
109
51
R02
ICPC
Shortness of breath/dyspnoea
2.3
142.1
1329
6529
J43.9
ICD-10 Finland
Emphysema, unspecified
5.3
141.5
290
563
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
141.1
1613
8589
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
10.3
139.7
157
156
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
343.9
135.1
136
*
R03AK08
ATC
formoterol and beclometasone; inhalant
3.6
134.7
471
1378
A07EC01
ATC
sulfasalazine; oral, rectal
2.8
134.4
723
2732
GDG10
NOMESCO Finland
Bilateral transplantation of lung
202.6
134.2
139
7
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.2
134.0
372
925
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
8.6
132.5
171
204
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
129.6
124
*
L01BA01
ATC
methotrexate; systemic
3.9
128.4
402
1090
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
128.2
1193
5827
J01MA12
ATC
levofloxacin; systemic
2.0
127.4
1715
9656
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.6
124.6
240
440
XX4BW, ,
NOMESCO Finland
37.1
124.1
77
21
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.6
123.9
429
1246
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.2
122.8
336
826
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
121.2
2161
13353
WX892
NOMESCO Finland
Monitored bed care
2.6
120.5
796
3330
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.7
120.4
283
617
127
Kela drug reimbursment
Transplant complication
6.4
120.3
202
324
R03BA08
ATC
ciclesonide; inhalant
2.7
120.2
728
2918
L04AD01
ATC
ciclosporin; systemic
5.7
117.2
221
397
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.8
114.2
262
560
R04.2
ICD-10 Finland
Haemoptysis
3.2
110.1
463
1518
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
108.6
1508
8521
I50.9
ICD-10 Finland
Heart failure, unspecified
1.9
108.2
1620
9391
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
4.3
106.2
278
660
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
103.9
1115
5725
R99
ICPC
Respiratory disease other
4.6
102.8
249
556
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
27.9
102.0
69
25
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
101.7
556
2109
R81
ICPC
Pneumonia
3.1
100.1
430
1426
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
15.3
98.2
86
57
R50.9
ICD-10 Finland
Fever, unspecified
2.0
97.7
1262
6924
L88
ICPC
Rheumatoid/seropositive arthritis
3.3
97.3
394
1261
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.9
96.5
1691
10262
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
94.8
1803
11212
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
94.5
2345
15754
ZX108
NOMESCO Finland
Inhalation
7.9
93.9
129
166
R4110
NOMESCO Finland
Physiotherapy
1.8
93.5
2121
13883
WW200
NOMESCO Finland
Immunization
3.9
93.1
283
750
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
93.0
3397
25280
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
92.7
749
3416
J01AA02
ATC
doxycycline; systemic
1.8
91.3
5336
44948
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
8.3
91.0
120
147
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.8
90.9
142
211
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.6
89.3
544
2176
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
88.9
625
2677
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
88.7
2110
13957
XG466
NOMESCO Finland
Sleep oxymetry
3.4
87.5
332
1020
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.4
86.8
322
975
R05
ICPC
Cough
1.8
86.0
1752
11070
WX726
NOMESCO Finland
High-flow oxygen therapy
17.9
85.3
69
39
R28
ICPC
Limited function/disability (R)
4.7
85.3
198
427
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.5
84.7
570
2391
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
83.5
1688
10628
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
82.8
1148
6419
GX2C5
NOMESCO Finland
Short-lasting oximetry
8.8
82.7
104
120
J01FA06
ATC
roxithromycin; oral
1.6
81.7
2687
19263
D86.0
ICD-10 Finland
Sarcoidosis of lung
5.8
81.4
151
267
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.1
80.7
140
232
L04AD02
ATC
tacrolimus; systemic
7.0
78.2
120
175
H02AB07
ATC
prednisone; oral
1.9
77.0
1083
6073
N02AA01
ATC
morphine; systemic, rectal
3.5
77.0
267
774
XX2RW, ,
NOMESCO Finland
4.7
75.9
177
383
GDA10
NOMESCO Finland
Biopsy of lung
16.1
75.3
64
40
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
3.6
74.0
253
726
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
73.9
1469
9157
XX9XE
NOMESCO Finland
Other ultrasound examination
7.0
73.5
112
162
J43.8
ICD-10 Finland
Other emphysema
10.6
73.4
80
76
L04AA24
ATC
abatacept; parenteral
11.7
73.1
75
65
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
72.4
514
2206
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
13.0
69.9
67
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
69.2
1067
6147
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
69.2
354
1292
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.1
68.7
193
483
ZXE00
NOMESCO Finland
One hour or less
1.6
68.1
2603
19119
ZX120
NOMESCO Finland
Intravenous
2.0
67.7
764
3956
J80
ICD-10 Finland
Adult respiratory distress syndrome
9.8
65.1
75
77
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
22.0
64.9
48
22
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
7.3
64.3
94
130
N02AX02
ATC
tramadol; systemic, rectal
1.5
64.2
3057
23489
120
Kela drug reimbursment
Hypogammaglobulinaemia
22.5
64.2
47
21
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
63.7
1248
7711
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
10.4
63.2
70
68
J01CA04
ATC
amoxicillin; systemic
1.6
62.9
5203
45066
Z3226
NOMESCO Finland
Physiotherapist
1.7
62.5
1312
8259
F1246, ,
NOMESCO Finland
16.2
62.4
53
33
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
3.9
61.8
187
494
L04AB01
ATC
etanercept; parenteral
4.9
60.7
135
281
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
6.5
60.3
99
155
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
60.3
1297
8211
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
27.5
60.2
41
15
JN4AD
NOMESCO Finland
Body CT examination
1.8
60.0
1006
5928
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.9
59.9
785
4274
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
14.3
59.6
54
38
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
59.5
2481
18430
M34.1
ICD-10 Finland
CR(E)ST syndrome
9.5
59.5
70
74
XG474
NOMESCO Finland
Exhalation nntrogen oxide
3.5
59.2
211
622
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.6
58.8
2128
15309
M01CB01
ATC
sodium aurothiomalate; parenteral
4.4
58.8
149
345
L04AA01
ATC
[U] ciclosporin
4.5
58.4
145
330
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
58.1
970
5704
R5140
NOMESCO Finland
Monitoring the use of the aid
1.9
58.1
846
4768
J43.2
ICD-10 Finland
Centrilobular emphysema
8.4
57.8
75
90
I50.0
ICD-10 Finland
Congestive heart failure
1.9
57.8
812
4523
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
24.3
57.6
41
17
R03BA02
ATC
budesonide; inhalant
1.7
57.3
1162
7228
A03
ICPC
Fever
1.8
57.0
963
5680
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
13.7
57.0
53
39
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
18.9
57.0
45
24
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.0
55.5
157
395
J84
ICD-10 Finland
Other interstitial pulmonary diseases
542.4
54.6
54
*
C07AB07
ATC
bisoprolol; oral
1.5
54.4
3819
31385
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
54.3
543
2680
A02BC01
ATC
omeprazole; systemic
1.5
52.9
1959
14098
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
74.5
52.0
59
8
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
52.0
1004
6145
F2680, ,
NOMESCO Finland
13.3
51.9
49
37
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.2
51.7
211
677
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
51.5
778
4425
A07AA02
ATC
nystatin; oral
2.2
51.3
486
2348
M05BA07
ATC
risedronic acid; oral
2.7
51.2
278
1045
A02BC05
ATC
esomeprazole; systemic
1.5
51.2
2664
20543
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
50.8
626
3329
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.6
50.5
167
469
Z2221
NOMESCO Finland
Medical doctor
1.5
50.4
1771
12574
Z51.5
ICD-10 Finland
Palliative care
1.8
50.4
845
4962
GX2D5
NOMESCO Finland
Sleep oximetry
6.6
50.0
80
122
L04AB04
ATC
adalimumab; parenteral
3.8
49.6
152
405
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
49.4
1669
11738
Z3231
NOMESCO Finland
Registered nurse
1.5
49.3
1902
13766
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.3
49.3
191
594
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.4
48.8
177
528
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
10.7
48.8
53
50
J96.0
ICD-10 Finland
Acute respiratory failure
3.6
48.8
160
447
5AB14, ,
NOMESCO Finland
19.1
48.4
38
20
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.1
48.1
481
2372
R03BA05
ATC
fluticasone; inhalant
1.7
47.9
1128
7268
Z57.2
ICD-10 Finland
Occupational exposure to dust
7.3
47.4
69
95
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
47.1
2807
22116
XW000
NOMESCO Finland
Bone marrow biopsy
2.3
47.0
371
1663
M05.1
ICD-10 Finland
Rheumatoid lung disease
164.5
46.9
49
*
G47.3
ICD-10 Finland
Sleep apnoea
1.6
46.8
1496
10372
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.9
46.7
230
821
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.7
46.6
74
112
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.9
46.4
659
3672
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
5.5
46.3
89
163
M35.1
ICD-10 Finland
Other overlap syndromes
7.4
45.7
66
90
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
10.3
44.8
50
49
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.0
44.8
537
2825
J01FA10
ATC
azithromycin; systemic
1.4
44.8
3114
25163
WZC30
NOMESCO Finland
Teaching
1.6
44.8
1181
7815
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.5
44.8
299
1244
XPX04
NOMESCO Finland
Angioscopy
10.7
44.4
48
45
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
8.4
44.1
57
68
J12.8
ICD-10 Finland
Other viral pneumonia
4.6
43.5
104
230
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
43.3
918
5743
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
43.2
413
1999
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.8
43.0
742
4384
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.7
42.9
992
6349
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.1
42.8
120
300
R03BA01
ATC
beclometasone; inhalant
1.7
42.7
936
5905
R03DC03
ATC
montelukast; oral
1.7
42.0
939
5954
J01FF01
ATC
clindamycin; systemic
1.5
42.0
1733
12646
XJC10
NOMESCO Finland
Oesophageal pH monitoring
6.2
41.9
71
115
M34.0
ICD-10 Finland
Progressive systemic sclerosis
14.1
41.6
38
27
WZA10
NOMESCO Finland
Extensive medical or dental certificate
4.2
41.6
112
272
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
5.1
41.5
88
176
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.8
41.3
92
192
M13.9
ICD-10 Finland
Arthritis, unspecified
1.9
41.0
513
2737
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
4.7
39.8
92
198
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
39.8
298
1305
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.8
39.7
122
326
D07AC01
ATC
betamethasone; topical
1.4
39.3
2361
18457
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.3
38.3
300
1339
R06AE07
ATC
cetirizine; oral
1.4
38.3
2457
19406
R03AK03
ATC
[U] fenoterol and ipratropium bromide
1.9
38.2
486
2606
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
196.1
37.8
39
*
M04AA01
ATC
allopurinol; systemic
1.6
37.7
1153
7870
J20
ICD-10 Finland
Acute bronchitis
1.8
36.7
641
3793
E0000UV, ,
ATC
1.4
35.7
2573
20660
XF400
NOMESCO Finland
ECG with 12 standard connections
1.5
35.7
1183
8209
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
35.4
477
2605
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
2.2
35.4
315
1482
J67.0
ICD-10 Finland
Farmer lung
10.1
35.3
40
40
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.1
35.3
328
1569
A02BC03
ATC
lansoprazole; oral
1.4
35.2
1900
14506
TGD00
NOMESCO Finland
Needle biopsy of lung
5.4
35.1
69
129
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.5
35.1
233
967
RS123, ,
NOMESCO Finland
13.3
34.8
33
25
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
95.6
34.7
38
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
34.6
2080
16176
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.1
34.3
327
1580
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
34.3
2278
18013
C01DA14
ATC
isosorbide mononitrate; oral
1.5
34.2
1444
10522
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
34.1
466
2556
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
12.2
34.1
34
28
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.5
34.1
119
347
R06.2
ICD-10 Finland
Wheezing
2.2
34.1
302
1419
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
7.2
33.8
50
70
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
4.8
33.8
75
156
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.1
33.5
92
227
Z2446
NOMESCO Finland
Social worker
2.0
33.4
398
2087
J94.1
ICD-10 Finland
Fibrothorax
38.4
33.3
42
11
L01AA01
ATC
cyclophosphamide; systemic
5.6
33.2
63
114
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
5.2
33.0
67
129
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
33.0
2561
20735
M33.2
ICD-10 Finland
Polymyositis
7.8
32.7
45
58
J01DB01
ATC
cefalexin; oral
1.4
32.7
5259
47752
XG460
NOMESCO Finland
Short time oxymetry
3.0
32.7
147
500
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
4.0
32.3
91
229
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
32.2
695
4349
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.0
32.2
349
1769
H02AB04
ATC
methylprednisolone; systemic
1.6
32.2
910
6083
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
6.2
32.2
55
90
JN4BD
NOMESCO Finland
Extensive body CT
1.6
32.1
771
4957
J99.0
ICD-10 Finland
Rheumatoid lung disease
318.6
31.9
32
*
M33.1
ICD-10 Finland
Other dermatomyositis
12.5
31.5
31
25
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
3.3
31.4
116
351
A01AB09
ATC
miconazole; local oral
1.7
31.2
566
3379
N03AX16
ATC
[U] pregabalin
1.4
31.2
1460
10819
1XC02, ,
NOMESCO Finland
4.6
31.2
74
163
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
31.1
2306
18487
XG405
NOMESCO Finland
Education on PEF monitoring
3.2
31.1
125
398
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.6
31.0
185
730
WX722
NOMESCO Finland
PEEP
2.0
30.3
343
1765
SPAT1262
SPAT
Handing over of treatment supplies
1.5
30.2
1252
9060
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
11.5
30.0
31
27
H02AB09
ATC
hydrocortisone; systemic
2.6
29.9
169
649
GAA31
NOMESCO Finland
Thoracoscopy
5.9
29.9
53
90
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
4.8
29.9
67
141
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.7
29.6
162
612
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
29.6
2411
19578
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
29.4
2812
23390
R03AK11
ATC
formoterol and fluticasone; inhalant
2.6
29.3
172
673
M81.4
ICD-10 Finland
Drug-induced osteoporosis
5.0
29.3
63
128
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
29.0
1612
12296
1CX01, ,
NOMESCO Finland
10.4
28.9
32
31
AN1
HP
Coronary angiography
1.5
28.8
927
6368
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.0
28.8
299
1493
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
28.6
1577
12006
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.6
28.6
167
652
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.5
28.4
68
151
2AX04, ,
NOMESCO Finland
48.8
28.4
34
7
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.4
28.2
195
825
J98.4
ICD-10 Finland
Other disorders of lung
7.7
28.0
39
51
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.3
28.0
104
316
J01FA15
ATC
telithromycin; oral
1.7
28.0
543
3301
N02BE01
ATC
paracetamol; systemic, rectal
1.5
27.9
5872
54820
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
27.9
903
6205
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.6
27.9
92
259
R29
ICPC
Respiratory symptom/complaint other
1.8
27.8
431
2457
J45.8
ICD-10 Finland
Mixed asthma
2.3
27.8
218
975
R4190
NOMESCO Finland
Nutritional therapy
2.2
27.3
237
1104
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
27.2
1011
7149
ZXA10
NOMESCO Finland
Bilateral
1.4
27.2
1241
9129
J01FA09
ATC
clarithromycin; systemic
1.4
27.1
1666
12902
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
27.1
1143
8283
J93.8
ICD-10 Finland
Other pneumothorax
4.7
27.0
62
133
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
8.4
27.0
35
42
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
26.9
872
5992
J05AB11
ATC
valaciclovir; oral
1.5
26.9
863
5919
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
26.8
805
5441
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
4.5
26.3
63
140
SPAT1263
SPAT
Sampling
1.3
26.2
2564
21285
L04AB06
ATC
golimumab; parenteral
4.9
26.2
57
117
N02AA05
ATC
oxycodone; systemic
1.4
25.9
1419
10768
SPAT1325
SPAT
Vaccination
1.3
25.8
2300
18829
I73.0
ICD-10 Finland
Raynaud syndrome
3.1
25.7
108
354
WX110
NOMESCO Finland
Infiltration anesthesia
1.3
25.6
4192
37303
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.8
25.5
395
2252
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
25.4
402
2305
A10AC01
ATC
insulin (human); parenteral
1.7
25.4
528
3266
M31.3
ICD-10 Finland
Wegener granulomatosis
5.8
25.3
46
80
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.8
25.3
131
482
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
25.3
2364
19475
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
25.2
1212
8985
B01AA03
ATC
warfarin; systemic
1.4
25.1
1599
12427
RK110, ,
NOMESCO Finland
3.8
25.1
75
197
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
25.1
1742
13728
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.5
25.1
84
239
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
+∞
25.0
24
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.6
25.0
146
571
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.9
24.7
72
186
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
24.7
393
2259
L04AC07
ATC
tocilizumab; parenteral
6.6
24.6
39
59
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
24.5
334
1831
WPA11
NOMESCO Finland
Developing a plan for palliative care
5.8
24.4
44
76
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
24.4
1632
12777
RK320, ,
NOMESCO Finland
3.6
24.3
80
225
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.3
24.3
189
843
WX872
NOMESCO Finland
Intensive care
1.8
24.2
381
2181
J15.8
ICD-10 Finland
Other bacterial pneumonia
3.5
24.2
82
235
WX723
NOMESCO Finland
CPAP therapy
2.0
24.2
254
1273
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
24.1
1098
8057
N05CF01
ATC
zopiclone; oral
1.3
24.0
2114
17236
3A006, ,
NOMESCO Finland
+∞
24.0
23
*
WPA13
NOMESCO Finland
Palliative consultation
4.3
23.8
60
139
J46
ICD-10 Finland
Status asthmaticus
2.2
23.8
192
869
L04AA17
ATC
[U] adalimumab
6.8
23.7
37
55
L04AB05
ATC
certolizumab pegol; parenteral
6.8
23.7
37
55
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.2
23.5
94
299
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.0
23.5
66
166
3006
Kela drug reimbursment
Baricitinib
9.4
23.5
28
30
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.6
23.5
539
3418
D07AC13
ATC
mometasone; topical
1.3
23.4
1706
13516
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
23.2
173
757
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
1.9
23.2
310
1687
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.3
23.2
176
776
L04AA37
ATC
[U] baricitinib
9.7
23.2
27
28
N03AX12
ATC
[U] gabapentin; oral
1.4
23.2
976
7053
318
Kela drug reimbursment
Teriparatide
4.4
23.1
58
134
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.5
23.1
675
4530
H05AA02
ATC
teriparatide; parenteral
4.6
23.1
54
118
XA421
NOMESCO Finland
Nocturnal polygraphy
5.1
23.0
48
95
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.7
23.0
395
2320
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
+∞
22.9
22
*
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
6.9
22.9
35
51
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.4
22.8
153
640
5BA08, ,
NOMESCO Finland
4.3
22.6
57
132
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
5.9
22.6
40
68
R03BB07
ATC
umeclidinium bromide; inhalant
3.4
22.5
80
237
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.1
22.5
62
154
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
22.4
1521
11910
J05AB01
ATC
aciclovir; systemic
1.4
22.2
1252
9520
291
Kela drug reimbursment
Tofacitinib
7.9
22.1
30
38
R01AD09
ATC
mometasone; nasal
1.3
22.1
2339
19505
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
22.0
651
4379
UJF32
NOMESCO Finland
Coloscopy
1.3
21.9
1775
14259
J96.9
ICD-10 Finland
Respiratory failure, unspecified
3.7
21.9
70
193
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.8
21.9
339
1932
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.9
21.9
102
355
1240
FHL
Bronchoscopy
3.0
21.5
96
326
A10AB05
ATC
insulin aspart; parenteral
1.6
21.3
509
3260
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.4
21.1
74
217
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.6
21.0
492
3133
R74
ICPC
Upper respiratory infection acute
1.4
21.0
1363
10582
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.0
20.8
214
1066
R01AD08
ATC
fluticasone; nasal
1.3
20.7
1445
11346
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
2.7
20.7
108
400
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1.8
20.6
326
1870
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
20.5
1313
10170
J02AC03
ATC
voriconazole; systemic
6.3
20.5
34
54
R24
ICPC
Haemoptysis
3.5
20.5
71
207
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.9
20.5
263
1414
WX002
NOMESCO Finland
Sedation and analgesia
1.4
20.5
1240
9522
C09AA05
ATC
ramipril; oral
1.3
20.3
1864
15210
132
Kela drug reimbursment
Sarcoidosis
3.9
20.3
58
148
J01MA02
ATC
ciprofloxacin; systemic
1.3
20.3
2601
22160
R03BB01
ATC
ipratropium bromide; inhalant
1.8
20.3
307
1738
R76.0
ICD-10 Finland
Raised antibody titre
6.1
20.3
35
58
ZXE20
NOMESCO Finland
More than three and less than five hours
1.4
20.2
876
6353
C03DA01
ATC
spironolactone; oral
1.4
20.2
907
6620
R01AD12
ATC
fluticasone furoate; nasal
1.3
20.2
1426
11210
WX882
NOMESCO Finland
High dependency care
2.1
20.2
200
983
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.7
20.1
352
2080
XQ800
NOMESCO Finland
Prick test
1.8
20.1
315
1803
XF622
NOMESCO Finland
Measurement of minute volume of heart
5.1
20.0
41
80
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
20.0
539
3549
I27.0
ICD-10 Finland
Primary pulmonary hypertension
6.8
19.9
31
46
R03DA04
ATC
theophylline; systemic, rectal
1.7
19.9
394
2405
J02AC01
ATC
fluconazole; systemic
1.3
19.9
1834
14967
M05BX04
ATC
denosumab; parenteral
1.6
19.8
445
2807
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
19.7
354
2105
ZXD05
NOMESCO Finland
Urgent procedure
1.3
19.7
1815
14806
R03AC12
ATC
salmeterol; inhalant
1.8
19.7
312
1791
XF402
NOMESCO Finland
ECG with work load test
1.5
19.7
729
5132
L01CB
ATC
Podophyllotoxin derivatives
6.4
19.6
32
50
R03AC03
ATC
terbutaline; inhalant
1.5
19.5
755
5358
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
24.6
19.5
27
11
WX402
NOMESCO Finland
General anaesthesia
1.4
19.4
1222
9432
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
19.3
210
1067
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.2
19.1
163
756
L04AA29
ATC
[U] tofacitinib
6.9
19.1
29
42
R03AC13
ATC
formoterol; inhalant
1.8
19.1
317
1845
J01DA01
ATC
[U] cefalexin
1.3
18.9
3693
32973
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
18.8
206
1049
ZXA00
NOMESCO Finland
Right side
1.3
18.8
1711
13919
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
18.8
556
3736
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.1
18.8
182
887
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.1
18.7
179
868
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
6.5
18.7
30
46
B02.9
ICD-10 Finland
Zoster without complication
1.6
18.5
473
3075
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
6.2
18.4
31
50
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
5.2
18.4
37
71
J42
ICD-10 Finland
Unspecified chronic bronchitis
2.7
18.4
98
367
M01CB03
ATC
auranofin; oral
3.5
18.4
61
173
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.2
18.3
73
233
J94.8
ICD-10 Finland
Other specified pleural conditions
2.3
18.2
140
622
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
2.5
18.2
115
468
M05BA06
ATC
ibandronic acid; systemic
2.3
18.1
136
598
TNG10
NOMESCO Finland
Puncture of knee
2.9
18.0
82
282
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
18.0
1850
15277
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
52.6
17.9
21
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
17.9
326
1946
M10.9
ICD-10 Finland
Gout, unspecified
1.5
17.9
557
3782
GD1CQ
NOMESCO Finland
Lung circulation SPECT with low dose CT
6.7
17.8
28
42
ED1AA
NOMESCO Finland
Mandibular X-ray examination
3.8
17.8
54
144
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
7.6
17.8
25
33
NDG30
NOMESCO Finland
Fusion of wrist, total
4.3
17.8
45
105
N07BA03
ATC
varenicline; oral
1.9
17.7
213
1122
SPAT1255
SPAT
Intravenous administration of medicine
1.6
17.7
454
2956
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
5.7
17.6
32
56
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.5
17.5
499
3325
GD1AA, ,
SPAT
1.4
17.5
696
4962
B01AC04
ATC
clopidogrel; oral
1.3
17.5
1298
10253
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
17.3
1075
8267
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
18.6
17.3
26
14
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
17.3
1785
14737
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.7
17.2
340
2074
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
17.2
1010
7701
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.2
17.2
137
619
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
17.0
548
3747
R2110
NOMESCO Finland
Giving the first information
1.7
16.9
326
1976
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
5.0
16.8
36
73
E000001, ,
ATC
1.4
16.8
1060
8168
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
16.8
2598
22481
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
16.8
208
1107
A46
ICD-10 Finland
Erysipelas
1.4
16.8
1025
7861
R03AC19
ATC
olodaterol
4.1
16.7
45
110
6BA02, ,
NOMESCO Finland
6.2
16.7
28
45
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
16.6
574
3980
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
3.5
16.6
56
161
81
HP
Angiography of the heart and coronary arteries
1.5
16.5
511
3467
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
16.4
467
3110
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
16.4
1812
15064
M25.5
ICD-10 Finland
Pain in joint
1.3
16.4
1707
14090
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
40.2
16.3
20
5
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
4.6
16.3
38
83
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.1
16.3
44
108
XX3DW
NOMESCO Finland
Time consuming IT work
1.4
16.2
683
4918
J45
ICD-10 Finland
Asthma
1.5
16.2
529
3626
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
16.2
722
5254
ZY010
NOMESCO Finland
Hospital outpatient
1.9
16.1
216
1179
3AC01, ,
NOMESCO Finland
3.0
16.1
69
230
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
3.2
16.1
62
194
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
1.9
16.0
202
1081
L95
ICPC
Osteoporosis
1.8
16.0
257
1482
SPAT1260
SPAT
Consultation of another employee
1.3
15.9
1048
8123
ZX114
NOMESCO Finland
Intramuscular
2.7
15.9
84
314
WVA20
NOMESCO Finland
Medicine administration
1.9
15.9
183
951
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
3.6
15.8
52
147
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
15.8
144
687
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.1
15.7
146
701
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
5.9
15.7
28
48
C08CA05
ATC
nifedipine; systemic
1.5
15.7
430
2841
A28
ICPC
Limited function/disability NOS
1.3
15.7
1405
11367
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.5
15.6
53
153
J01XB01
ATC
colistin; inhalant, parenteral
26.3
15.6
21
8
D64.9
ICD-10 Finland
Anaemia, unspecified
1.4
15.6
839
6303
L04AK01
ATC
leflunomide; oral
3.8
15.5
46
121
AK3
HP
BLTX (both lung transplants)
160.4
15.5
16
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.5
15.4
93
371
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.8
15.4
252
1462
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.5
15.4
94
378
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
15.3
337
2114
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.2
15.3
132
616
D07AB08
ATC
desonide; topical
1.4
15.3
598
4246
A41.9
ICD-10 Finland
Sepsis, unspecified
1.7
15.3
261
1531
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
3.8
15.2
45
118
J98.2
ICD-10 Finland
Interstitial emphysema
11.2
15.2
28
25
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
3.4
15.1
54
161
ZXA05
NOMESCO Finland
Left side
1.3
15.1
1553
12775
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
15.1
252
1469
D07XC01
ATC
betamethasone; topical
1.4
15.1
724
5332
R4120
NOMESCO Finland
Occupational therapy
1.6
15.0
373
2409
R03BB06
ATC
glycopyrronium bromide; inhalant
3.8
15.0
44
115
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
14.9
1958
16583
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.3
14.8
112
495
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
2.7
14.8
78
291
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.5
14.7
406
2685
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
3.6
14.7
48
135
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
14.7
139
673
B01AB05
ATC
enoxaparin; parenteral
1.2
14.6
2000
17002
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.5
14.6
502
3477
U09.9
ICD-10 Finland
Post COVID-19 condition, unspecified
3.6
14.6
47
131
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
2.9
14.6
66
227
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
14.5
1261
10146
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
14.5
1989
16911
H26.3
ICD-10 Finland
Drug-induced cataract
3.6
14.5
46
127
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.4
14.5
50
146
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
2.5
14.5
91
371
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
6.6
14.5
23
35
ZYC01
NOMESCO Finland
Remote contact by phone
1.6
14.4
319
2004
M54.5
ICD-10 Finland
Low back pain
1.2
14.4
1955
16603
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
2.6
14.4
81
313
I50
ICD-10 Finland
Heart failure
1.7
14.4
253
1498
D07AD01
ATC
clobetasol; topical
1.3
14.4
918
7076
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
14.4
234
1356
J01GB01
ATC
tobramycin; inhalant, parenteral
12.5
14.3
25
20
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
3.3
14.3
52
157
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
11.3
14.2
26
23
C10AA03
ATC
pravastatin; oral
1.5
14.2
511
3571
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
14.2
220
3711
293
Kela drug reimbursment
Baricitinib
10.4
14.2
27
26
R04.0
ICD-10 Finland
Epistaxis
1.4
14.2
543
3841
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.3
14.2
52
158
B01AB04
ATC
dalteparin; parenteral
1.6
14.2
321
2029
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.3
14.1
108
480
NG1DA
NOMESCO Finland
X-ray of knees
2.2
14.1
119
551
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
42.6
14.1
17
*
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.3
14.0
106
469
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
4.0
14.0
39
98
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.3
14.0
101
438
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
1.9
14.0
186
1014
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
10.9
14.0
26
24
XX1VW
NOMESCO Finland
Written report from radiologist
3.0
13.9
60
201
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.9
13.9
62
212
I50.1
ICD-10 Finland
Left ventricular failure
1.5
13.9
391
2599
WX780
NOMESCO Finland
Remote monitoring CPAP
1.7
13.8
230
1341
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.6
13.8
323
2059
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.0
13.8
59
197
L04AA11
ATC
[U] etanercept
4.7
13.7
31
66
R01AD58
ATC
fluticasone, combinations; nasal
1.3
13.7
1018
8013
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.5
13.7
425
2882
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
3.5
13.7
46
132
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
2.7
13.7
72
269
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
13.7
712
5315
N18.8
ICD-10 Finland
Other chronic renal failure
1.8
13.7
187
1029
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.0
13.6
58
193
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
75.3
13.6
15
*
H25.1
ICD-10 Finland
Senile nuclear cataract
1.2
13.6
2167
18702
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.3
13.5
105
470
ZX100
NOMESCO Finland
Oral
2.3
13.5
101
445
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.7
13.5
230
1350
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
4.5
13.5
32
71
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
13.5
587
4249
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.7
13.5
244
1456
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.3
13.5
50
153
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
13.5
2530
22197
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
13.5
503
3541
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
4.1
13.4
36
88
SBA10
NOMESCO Finland
Measurement of salivary flow rate
2.8
13.4
65
233
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.6
13.3
75
290
A02BA02
ATC
ranitidine; systemic
1.3
13.3
1214
9819
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
21.2
13.3
19
9
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
1.8
13.3
182
1002
N06DX01
ATC
memantine; oral
0.6
13.3
310
4738
M06
ICD-10 Finland
Other rheumatoid arthritis
3.2
13.2
50
155
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
3.3
13.2
49
150
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
2.6
13.2
72
274
NJ3CG
NOMESCO Finland
Extensive MRI examination of extremities with median high magnet
4.1
13.2
35
85
WX740
NOMESCO Finland
Nitrogen oxide therapy
9.7
13.2
26
27
-1, ,
NOMESCO Finland
1.3
13.1
1578
13192
WX727
NOMESCO Finland
Estimation of exercise oxygen therapy
40.1
13.1
16
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.3
13.1
95
413
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
4.2
13.1
34
81
S97
ICPC
Chronic ulcer skin
1.5
13.1
454
3149
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
13.1
257
1568
C02KX04
ATC
macitentan; oral
15.0
13.1
21
14
L01BB01, ,
ATC
5.9
13.0
23
39
WPB10
NOMESCO Finland
Making a convalescent care decision
3.5
13.0
44
127
H03AA01
ATC
levothyroxine sodium; systemic
1.3
12.9
1218
9894
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.2
12.8
103
468
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
50.1
12.8
15
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
2.7
12.8
65
239
A02BA03
ATC
famotidine; systemic
1.7
12.7
244
1479
R03AL11
ATC
formoterol, glycopyrronium bromide and budesonide; inhalant
2.7
12.7
66
245
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
3.4
12.7
44
129
XG422
NOMESCO Finland
Time-volume spirometry with bronchodialtation
6.0
12.6
22
37
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
32.1
12.6
16
5
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
3.3
12.6
45
135
N06DA03
ATC
rivastigmine; oral, transdermal
0.5
12.5
129
2447
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.4
12.5
523
3759
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
12.5
12
*
WX720
NOMESCO Finland
Own respiration
1.6
12.5
284
1799
E000002, ,
ATC
1.4
12.5
512
3669
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
5.0
12.4
26
52
TK800
NOMESCO Finland
Hemodialysis
2.0
12.4
137
704
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.3
12.4
899
7052
WPA45
NOMESCO Finland
Continuous drug infusion in palliative care
4.5
12.3
29
64
L03
ICPC
Low back symptom/complaint
1.2
12.3
1541
12930
B07.9
ICD-10 Finland
Verruca simplex
1.8
12.3
174
969
Z94.3
ICD-10 Finland
Heart and lungs transplant status
37.6
12.2
15
*
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
12.1
180
1016
XF404
NOMESCO Finland
Ambulatory ECG
1.4
12.1
555
4052
ZX197, ,
NOMESCO Finland
15.9
12.1
19
12
D11
ICPC
Diarrhoea
1.4
12.1
534
3874
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
12.1
50
164
SBA00
NOMESCO Finland
Microbiological examinations
1.9
12.0
142
747
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.5
12.0
346
2314
N06AX11
ATC
mirtazapine; oral
1.2
11.9
1899
16337
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.4
11.9
452
3191
J86.9
ICD-10 Finland
Pyothorax without fistula
2.5
11.9
70
277
OAB50, ,
SPAT
1.4
11.8
496
3566
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.4
11.8
76
314
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.6
11.8
279
1783
XX7LW, ,
NOMESCO Finland
5.4
11.8
23
43
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.7
11.8
223
1349
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
11.7
216
1298
R04
ICPC
Breathing problem other
1.7
11.6
220
1330
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.5
11.6
340
2280
I25.2
ICD-10 Finland
Old myocardial infarction
1.4
11.6
530
3869
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
11.6
160
884
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
1.7
11.6
188
1090
R60.0
ICD-10 Finland
Localized oedema
1.3
11.6
831
6503
L03AA02
ATC
filgrastim; parenteral
1.8
11.5
171
966
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
11.5
1593
13500
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
3.3
11.5
41
123
5168X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies
+∞
11.5
11
*
51701
ICD-8 Finland
Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)
+∞
11.5
11
*
C10AA01
ATC
simvastatin; oral
1.2
11.4
3064
27658
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.6
11.4
246
1537
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
2.8
11.4
56
202
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
13.6
11.4
19
14
4040, ,
NOMESCO Finland
13.6
11.4
19
14
304
Kela drug reimbursment
Dornase alfa
120.2
11.4
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
120.2
11.4
12
*
H04.10
ICD-10 Finland
Dry eye syndrome
1.4
11.4
609
4562
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.5
11.3
67
266
NDF10
NOMESCO Finland
Synovectomy of wrist
5.4
11.3
22
41
R4130
NOMESCO Finland
Speech therapy
1.8
11.3
164
920
G53.0
ICD-10 Finland
Postzoster neuralgia
2.7
11.3
57
209
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
2.7
11.3
60
226
ZY000
NOMESCO Finland
Hospital inpatient
2.8
11.3
55
198
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.7
11.2
216
1312
QC6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in hand
8.9
11.2
23
26
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.4
11.2
603
4522
M79.6
ICD-10 Finland
Pain in limb
1.2
11.2
2454
21743
RK120, ,
NOMESCO Finland
4.4
11.2
27
61
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
4.7
11.2
25
53
J67.8
ICD-10 Finland
Hypersensitivity pneumonitis due to other organic dusts
25.0
11.1
15
6
M48.0
ICD-10 Finland
Spinal stenosis
1.3
11.1
833
6557
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
3.1
11.1
45
146
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
2.5
11.1
70
287
C10AA05
ATC
atorvastatin; oral
1.2
11.1
2911
26211
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
11.0
178
1031
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
8.5
11.0
23
27
J93.9
ICD-10 Finland
Pneumothorax, unspecified
3.1
11.0
45
147
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.0
10.9
122
629
R05FB02
ATC
cough suppressants and expectorants; systemic
1.2
10.9
2202
19347
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
4.5
10.9
26
58
R06AX27
ATC
desloratadine; oral
1.3
10.9
1214
10035
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
1.9
10.9
134
714
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.5
10.9
358
2459
B37.0
ICD-10 Finland
Candidal stomatitis
2.6
10.9
63
248
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
10.9
431
3069
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
10.8
96
1909
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
10.8
3705
34099
RS221, ,
NOMESCO Finland
2.3
10.8
78
340
TFP20
NOMESCO Finland
Cardiodefibrillation
1.4
10.8
506
3710
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.4
10.8
449
3225
XQ848
NOMESCO Finland
Dermatological photography
1.7
10.8
184
1083
NDG74
NOMESCO Finland
Fusion of first IP joint
4.3
10.7
27
63
ZX121
NOMESCO Finland
Central venous catheter
4.0
10.7
30
76
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
9.6
10.7
21
22
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.6
10.7
25
55
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
1.7
10.7
179
1048
D02AE01
ATC
carbamide; topical
1.5
10.7
330
2239
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
1.9
10.6
132
706
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
60.1
10.6
12
*
S22.2
ICD-10 Finland
Fracture of sternum
3.0
10.6
45
150
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.8
10.6
160
909
A07EC02
ATC
mesalazine; oral, rectal
1.6
10.6
254
1630
S18
ICPC
Laceration/cut
1.2
10.6
2981
26961
XG420
NOMESCO Finland
Time-volume spirometry
5.3
10.6
21
40
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
2.5
10.5
66
270
J43.1
ICD-10 Finland
Panlobular emphysema
10.0
10.5
20
20
K02.1
ICD-10 Finland
Caries of dentine
1.2
10.5
3006
27225
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
1.8
10.5
138
753
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
1.8
10.4
141
775
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.1
10.4
90
423
F03
ICD-10 Finland
Unspecified dementia
0.6
10.4
132
2348
J32.4
ICD-10 Finland
Chronic pansinusitis
2.3
10.4
78
346
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
3.2
10.4
39
121
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
3.3
10.4
38
116
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
16.0
10.3
16
10
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
10.3
2176
19178
SPAT1310
SPAT
Counselling related to known health issue
1.2
10.3
1779
15389
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
2.3
10.3
73
316
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
4.3
10.3
26
61
B01AF02
ATC
apixaban; oral
1.3
10.3
990
8043
B59
ICD-10 Finland
Pneumocystosis
8.8
10.2
21
24
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
18.8
10.2
15
8
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.0
10.2
108
547
A01AB04
ATC
amphotericin B; local oral
1.5
10.2
272
1788
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.0
10.2
109
554
D72.1
ICD-10 Finland
Eosinophilia
3.6
10.2
32
88
DHA10
NOMESCO Finland
Biopsy of cavity of nose
2.8
10.2
50
181
N06DA02
ATC
donepezil; oral
0.6
10.2
231
3552
B34.9
ICD-10 Finland
Viral infection, unspecified
1.9
10.1
121
640
P01AB01
ATC
metronidazole; oral, rectal
1.2
10.1
2062
18111
RS230, ,
NOMESCO Finland
3.2
10.1
38
118
A04
ICPC
Weakness/tiredness general
1.3
10.1
929
7505
WX730
NOMESCO Finland
Conventional respirator
2.0
10.1
101
502
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.8
10.1
149
842
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.4
10.1
473
3470
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
1.7
10.1
160
924
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
1.7
10.0
166
969
J98.6
ICD-10 Finland
Disorders of diaphragm
3.2
10.0
39
124
SPAT1059
SPAT
Spirometry at the office
1.5
10.0
292
1960
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.1
10.0
91
437
M01AE02
ATC
naproxen; oral, rectal
1.2
9.9
2996
27202
M01AB05
ATC
diclofenac; systemic, rectal
1.2
9.9
3752
34706
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
9.9
479
3532
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.4
9.9
416
2995
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
9.9
2890
26173
11
HP
Coronary artery bypass surgery
1.7
9.8
177
1058
207
Kela drug reimbursment
Chronic arrhythmias
1.2
9.8
1211
10116
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
4.9
9.8
21
43
N19
ICD-10 Finland
Unspecified kidney failure
1.5
9.7
272
1808
R78
ICPC
Acute bronchitis/bronchiolitis
1.9
9.7
114
599
M03BX02
ATC
tizanidine; oral
1.2
9.7
3219
29435
R53
ICD-10 Finland
Malaise and fatigue
1.2
9.7
1449
12351
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1.8
9.7
136
758
WPA44
NOMESCO Finland
Nursing home for palliative care
3.8
9.7
28
73
M01AH02
ATC
rofecoxib; oral
1.3
9.6
748
5914
RK250, ,
NOMESCO Finland
3.1
9.6
39
127
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
2.2
9.6
80
371
EBA10
NOMESCO Finland
Operative extraction of tooth
1.4
9.6
481
3567
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.7
9.6
170
1013
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
5.0
9.6
20
40
M10
ICD-10 Finland
Gout
1.5
9.6
302
2060
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.5
9.6
97
1843
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
1.9
9.5
115
610
XX4AW, ,
NOMESCO Finland
9.1
9.5
19
21
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.1
9.5
91
446
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
9.5
2324
20719
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
9.4
176
1064
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.4
9.4
423
3082
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
9.4
2161
19159
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
9.4
330
2300
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
9.4
541
4102
J70.1
ICD-10 Finland
Chronic and other pulmonary manifestations due to radiation
21.7
9.3
13
6
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
21.7
9.3
13
6
J01FA01
ATC
erythromycin; systemic
1.3
9.3
554
4217
M54
ICD-10 Finland
Dorsalgia
1.3
9.3
551
4191
I26
ICD-10 Finland
Pulmonary embolism
2.4
9.3
60
249
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
3.4
9.3
32
94
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
4.5
9.3
22
49
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.2
9.3
1680
14574
G04BE08
ATC
tadalafil; oral
4.0
9.2
25
62
D07BC01
ATC
betamethasone and antiseptics; topical
1.3
9.2
653
5101
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.6
9.2
199
1249
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
9.2
821
6607
WX213
NOMESCO Finland
Lower leg blockade
2.4
9.2
58
239
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
4.1
9.2
24
58
S29
ICPC
Skin symptom/complaint other
1.2
9.1
1183
9926
3A064, ,
NOMESCO Finland
3.2
9.1
34
105
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
2.9
9.1
42
147
N06AA09
ATC
amitriptyline; systemic
1.3
9.1
525
3977
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.6
9.1
187
1157
RT271, ,
NOMESCO Finland
7.7
9.1
20
26
D05AX52
ATC
calcipotriol, combinations; topical
1.5
9.1
274
1851
M01CC01
ATC
penicillamine; oral
5.0
9.1
19
38
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.3
9.1
548
4182
R52.0
ICD-10 Finland
Acute pain
1.7
9.1
155
915
GX1R5
NOMESCO Finland
Peak expiratory flow (PEF) measurement
11.5
9.0
16
14
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
3.1
9.0
36
116
RS220, ,
NOMESCO Finland
2.3
9.0
66
290
I20.09
ICD-10 Finland
Unstable angina
1.4
9.0
400
2907
R03AC18
ATC
indacaterol; inhalant
2.4
9.0
58
241
G73.7*M35.0
ICD-10 Finland
Myopathy in sicca syndrome [Sjögren]
10.0
9.0
17
17
D05BB02
ATC
acitretin; oral
1.8
9.0
127
709
R06AE09
ATC
levocetirizine; oral
1.3
9.0
581
4477
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.6
9.0
212
1358
SPAT1254
SPAT
Administration of medicine
1.3
9.0
909
7423
FXE00
NOMESCO Finland
Use of ECLA
18.6
8.9
13
7
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
3.1
8.9
36
117
AA1AD
NOMESCO Finland
CT of head and brain
1.2
8.9
1967
17359
L28
ICPC
Limited function/disability (L)
1.2
8.9
1294
10987
E000003, ,
ATC
1.6
8.9
208
1330
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.7
8.9
145
845
UDC00
NOMESCO Finland
Ear microscopy
1.4
8.9
410
3001
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
8.9
223
1450
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
12.5
8.8
15
12
51709
ICD-8 Finland
Other chronic interstitial pneumonia, Unspecified
7.9
8.8
19
24
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
8.8
383
2773
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.5
8.8
306
2128
M02AA07
ATC
piroxicam; topical
1.2
8.8
2118
18823
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
8.6
8.8
18
21
5010A
ICD-9 Finland
Asbestosis[ASBESTOSIS]
9.5
8.8
17
18
R03BB05
ATC
aclidinium bromide; inhalant
3.4
8.7
30
88
NDG76
NOMESCO Finland
Fusion of DIP joint
2.6
8.7
49
191
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
2.0
8.7
84
413
S22.3
ICD-10 Finland
Fracture of rib
1.4
8.7
421
3105
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.5
8.7
263
1780
C02KX01
ATC
bosentan; oral
14.0
8.7
14
10
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
50.0
8.7
10
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.5
8.7
282
1936
SPAT1281
SPAT
Other administrative function
1.4
8.6
408
2997
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.3
8.6
62
271
WNF00
NOMESCO Finland
Infection source and contact determination
3.2
8.6
32
99
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.4
8.6
343
2448
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
2.3
8.6
64
284
R63.4
ICD-10 Finland
Abnormal weight loss
1.5
8.6
254
1711
3005
Kela drug reimbursment
Tofacitinib
4.6
8.6
20
44
A11
ICPC
Chest pain NOS
1.3
8.6
518
3954
L17
ICPC
Foot/toe symptom/complaint
1.2
8.6
1760
15425
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.0
8.5
90
457
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.5
8.5
230
1519
R11
ICD-10 Finland
Nausea and vomiting
1.4
8.5
455
3409
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.4
8.5
341
2436
A06AD11
ATC
lactulose; oral
1.2
8.5
1013
8423
B48.5
ICD-10 Finland
Pneumocystosis
27.5
8.5
11
*
XJC00
NOMESCO Finland
Oesophageal manometry
3.4
8.5
29
85
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
20.0
8.5
12
6
J70.3
ICD-10 Finland
Chronic drug-induced interstitial lung disorders
20.0
8.5
12
6
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
4.2
8.4
22
53
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
90.2
8.4
9
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.4
3799
35417
P70
ICPC
Dementia
0.4
8.4
54
1198
M01AB55
ATC
diclofenac, combinations; oral
1.4
8.4
387
2833
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
1.8
8.4
116
645
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
4.9
8.3
18
37
M31.7
ICD-10 Finland
Microscopic polyangiitis
6.7
8.3
20
30
UGC08
NOMESCO Finland
Rigid bronchoscopy with biopsy of lung
+∞
8.3
8
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
1.9
8.3
99
524
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.4
8.3
376
2742
ZX140
NOMESCO Finland
Intra articular
2.5
8.3
48
190
U08.9
ICD-10 Finland
Personal history of COVID-19, unspecified
3.6
8.3
26
72
L57.0
ICD-10 Finland
Actinic keratosis
1.3
8.3
763
6161
M01AX17
ATC
nimesulide; oral
1.2
8.3
1388
11942
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.3
8.2
744
5992
SPAT1097
SPAT
Recording of ECG
1.2
8.2
902
7429
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
8.2
3392
31385
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
3.5
8.2
27
77
C01AA05
ATC
digoxin; systemic
1.3
8.2
603
4729
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.8
8.2
122
693
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.6
8.2
205
1332
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
2.8
8.2
38
134
602
Kela drug reimbursment
Children's severe malnutrition
14.5
8.2
13
9
4130B
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]
1.8
8.2
121
686
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
3.0
8.2
35
118
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
8.1
368
2684
XX9XW, ,
NOMESCO Finland
2.8
8.1
39
140
L04AC14
ATC
sarilumab; systemic
7.5
8.1
18
24
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.5
8.1
234
1568
WX204
NOMESCO Finland
Axillary plexus blockaced
1.6
8.1
167
1036
C08CA02
ATC
felodipine; oral
1.3
8.1
642
5087
M81.8
ICD-10 Finland
Other osteoporosis
2.3
8.1
60
266
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.2
8.1
1528
13284
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
17.2
8.1
12
7
T90
ICPC
Diabetes non-insulin dependent
1.2
8.0
1588
13857
R01
ICPC
Pain respiratory system
2.0
8.0
81
405
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
1.9
8.0
90
468
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
2.1
8.0
69
326
B01AB10
ATC
tinzaparin; parenteral
1.3
7.9
603
4751
RK310, ,
NOMESCO Finland
7.2
7.9
18
25
N02BF02
ATC
pregabalin; oral
1.4
7.9
332
2390
K08.3
ICD-10 Finland
Retained dental root
1.3
7.9
448
3386
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
2.3
7.9
59
262
NXL00
NOMESCO Finland
Biopsy of muscle
3.2
7.9
30
94
D07AA02
ATC
hydrocortisone; topical
1.3
7.9
653
5200
Z71.8
ICD-10 Finland
Other specified counselling
1.2
7.9
1736
15284
R13
ICD-10 Finland
Dysphagia
1.4
7.9
424
3180
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
7.9
2166
19419
7102A
ICD-9 Finland
Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]
13.0
7.9
13
10
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
7.7
7.9
17
22
J01DA06
ATC
[U] cefuroxime
1.3
7.9
699
5619
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
7.8
1353
11662
K29.3
ICD-10 Finland
Chronic superficial gastritis
1.6
7.8
192
1242
SPAT1058
SPAT
PEF monitoring instruction
1.4
7.8
418
3132
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2.4
7.8
53
226
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.2
7.8
923
7663
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
1.9
7.8
99
536
RK220, ,
NOMESCO Finland
3.5
7.8
26
75
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
4.0
7.8
21
52
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.4
7.8
325
2340
M32
ICD-10 Finland
Systemic lupus erythematosus
9.4
7.8
15
16
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
6.9
7.8
18
26
M60.9
ICD-10 Finland
Myositis, unspecified
2.7
7.7
39
144
4038, ,
NOMESCO Finland
45.0
7.7
9
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.0
7.7
74
364
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
2.9
7.7
34
117
A01
ICPC
Pain general/multiple sites
1.3
7.6
553
4330
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
1.5
7.6
263
1828
SAA04
NOMESCO Finland
Special examination of mouth
1.5
7.6
224
1508
N17.8
ICD-10 Finland
Other acute renal failure
1.9
7.6
86
448
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
2.8
7.6
36
129
R06AX22
ATC
ebastine; oral
1.3
7.5
715
5792
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
2.3
7.5
52
224
B01AC06
ATC
acetylsalicylic acid; oral
1.5
7.5
244
1677
N05AX08
ATC
risperidone; systemic
0.7
7.5
289
4010
L95.8
ICD-10 Finland
Other vasculitis limited to skin
3.7
7.4
23
63
C01BD01
ATC
amiodarone; systemic
1.5
7.4
188
1226
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
7.4
654
5250
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
7.4
569
4489
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.6
7.4
152
943
F2682, ,
NOMESCO Finland
4.4
7.4
18
41
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.4
7.4
325
2360
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.4
7.4
385
2874
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.2
7.4
1404
12199
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.4
7.4
260
1816
M10.0
ICD-10 Finland
Idiopathic gout
1.5
7.4
237
1626
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
7.4
1134
9667
R95
ICPC
Chron obstructive pulmonary disease
1.5
7.4
201
1333
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
3.3
7.4
27
83
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.2
7.3
1432
12471
JN6AD
NOMESCO Finland
CT of torso and neck
1.8
7.3
103
576
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
7.3
719
5847
UJD02
NOMESCO Finland
Gastroscopy
1.4
7.3
272
1919
6BB16, ,
NOMESCO Finland
+∞
7.3
7
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.0
7.3
70
345
D07CC01
ATC
betamethasone and antibiotics; topical
1.3
7.3
618
4940
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.2
7.3
1250
10766
NJ3BG
NOMESCO Finland
MRI examination of extremities with high intensity magnet
3.2
7.2
28
89
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.4
7.2
366
2722
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
4.3
7.2
18
42
K51.8
ICD-10 Finland
Other ulcerative colitis
2.1
7.2
65
313
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
7.2
131
790
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
30.0
7.1
9
*
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
2.5
7.1
43
174
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.8
7.1
495
6294
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.0
7.1
75
382
B37.08
ICD-10 Finland
Other candidal stomatitis
2.3
7.1
53
236
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
7.1
919
10891
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
1.9
7.1
90
488
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.1
7.1
64
308
5823
FHL
Lung avobiopsy and wedge resection
6.6
7.1
17
26
J92
ICD-10 Finland
Pleural plaque
6.6
7.1
17
26
I47.2
ICD-10 Finland
Ventricular tachycardia
1.7
7.1
129
777
M06.4
ICD-10 Finland
Inflammatory polyarthropathy
3.3
7.1
26
80
A07EA06
ATC
budesonide; oral, local oral
1.6
7.1
164
1049
D68.8
ICD-10 Finland
Other specified coagulation defects
2.3
7.1
51
224
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
2.7
7.1
36
134
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
2.5
7.1
43
175
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
7.0
33
829
UJF92
NOMESCO Finland
Capsular endoscopy
1.8
7.0
104
591
UDM02
NOMESCO Finland
Sinoscopy
1.8
7.0
101
570
RK520, ,
NOMESCO Finland
3.1
7.0
28
91
K59.1
ICD-10 Finland
Functional diarrhoea
1.4
7.0
292
2104
R07.3
ICD-10 Finland
Other chest pain
1.3
7.0
566
4498
Z57.3
ICD-10 Finland
Occupational exposure to other air contaminants
3.5
7.0
23
66
WW500
NOMESCO Finland
Blood transfusion
1.5
7.0
230
1587
WW300
NOMESCO Finland
Transfer of autologic stem cells
3.2
7.0
26
81
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
3.2
7.0
26
81
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
3.3
6.9
25
76
M05BA01
ATC
etidronic acid; systemic
2.6
6.9
37
141
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.2
6.9
2175
19654
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
6.9
1724
15309
B01AE07
ATC
dabigatran etexilate; oral
1.4
6.9
243
1697
RT272, ,
NOMESCO Finland
3.7
6.9
21
57
M34
ICD-10 Finland
Systemic sclerosis
13.8
6.9
11
8
N06AX21
ATC
duloxetine; oral
1.3
6.9
529
4177
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.6
6.9
133
815
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
2.4
6.8
45
190
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
2.9
6.8
30
103
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.8
6.8
471
5992
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.2
6.8
698
5704
K29.7
ICD-10 Finland
Gastritis, unspecified
1.5
6.8
197
1324
R05CB01
ATC
acetylcysteine; inhalant, oral
1.8
6.8
94
524
212
Kela drug reimbursment
Gout
1.6
6.8
141
880
C07AB02
ATC
metoprolol; systemic
1.2
6.8
1354
11811
XV5WT, ,
NOMESCO Finland
40.1
6.8
8
*
M01AH05
ATC
etoricoxib; oral
1.1
6.7
3284
30571
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.6
6.7
149
943
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
5.6
6.7
18
32
K22.7
ICD-10 Finland
Barrett oesophagus
1.9
6.7
80
425
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
4.3
6.7
17
40
D06BB04
ATC
podophyllotoxin; topical
1.6
6.7
129
788
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
6.7
218
1499
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.2
6.7
995
8446
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
1.7
6.7
123
743
R79
ICPC
Chronic bronchitis
3.5
6.7
22
63
EB1WA, ,
NOMESCO Finland
2.6
6.7
36
138
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
2.3
6.7
49
217
Z50.1
ICD-10 Finland
Other physical therapy
1.4
6.7
283
2045
Z31.5
ICD-10 Finland
Genetic counselling
1.5
6.7
172
1128
TKC20
NOMESCO Finland
Catheterisation of bladder
1.3
6.7
442
3421
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
6.7
182
1209
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.4
6.7
237
1660
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.0
6.7
70
357
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
1.5
6.6
170
1113
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.2
6.6
702
5756
-44
ICPC
Preventive immunization/medic
1.3
6.6
481
3768
RK290, ,
NOMESCO Finland
3.7
6.6
20
54
J01DA08
ATC
[U] cefaclor
1.3
6.6
363
2734
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
1.7
6.6
120
723
N05CD07
ATC
temazepam; oral
1.2
6.6
720
5923
GX1P5
NOMESCO Finland
Nocturnal CO2 monitoring
7.8
6.6
14
18
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
1.5
6.6
169
1107
I80.9
ICD-10 Finland
Phlebitis and thrombophlebitis of unspecified site
1.9
6.6
75
393
NCB20
NOMESCO Finland
Primary total prosthetic replacement of elbow joint
5.5
6.6
18
33
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
1.6
6.6
137
855
C10AC01
ATC
colestyramine; oral
1.6
6.6
133
824
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
1.7
6.6
121
732
NB2AT
NOMESCO Finland
Intra artrial injection of shoulder with ultrasound guidance
2.0
6.6
62
304
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.3
6.5
389
2966
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
1.7
6.5
104
605
M05BB04
ATC
risedronic acid, calcium and colecalciferol, sequential; oral
3.8
6.5
19
50
SPAT1211
SPAT
Application of soft bandage
1.3
6.5
469
3671
49099
ICD-8 Finland
Bronchitis, unspecified
2.1
6.5
56
265
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
1.6
6.5
135
842
G44.2
ICD-10 Finland
Tension-type headache
1.3
6.5
576
4628
N06AX16
ATC
venlafaxine; oral
1.3
6.5
554
4431
L01
ICPC
Neck symptom/complaint
1.2
6.5
743
6145
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.5
6.5
177
1176
SFA10
NOMESCO Finland
One-surface restoration
1.1
6.5
2796
25798
K51.5
ICD-10 Finland
Left sided colitis
1.7
6.5
109
644
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
2.3
6.5
48
214
C83.1
ICD-10 Finland
Mantle cell lymphoma
2.8
6.5
31
112
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.6
6.4
159
1033
OAA67, ,
SPAT
0.7
6.4
236
3300
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.2
6.4
717
5914
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.6
6.4
124
760
K11.2
ICD-10 Finland
Sialoadenitis
1.6
6.4
152
979
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.2
6.4
985
8390
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
6.4
958
8139
WX320
NOMESCO Finland
Spinalanesthesy
1.2
6.4
1453
12799
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
6.4
1641
14593
WPB11
NOMESCO Finland
Palliative sedation
14.3
6.4
10
7
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.3
6.4
474
3728
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.6
6.4
143
910
M01AH01
ATC
celecoxib; oral
1.2
6.4
957
8136
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
3.7
6.4
19
51
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
1.8
6.3
89
499
NG1EA
NOMESCO Finland
Knee X-ray examination with wrench
1.9
6.3
77
413
XG430
NOMESCO Finland
Spiroegometry
8.1
6.3
13
16
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
8.1
6.3
13
16
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.2
6.3
965
8215
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.9
6.3
70
364
TEA00
NOMESCO Finland
Biopsy of lip
2.1
6.3
55
262
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
3.6
6.3
20
56
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
2.9
6.3
28
97
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
1.5
6.3
160
1047
M05.0
ICD-10 Finland
Felty syndrome
5.9
6.3
16
27
X58
ICD-10 Finland
Exposure to other specified factors
1.2
6.3
677
5563
D84.9
ICD-10 Finland
Immunodeficiency, unspecified
9.2
6.3
12
13
B37.00
ICD-10 Finland
Acute pseudomembraneuous candidal stomatitis
3.2
6.3
23
71
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.3
6.3
470
3700
XG413
NOMESCO Finland
Spirometry with oscillometry
18.0
6.3
9
5
A02BA04
ATC
nizatidine; systemic
1.3
6.3
436
3399
R51.80
ICD-10 Finland
Headache
1.2
6.3
657
5384
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.3
6.2
462
3630
K76.9
ICD-10 Finland
Liver disease, unspecified
2.0
6.2
67
345
K77
ICPC
Heart failure
1.5
6.2
164
1082
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
6.2
1286
11241
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
1.6
6.2
137
868
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.4
6.2
293
2157
R07.1
ICD-10 Finland
Chest pain on breathing
1.9
6.2
72
381
M05BX03
ATC
strontium ranelate; oral
2.5
6.2
37
150
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.4
6.2
223
1568
J98.1
ICD-10 Finland
Pulmonary collapse
2.2
6.1
46
206
NDF60
NOMESCO Finland
Operation for osteochondritis of a joint of hand,v
3.5
6.1
20
57
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
1.4
6.1
242
1728
RS224, ,
NOMESCO Finland
2.9
6.1
27
93
E66.8
ICD-10 Finland
Other obesity
1.5
6.1
191
1305
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
3.3
6.1
22
67
RD210, ,
NOMESCO Finland
1.9
6.1
74
397
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
1.5
6.1
179
1209
Z94.1
ICD-10 Finland
Heart transplant status
4.1
6.1
16
39
1512
Kela drug reimbursment
Ibrutinib
4.1
6.1
16
39
GDB10
NOMESCO Finland
Wedge resection of lung
3.8
6.1
18
48
WW409
NOMESCO Finland
Other aferesis
3.8
6.1
18
48
R03DC01
ATC
zafirlukast; oral
1.8
6.1
82
455
SPAT1094
SPAT
Continuous Positive Airway Pressure
2.0
6.1
60
300
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
6.0
154
1009
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
2.6
6.0
32
122
R27
ICPC
Fear of respiratory disease other
2.0
6.0
63
321
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.3
6.0
459
3620
A04AA01
ATC
ondansetron; systemic, rectal
1.3
6.0
418
3257
B37.03
ICD-10 Finland
Chronic atrophic candida infection in the mouth
3.1
6.0
24
78
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
2.6
6.0
33
128
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
1.8
6.0
84
471
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
6.0
1747
15670
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pulmonary Disease
29 [38004472]
29 [38004472]
9.0e-01
2.1e+00
3.3e+00
9.0e+00
4.3e+00
4.4e+00
3.2e+00
cases:23.32%
controls:11.00%
cases:33.69%
controls:5.60%
cases:22.27%
controls:1.01%
cases:78.23%
controls:0.05%
cases:42.89%
controls:0.99%
cases:82.87%
controls:5.50%
cases:77.08%
controls:11.57%
1573
7411
5172
59966
2274
3772
4475
63642
1503
678
5246
66736
5280
31
1469
67383
2800
666
3728
66550
4986
3552
1031
61002
3403
5875
1012
44911
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.4e+00
3.3e+00
4.7e+00
6.3e+00
4.4e+00
3.0e+00
1.7e+00
cases:5.77%
controls:1.44%
cases:13.42%
controls:0.59%
cases:9.26%
controls:0.09%
cases:4.46%
controls:0.01%
cases:6.04%
controls:0.08%
cases:9.72%
controls:0.55%
cases:8.40%
controls:1.67%
389
968
6356
66409
906
395
5843
67019
625
61
6124
67353
301
6
6448
67408
394
51
6134
67165
585
358
5432
64196
371
847
4044
49939
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
1.7e+00
3.6e+00
5.3e+00
—
5.1e+00
4.9e+00
4.0e+00
cases:2.83%
controls:0.55%
cases:5.87%
controls:0.17%
cases:3.16%
controls:0.02%
—
—
cases:2.19%
controls:0.01%
cases:15.04%
controls:0.13%
cases:20.16%
controls:0.47%
191
368
6554
67009
396
114
6353
67300
213
11
6536
67403
—
143
9
6385
67207
905
85
5112
64469
890
238
3525
50548
Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
35333-4 [3036086]
35333-4 [3036086]
1.2e+00
3.0e+00
6.0e+00
1.0e+50
5.8e+00
3.5e+00
2.2e+00
cases:1.16%
controls:0.34%
cases:2.83%
controls:0.15%
cases:3.87%
controls:0.01%
cases:0.58%
controls:0.00%
cases:3.58%
controls:0.01%
cases:4.01%
controls:0.12%
cases:4.85%
controls:0.55%
78
227
6667
67150
191
102
6558
67312
261
7
6488
67407
39
0
6710
67414
234
8
6294
67208
241
79
5776
64475
214
278
4201
50508
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
1.4e+00
2.9e+00
4.8e+00
—
5.8e+00
3.4e+00
2.2e+00
cases:3.19%
controls:0.84%
cases:4.93%
controls:0.29%
cases:3.51%
controls:0.03%
—
—
cases:8.95%
controls:0.03%
cases:5.53%
controls:0.20%
cases:7.32%
controls:0.89%
215
565
6530
66812
333
195
6416
67219
237
20
6512
67394
—
584
21
5944
67195
333
131
5684
64423
323
454
4092
50332
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
1.5e+00
2.8e+00
4.6e+00
1.0e+50
5.7e+00
3.0e+00
2.1e+00
cases:1.68%
controls:0.40%
cases:2.65%
controls:0.17%
cases:1.75%
controls:0.02%
cases:0.98%
controls:0.00%
cases:5.44%
controls:0.02%
cases:3.21%
controls:0.17%
cases:4.67%
controls:0.57%
113
268
6632
67109
179
117
6570
67297
118
12
6631
67402
66
0
6683
67414
355
13
6173
67203
193
109
5824
64445
206
289
4209
50497
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
8.2e-01
2.1e+00
3.8e+00
6.8e+00
3.0e+00
1.8e+00
1.2e+00
cases:9.27%
controls:4.30%
cases:13.17%
controls:1.77%
cases:9.66%
controls:0.24%
cases:7.50%
controls:0.01%
cases:4.34%
controls:0.23%
cases:10.69%
controls:2.01%
cases:20.09%
controls:6.90%
625
2900
6120
64477
889
1192
5860
66222
652
161
6097
67253
506
6
6243
67408
283
156
6245
67060
643
1300
5374
63254
887
3506
3528
47280
immunoglobulins, normal human, for extravascular adm.
J06BA01 [21601256]
J06BA01 [21601256]
3.1e+00
3.3e+00
2.9e+00
—
3.0e+00
3.7e+00
3.5e+00
cases:0.22%
controls:0.01%
cases:0.31%
controls:0.01%
cases:0.16%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.48%
controls:0.01%
cases:0.68%
controls:0.02%
15
7
6730
67370
21
8
6728
67406
11
6
6738
67408
—
12
6
6516
67210
29
8
5988
64546
30
11
4385
50775
immunoglobulins, normal human, for intravascular adm.
J06BA02 [21601257]
J06BA02 [21601257]
3.1e+00
3.3e+00
2.9e+00
—
3.0e+00
3.7e+00
3.5e+00
cases:0.22%
controls:0.01%
cases:0.31%
controls:0.01%
cases:0.16%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.48%
controls:0.01%
cases:0.68%
controls:0.02%
15
7
6730
67370
21
8
6728
67406
11
6
6738
67408
—
12
6
6516
67210
29
8
5988
64546
30
11
4385
50775
SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
26975-3 [3025245]
26975-3 [3025245]
1.1e+00
2.6e+00
5.5e+00
1.0e+50
5.1e+00
3.0e+00
1.8e+00
cases:0.95%
controls:0.31%
cases:2.12%
controls:0.15%
cases:2.76%
controls:0.01%
cases:0.34%
controls:0.00%
cases:2.08%
controls:0.01%
cases:2.46%
controls:0.12%
cases:3.26%
controls:0.56%
64
212
6681
67165
143
104
6606
67310
186
8
6563
67406
23
0
6726
67414
136
9
6392
67207
148
79
5869
64475
144
286
4271
50500
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 [3031478]
34645-2 [3031478]
1.4e+00
3.1e+00
4.6e+00
—
4.9e+00
2.8e+00
2.3e+00
cases:0.85%
controls:0.22%
cases:2.42%
controls:0.11%
cases:1.48%
controls:0.01%
—
—
cases:2.88%
controls:0.02%
cases:1.93%
controls:0.12%
cases:4.85%
controls:0.51%
57
146
6688
67231
163
75
6586
67339
100
10
6649
67404
—
188
15
6340
67201
116
79
5901
64475
214
257
4201
50529
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
5128-4 [3001334]
1.0e+00
2.6e+00
5.6e+00
—
5.5e+00
2.5e+00
1.6e+00
cases:2.19%
controls:0.81%
cases:3.72%
controls:0.28%
cases:4.00%
controls:0.01%
—
—
cases:4.01%
controls:0.02%
cases:2.79%
controls:0.23%
cases:3.90%
controls:0.79%
148
547
6597
66830
251
189
6498
67225
270
10
6479
67404
—
262
11
6266
67205
168
147
5849
64407
172
402
4243
50384
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-2.9e-01
5.2e-01
2.3e+00
5.2e+00
3.8e+00
3.9e+00
3.6e+00
cases:20.27%
controls:25.29%
cases:12.34%
controls:7.72%
cases:6.58%
controls:0.73%
cases:4.15%
controls:0.02%
cases:3.05%
controls:0.07%
cases:21.82%
controls:0.57%
cases:35.06%
controls:1.52%
1367
17042
5378
50335
833
5205
5916
62209
444
493
6305
66921
280
16
6469
67398
199
47
6329
67169
1313
371
4704
64183
1548
773
2867
50013
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
6968-2 [3009445]
1.0e+00
2.7e+00
5.2e+00
—
5.6e+00
2.6e+00
1.8e+00
cases:2.18%
controls:0.81%
cases:4.61%
controls:0.34%
cases:5.45%
controls:0.03%
—
—
cases:5.93%
controls:0.02%
cases:3.91%
controls:0.30%
cases:5.53%
controls:1.00%
147
547
6598
66830
311
226
6438
67188
368
21
6381
67393
—
387
15
6141
67201
235
195
5782
64359
244
509
4171
50277
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 [3020565]
21363-7 [3020565]
1.3e+00
3.1e+00
4.7e+00
—
4.9e+00
2.7e+00
2.1e+00
cases:0.76%
controls:0.22%
cases:2.13%
controls:0.10%
cases:1.35%
controls:0.01%
—
—
cases:2.28%
controls:0.02%
cases:1.55%
controls:0.10%
cases:3.40%
controls:0.43%
51
146
6694
67231
144
65
6605
67349
91
8
6658
67406
—
149
12
6379
67204
93
65
5924
64489
150
216
4265
50570
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
6521-9 [3009595]
2.0e+00
3.7e+00
—
1.0e+50
5.9e+00
3.8e+00
3.4e+00
cases:0.67%
controls:0.09%
cases:1.85%
controls:0.05%
—
—
cases:0.37%
controls:0.00%
cases:3.57%
controls:0.01%
cases:1.93%
controls:0.04%
cases:4.03%
controls:0.14%
45
60
6700
67317
125
31
6624
67383
—
25
0
6724
67414
233
7
6295
67209
116
28
5901
64526
178
71
4237
50715
Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
41001-9 [3042596]
41001-9 [3042596]
1.4e+00
2.9e+00
4.4e+00
—
4.8e+00
2.7e+00
2.6e+00
cases:0.73%
controls:0.18%
cases:1.57%
controls:0.09%
cases:0.99%
controls:0.01%
—
—
cases:1.99%
controls:0.02%
cases:1.33%
controls:0.09%
cases:3.78%
controls:0.29%
49
122
6696
67255
106
60
6643
67354
67
8
6682
67406
—
130
11
6398
67205
80
61
5937
64493
167
149
4248
50637
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 [3002482]
29257-3 [3002482]
1.3e+00
3.0e+00
4.7e+00
—
4.9e+00
2.7e+00
2.2e+00
cases:1.01%
controls:0.28%
cases:2.65%
controls:0.13%
cases:1.69%
controls:0.02%
—
—
cases:3.19%
controls:0.03%
cases:2.11%
controls:0.15%
cases:5.35%
controls:0.60%
68
191
6677
67186
179
90
6570
67324
114
11
6635
67403
—
208
17
6320
67199
127
94
5890
64460
236
307
4179
50479
Smith extractable nuclear Ab [Units/volume] in Serum
11090-8 [3016921]
11090-8 [3016921]
1.1e+00
2.6e+00
5.5e+00
1.0e+50
4.8e+00
2.9e+00
1.8e+00
cases:1.19%
controls:0.39%
cases:2.30%
controls:0.17%
cases:2.79%
controls:0.01%
cases:0.37%
controls:0.00%
cases:2.25%
controls:0.02%
cases:2.61%
controls:0.15%
cases:3.44%
controls:0.61%
80
262
6665
67115
155
113
6594
67301
188
8
6561
67406
25
0
6724
67414
147
13
6381
67203
157
94
5860
64460
152
309
4263
50477
Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
61365-3 [40764126]
61365-3 [40764126]
1.5e+00
2.8e+00
4.3e+00
—
4.9e+00
2.7e+00
2.3e+00
cases:0.56%
controls:0.13%
cases:1.05%
controls:0.06%
cases:0.76%
controls:0.01%
—
—
cases:1.41%
controls:0.01%
cases:0.90%
controls:0.06%
cases:1.86%
controls:0.18%
38
86
6707
67291
71
42
6678
67372
51
7
6698
67407
—
92
7
6436
67209
54
38
5963
64516
82
92
4333
50694
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.9e-01
1.6e+00
2.7e+00
6.8e+00
2.5e+00
2.5e+00
1.9e+00
cases:20.03%
controls:12.22%
cases:20.05%
controls:4.71%
cases:8.13%
controls:0.57%
cases:12.95%
controls:0.02%
cases:6.50%
controls:0.57%
cases:35.23%
controls:4.45%
cases:50.53%
controls:13.43%
1351
8233
5394
59144
1353
3175
5396
64239
549
387
6200
67027
874
11
5875
67403
424
386
6104
66830
2120
2870
3897
61684
2231
6821
2184
43965
Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
29374-6 [3006999]
29374-6 [3006999]
1.1e+00
2.6e+00
5.4e+00
1.0e+50
4.8e+00
2.9e+00
1.8e+00
cases:1.17%
controls:0.39%
cases:2.24%
controls:0.16%
cases:2.77%
controls:0.01%
cases:0.37%
controls:0.00%
cases:2.18%
controls:0.02%
cases:2.59%
controls:0.15%
cases:3.40%
controls:0.61%
79
261
6666
67116
151
111
6598
67303
187
9
6562
67405
25
0
6724
67414
142
12
6386
67204
156
97
5861
64457
150
308
4265
50478
Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
17791-5 [3027450]
17791-5 [3027450]
1.1e+00
2.6e+00
5.5e+00
1.0e+50
4.8e+00
2.9e+00
1.7e+00
cases:1.22%
controls:0.43%
cases:2.27%
controls:0.18%
cases:2.79%
controls:0.01%
cases:0.37%
controls:0.00%
cases:2.27%
controls:0.02%
cases:2.63%
controls:0.15%
cases:3.56%
controls:0.65%
82
288
6663
67089
153
118
6596
67296
188
8
6561
67406
25
0
6724
67414
148
13
6380
67203
158
97
5859
64457
157
332
4258
50454
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
1.3e+00
2.5e+00
4.2e+00
—
4.9e+00
3.0e+00
2.6e+00
cases:0.87%
controls:0.24%
cases:1.45%
controls:0.12%
cases:0.77%
controls:0.01%
—
—
cases:1.93%
controls:0.01%
cases:2.16%
controls:0.11%
cases:4.33%
controls:0.33%
59
165
6686
67212
98
79
6651
67335
52
8
6697
67406
—
126
10
6402
67206
130
73
5887
64481
191
166
4224
50620
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
48404-8 [3049804]
9.8e-01
2.5e+00
5.2e+00
—
5.7e+00
2.4e+00
1.5e+00
cases:1.47%
controls:0.56%
cases:2.92%
controls:0.24%
cases:3.82%
controls:0.02%
—
—
cases:3.39%
controls:0.01%
cases:2.38%
controls:0.22%
cases:3.06%
controls:0.67%
99
374
6646
67003
197
159
6552
67255
258
15
6491
67399
—
221
8
6307
67208
143
141
5874
64413
135
342
4280
50444
Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
50548-7 [3030692]
50548-7 [3030692]
1.4e+00
2.6e+00
4.1e+00
—
4.8e+00
2.8e+00
2.5e+00
cases:0.90%
controls:0.23%
cases:1.41%
controls:0.10%
cases:0.93%
controls:0.02%
—
—
cases:1.99%
controls:0.02%
cases:1.48%
controls:0.09%
cases:3.31%
controls:0.27%
61
157
6684
67220
95
68
6654
67346
63
11
6686
67403
—
130
11
6398
67205
89
57
5928
64497
146
137
4269
50649
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
23826-1 [3012477]
1.2e+00
2.9e+00
4.4e+00
—
4.9e+00
2.6e+00
2.0e+00
cases:0.79%
controls:0.24%
cases:2.19%
controls:0.12%
cases:1.36%
controls:0.02%
—
—
cases:2.45%
controls:0.02%
cases:1.73%
controls:0.13%
cases:3.87%
controls:0.52%
53
163
6692
67214
148
80
6601
67334
92
11
6657
67403
—
160
12
6368
67204
104
81
5913
64473
171
266
4244
50520
Extractable nuclear Ab [Units/volume] in Serum
30342-0 [3015171]
30342-0 [3015171]
8.3e-01
2.7e+00
4.8e+00
—
5.0e+00
3.0e+00
1.8e+00
cases:1.54%
controls:0.68%
cases:2.36%
controls:0.16%
cases:2.50%
controls:0.02%
—
—
cases:3.14%
controls:0.02%
cases:3.31%
controls:0.18%
cases:4.01%
controls:0.66%
104
457
6641
66920
159
111
6590
67303
169
14
6580
67400
—
205
14
6323
67202
199
115
5818
64439
177
334
4238
50452
DNA double strand Ab [Units/volume] in Serum
5130-0 [3023420]
5130-0 [3023420]
1.1e+00
2.5e+00
4.8e+00
1.0e+50
4.8e+00
3.0e+00
1.9e+00
cases:1.93%
controls:0.66%
cases:3.10%
controls:0.26%
cases:2.92%
controls:0.03%
cases:0.43%
controls:0.00%
cases:2.80%
controls:0.02%
cases:4.37%
controls:0.22%
cases:5.32%
controls:0.81%
130
448
6615
66929
209
172
6540
67242
197
17
6552
67397
29
0
6720
67414
183
16
6345
67200
263
142
5754
64412
235
412
4180
50374
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
M35.9 [45553174]
1.9e+00
2.7e+00
3.7e+00
1.0e+50
3.8e+00
3.3e+00
2.9e+00
cases:0.52%
controls:0.08%
cases:0.71%
controls:0.05%
cases:0.30%
controls:0.01%
cases:0.31%
controls:0.00%
cases:0.44%
controls:0.01%
cases:1.20%
controls:0.05%
cases:1.49%
controls:0.08%
35
55
6710
67322
48
33
6701
67381
20
5
6729
67409
21
0
6728
67414
29
7
6499
67209
72
30
5945
64524
66
43
4349
50743
Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
62424-7 [40765161]
62424-7 [40765161]
1.4e+00
2.8e+00
4.2e+00
—
4.8e+00
2.6e+00
2.4e+00
cases:1.14%
controls:0.30%
cases:2.10%
controls:0.14%
cases:1.21%
controls:0.02%
—
—
cases:2.30%
controls:0.02%
cases:1.60%
controls:0.12%
cases:4.08%
controls:0.40%
77
201
6668
67176
142
92
6607
67322
82
13
6667
67401
—
150
13
6378
67203
96
76
5921
64478
180
202
4235
50584
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
1.2e+00
2.6e+00
4.5e+00
—
4.9e+00
2.6e+00
1.9e+00
cases:2.37%
controls:0.72%
cases:4.21%
controls:0.32%
cases:2.98%
controls:0.03%
—
—
cases:6.31%
controls:0.05%
cases:3.97%
controls:0.32%
cases:6.73%
controls:1.05%
160
486
6585
66891
284
219
6465
67195
201
22
6548
67392
—
412
33
6116
67183
239
205
5778
64349
297
532
4118
50254
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
1.6e+00
1.9e+00
2.4e+00
5.2e+00
2.4e+00
2.2e+00
2.0e+00
cases:6.18%
controls:1.26%
cases:5.93%
controls:0.92%
cases:2.44%
controls:0.24%
cases:2.99%
controls:0.02%
cases:2.88%
controls:0.26%
cases:7.26%
controls:0.90%
cases:8.77%
controls:1.34%
417
851
6328
66526
400
617
6349
66797
165
159
6584
67255
202
11
6547
67403
188
172
6340
67044
437
583
5580
63971
387
679
4028
50107
Connective tissue diseases, rheumatoid arthritis and comparable disease
202 [2001600200]
202 [2001600200]
1.4e+00
2.1e+00
3.8e+00
—
4.5e+00
3.5e+00
2.4e+00
cases:2.65%
controls:0.69%
cases:1.50%
controls:0.19%
cases:0.40%
controls:0.01%
—
—
cases:1.13%
controls:0.01%
cases:3.59%
controls:0.12%
cases:4.30%
controls:0.43%
179
463
6566
66914
101
128
6648
67286
27
6
6722
67408
—
74
9
6454
67207
216
76
5801
64478
190
216
4225
50570
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.0e+00
2.3e+00
4.5e+00
1.0e+50
3.2e+00
3.5e+00
2.9e+00
cases:7.06%
controls:2.64%
cases:7.33%
controls:0.77%
cases:5.47%
controls:0.06%
cases:4.09%
controls:0.00%
cases:1.52%
controls:0.06%
cases:15.42%
controls:0.57%
cases:22.58%
controls:1.52%
476
1781
6269
65596
495
520
6254
66894
369
43
6380
67371
276
0
6473
67414
99
42
6429
67174
928
371
5089
64183
997
773
3418
50013
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.0e+00
2.3e+00
4.5e+00
1.0e+50
3.2e+00
3.5e+00
2.9e+00
cases:7.06%
controls:2.64%
cases:7.33%
controls:0.77%
cases:5.47%
controls:0.06%
cases:4.09%
controls:0.00%
cases:1.52%
controls:0.06%
cases:15.42%
controls:0.57%
cases:22.58%
controls:1.52%
476
1781
6269
65596
495
520
6254
66894
369
43
6380
67371
276
0
6473
67414
99
42
6429
67174
928
371
5089
64183
997
773
3418
50013
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.0e+00
2.3e+00
4.5e+00
1.0e+50
3.2e+00
3.5e+00
2.9e+00
cases:7.06%
controls:2.64%
cases:7.33%
controls:0.77%
cases:5.47%
controls:0.06%
cases:4.09%
controls:0.00%
cases:1.52%
controls:0.06%
cases:15.42%
controls:0.57%
cases:22.58%
controls:1.52%
476
1781
6269
65596
495
520
6254
66894
369
43
6380
67371
276
0
6473
67414
99
42
6429
67174
928
371
5089
64183
997
773
3418
50013
Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
40976-3 [3040853]
40976-3 [3040853]
1.2e+00
2.7e+00
4.0e+00
—
4.8e+00
2.5e+00
2.2e+00
cases:1.32%
controls:0.40%
cases:2.73%
controls:0.19%
cases:1.57%
controls:0.03%
—
—
cases:3.08%
controls:0.03%
cases:2.29%
controls:0.19%
cases:5.53%
controls:0.63%
89
270
6656
67107
184
130
6565
67284
106
19
6643
67395
—
201
18
6327
67198
138
124
5879
64430
244
319
4171
50467
Lung transplant status
Z94.2 [45609997]
Z94.2 [45609997]
2.6e+00
3.0e+00
—
1.0e+50
2.6e+00
4.0e+00
5.2e+00
cases:0.10%
controls:0.01%
cases:0.15%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.42%
controls:0.01%
cases:2.04%
controls:0.01%
7
5
6738
67372
10
5
6739
67409
—
8
0
6741
67414
8
6
6520
67210
25
5
5992
64549
90
6
4325
50780
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
38917-1 [3042194]
1.2e+00
2.7e+00
4.1e+00
—
4.6e+00
2.5e+00
2.3e+00
cases:1.39%
controls:0.42%
cases:2.73%
controls:0.19%
cases:1.51%
controls:0.03%
—
—
cases:3.00%
controls:0.03%
cases:2.14%
controls:0.18%
cases:5.57%
controls:0.60%
94
286
6651
67091
184
125
6565
67289
102
18
6647
67396
—
196
20
6332
67196
129
115
5888
64439
246
306
4169
50480
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 [3027544]
539-7 [3027544]
1.0e+00
2.5e+00
4.4e+00
1.0e+50
5.2e+00
2.1e+00
2.1e+00
cases:0.70%
controls:0.25%
cases:1.07%
controls:0.09%
cases:0.83%
controls:0.01%
cases:0.25%
controls:0.00%
cases:1.32%
controls:0.01%
cases:0.80%
controls:0.09%
cases:2.36%
controls:0.29%
47
168
6698
67209
72
62
6677
67352
56
7
6693
67407
17
0
6732
67414
86
5
6442
67211
48
61
5969
64493
104
147
4311
50639
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
7.5e-01
2.1e+00
3.3e+00
6.1e+00
2.4e+00
1.5e+00
1.1e+00
cases:9.68%
controls:4.81%
cases:13.35%
controls:1.77%
cases:5.26%
controls:0.21%
cases:3.82%
controls:0.01%
cases:2.50%
controls:0.23%
cases:8.39%
controls:1.91%
cases:16.15%
controls:6.05%
653
3238
6092
64139
901
1194
5848
66220
355
141
6394
67273
258
6
6491
67408
163
157
6365
67059
505
1233
5512
63321
713
3072
3702
47714
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.0e+00
2.4e+00
4.7e+00
1.0e+50
3.3e+00
3.2e+00
2.7e+00
cases:6.27%
controls:2.33%
cases:6.21%
controls:0.63%
cases:4.87%
controls:0.05%
cases:2.93%
controls:0.00%
cases:1.29%
controls:0.05%
cases:10.47%
controls:0.45%
cases:16.42%
controls:1.37%
423
1570
6322
65807
419
422
6330
66992
329
33
6420
67381
198
0
6551
67414
84
32
6444
67184
630
293
5387
64261
725
695
3690
50091
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.0e+00
2.4e+00
4.7e+00
1.0e+50
3.3e+00
3.2e+00
2.7e+00
cases:6.27%
controls:2.33%
cases:6.21%
controls:0.63%
cases:4.87%
controls:0.05%
cases:2.93%
controls:0.00%
cases:1.29%
controls:0.05%
cases:10.47%
controls:0.45%
cases:16.42%
controls:1.37%
423
1570
6322
65807
419
422
6330
66992
329
33
6420
67381
198
0
6551
67414
84
32
6444
67184
630
293
5387
64261
725
695
3690
50091
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.0e+00
2.4e+00
4.7e+00
1.0e+50
3.3e+00
3.2e+00
2.7e+00
cases:6.27%
controls:2.33%
cases:6.21%
controls:0.63%
cases:4.87%
controls:0.05%
cases:2.93%
controls:0.00%
cases:1.29%
controls:0.05%
cases:10.47%
controls:0.45%
cases:16.42%
controls:1.37%
423
1570
6322
65807
419
422
6330
66992
329
33
6420
67381
198
0
6551
67414
84
32
6444
67184
630
293
5387
64261
725
695
3690
50091
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.0e+00
2.4e+00
4.7e+00
1.0e+50
3.3e+00
3.2e+00
2.7e+00
cases:6.27%
controls:2.33%
cases:6.21%
controls:0.63%
cases:4.87%
controls:0.05%
cases:2.93%
controls:0.00%
cases:1.29%
controls:0.05%
cases:10.47%
controls:0.45%
cases:16.42%
controls:1.37%
423
1570
6322
65807
419
422
6330
66992
329
33
6420
67381
198
0
6551
67414
84
32
6444
67184
630
293
5387
64261
725
695
3690
50091
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.0e+00
2.4e+00
4.7e+00
1.0e+50
3.3e+00
3.2e+00
2.7e+00
cases:6.27%
controls:2.33%
cases:6.21%
controls:0.63%
cases:4.87%
controls:0.05%
cases:2.93%
controls:0.00%
cases:1.29%
controls:0.05%
cases:10.47%
controls:0.45%
cases:16.42%
controls:1.37%
423
1570
6322
65807
419
422
6330
66992
329
33
6420
67381
198
0
6551
67414
84
32
6444
67184
630
293
5387
64261
725
695
3690
50091
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
J01EE01 [21602961]
1.1e+00
1.8e+00
2.3e+00
3.0e+00
3.8e+00
2.8e+00
2.2e+00
cases:1.75%
controls:0.61%
cases:1.85%
controls:0.31%
cases:0.77%
controls:0.07%
cases:0.15%
controls:0.01%
cases:2.82%
controls:0.07%
cases:5.07%
controls:0.32%
cases:6.57%
controls:0.78%
118
414
6627
66963
125
207
6624
67207
52
50
6697
67364
10
5
6739
67409
184
44
6344
67172
305
209
5712
64345
290
396
4125
50390
Nonfamilial hypogammaglobulinaemia
D80.1 [45533001]
D80.1 [45533001]
2.8e+00
2.5e+00
2.4e+00
1.0e+50
2.2e+00
3.3e+00
3.7e+00
cases:0.31%
controls:0.02%
cases:0.19%
controls:0.02%
cases:0.12%
controls:0.01%
cases:0.18%
controls:0.00%
cases:0.09%
controls:0.01%
cases:0.38%
controls:0.01%
cases:0.57%
controls:0.01%
21
13
6724
67364
13
11
6736
67403
8
7
6741
67407
12
0
6737
67414
6
7
6522
67209
23
9
5994
64545
25
7
4390
50779
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
6.0e-01
1.5e+00
3.1e+00
5.9e+00
3.3e+00
1.4e+00
1.0e+00
cases:3.28%
controls:1.83%
cases:5.04%
controls:1.18%
cases:3.35%
controls:0.15%
cases:2.61%
controls:0.01%
cases:3.69%
controls:0.14%
cases:5.43%
controls:1.38%
cases:13.00%
controls:5.03%
221
1234
6524
66143
340
793
6409
66621
226
101
6523
67313
176
5
6573
67409
241
94
6287
67122
327
893
5690
63661
574
2552
3841
48234
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
4498-2 [3017766]
1.1e+00
2.1e+00
4.2e+00
1.0e+50
4.6e+00
3.0e+00
1.9e+00
cases:1.56%
controls:0.52%
cases:1.70%
controls:0.21%
cases:0.93%
controls:0.01%
cases:0.28%
controls:0.00%
cases:1.59%
controls:0.02%
cases:2.88%
controls:0.15%
cases:3.87%
controls:0.58%
105
353
6640
67024
115
144
6634
67270
63
10
6686
67404
19
0
6730
67414
104
11
6424
67205
173
99
5844
64455
171
296
4244
50490
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
8.5e-01
1.7e+00
2.2e+00
4.4e+00
3.4e+00
2.5e+00
1.9e+00
cases:25.09%
controls:12.56%
cases:25.09%
controls:5.84%
cases:8.74%
controls:1.07%
cases:4.10%
controls:0.05%
cases:23.97%
controls:1.08%
cases:43.98%
controls:6.06%
cases:49.45%
controls:13.23%
1692
8464
5053
58913
1693
3938
5056
63476
590
719
6159
66695
277
36
6472
67378
1565
729
4963
66487
2646
3912
3371
60642
2183
6720
2232
44066
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
2465-3 [3005719]
1.1e+00
1.9e+00
2.9e+00
3.3e+00
3.3e+00
2.4e+00
1.9e+00
cases:4.27%
controls:1.46%
cases:4.67%
controls:0.72%
cases:1.91%
controls:0.10%
cases:0.25%
controls:0.01%
cases:2.50%
controls:0.10%
cases:6.80%
controls:0.69%
cases:11.05%
controls:1.84%
288
987
6457
66390
315
487
6434
66927
129
69
6620
67345
17
6
6732
67408
163
66
6365
67150
409
444
5608
64110
488
935
3927
49851
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
8.4e-01
1.7e+00
2.2e+00
4.4e+00
3.4e+00
2.5e+00
1.9e+00
cases:25.09%
controls:12.61%
cases:25.11%
controls:5.86%
cases:8.74%
controls:1.07%
cases:4.10%
controls:0.05%
cases:23.97%
controls:1.09%
cases:44.01%
controls:6.09%
cases:49.49%
controls:13.30%
1692
8497
5053
58880
1695
3951
5054
63463
590
719
6159
66695
277
36
6472
67378
1565
731
4963
66485
2648
3930
3369
60624
2185
6754
2230
44032
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
4485-9 [3000620]
1.1e+00
2.1e+00
4.2e+00
1.0e+50
4.6e+00
2.9e+00
1.9e+00
cases:1.59%
controls:0.54%
cases:1.72%
controls:0.22%
cases:0.95%
controls:0.01%
cases:0.28%
controls:0.00%
cases:1.58%
controls:0.02%
cases:2.83%
controls:0.16%
cases:3.87%
controls:0.60%
107
363
6638
67014
116
145
6633
67269
64
10
6685
67404
19
0
6730
67414
103
11
6425
67205
170
102
5847
64452
171
305
4244
50481
Spirometry
127783003 [4133840]
127783003 [4133840]
8.7e-01
1.9e+00
3.0e+00
—
3.7e+00
4.0e+00
3.3e+00
cases:1.39%
controls:0.59%
cases:1.23%
controls:0.19%
cases:0.46%
controls:0.02%
—
—
cases:0.49%
controls:0.01%
cases:6.78%
controls:0.14%
cases:9.51%
controls:0.39%
94
397
6651
66980
83
130
6666
67284
31
16
6718
67398
—
32
8
6496
67208
408
89
5609
64465
420
197
3995
50589
Parainfluenza type 4 nucleic acid detection
810871000000102 [44806118]
810871000000102 [44806118]
8.3e-01
2.6e+00
3.8e+00
1.0e+50
4.6e+00
2.6e+00
2.3e+00
cases:0.46%
controls:0.20%
cases:1.02%
controls:0.08%
cases:0.55%
controls:0.01%
cases:0.39%
controls:0.00%
cases:1.26%
controls:0.01%
cases:1.10%
controls:0.08%
cases:2.97%
controls:0.32%
31
136
6714
67241
69
54
6680
67360
37
8
6712
67406
26
0
6723
67414
82
9
6446
67207
66
54
5951
64500
131
161
4284
50625
Parainfluenza type 1 nucleic acid detection
222341000000100 [44790047]
222341000000100 [44790047]
8.3e-01
2.6e+00
3.8e+00
1.0e+50
4.6e+00
2.6e+00
2.3e+00
cases:0.46%
controls:0.20%
cases:1.02%
controls:0.08%
cases:0.55%
controls:0.01%
cases:0.39%
controls:0.00%
cases:1.26%
controls:0.01%
cases:1.10%
controls:0.08%
cases:2.97%
controls:0.32%
31
136
6714
67241
69
54
6680
67360
37
8
6712
67406
26
0
6723
67414
82
9
6446
67207
66
54
5951
64500
131
161
4284
50625
Parainfluenza type 2 nucleic acid detection
222351000000102 [44790048]
222351000000102 [44790048]
8.3e-01
2.6e+00
3.8e+00
1.0e+50
4.6e+00
2.6e+00
2.3e+00
cases:0.46%
controls:0.20%
cases:1.02%
controls:0.08%
cases:0.55%
controls:0.01%
cases:0.39%
controls:0.00%
cases:1.26%
controls:0.01%
cases:1.10%
controls:0.08%
cases:2.97%
controls:0.32%
31
136
6714
67241
69
54
6680
67360
37
8
6712
67406
26
0
6723
67414
82
9
6446
67207
66
54
5951
64500
131
161
4284
50625
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
222361000000104 [44790049]
8.3e-01
2.6e+00
3.8e+00
1.0e+50
4.6e+00
2.6e+00
2.3e+00
cases:0.46%
controls:0.20%
cases:1.02%
controls:0.08%
cases:0.55%
controls:0.01%
cases:0.39%
controls:0.00%
cases:1.26%
controls:0.01%
cases:1.10%
controls:0.08%
cases:2.97%
controls:0.32%
31
136
6714
67241
69
54
6680
67360
37
8
6712
67406
26
0
6723
67414
82
9
6446
67207
66
54
5951
64500
131
161
4284
50625
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
29953-7 [3037522]
7.8e-01
2.2e+00
4.9e+00
—
4.7e+00
2.5e+00
1.5e+00
cases:5.37%
controls:2.53%
cases:7.28%
controls:0.88%
cases:8.58%
controls:0.07%
—
—
cases:7.31%
controls:0.07%
cases:8.69%
controls:0.77%
cases:11.64%
controls:2.77%
362
1704
6383
65673
491
593
6258
66821
579
49
6170
67365
—
477
49
6051
67167
523
495
5494
64059
514
1408
3901
49378
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
5.6e-01
1.4e+00
3.1e+00
5.9e+00
3.1e+00
1.3e+00
1.0e+00
cases:4.76%
controls:2.77%
cases:6.67%
controls:1.67%
cases:4.47%
controls:0.21%
cases:3.10%
controls:0.01%
cases:4.44%
controls:0.21%
cases:6.61%
controls:1.88%
cases:16.26%
controls:6.46%
321
1868
6424
65509
450
1124
6299
66290
302
140
6447
67274
209
6
6540
67408
290
142
6238
67074
398
1215
5619
63339
718
3283
3697
47503
IgG subclass 4 [Mass/volume] in Serum
2469-5 [3024980]
2469-5 [3024980]
9.6e-01
2.5e+00
4.5e+00
—
3.9e+00
2.6e+00
1.8e+00
cases:0.79%
controls:0.30%
cases:1.23%
controls:0.10%
cases:0.83%
controls:0.01%
—
—
cases:0.69%
controls:0.01%
cases:1.46%
controls:0.11%
cases:1.90%
controls:0.33%
53
203
6692
67174
83
70
6666
67344
56
6
6693
67408
—
45
9
6483
67207
88
69
5929
64485
84
170
4331
50616
Rheumatology
66 [38004491]
66 [38004491]
1.2e+00
1.8e+00
2.3e+00
4.0e+00
2.5e+00
2.4e+00
2.0e+00
cases:10.38%
controls:3.31%
cases:10.51%
controls:1.87%
cases:3.36%
controls:0.35%
cases:1.23%
controls:0.02%
cases:4.38%
controls:0.37%
cases:16.24%
controls:1.74%
cases:19.52%
controls:3.15%
700
2230
6045
65147
709
1258
6040
66156
227
236
6522
67178
83
15
6666
67399
286
246
6242
66970
977
1122
5040
63432
862
1598
3553
49188
Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
61366-1 [40764127]
61366-1 [40764127]
1.9e+00
3.3e+00
—
—
5.1e+00
3.3e+00
2.7e+00
cases:0.42%
controls:0.06%
cases:0.98%
controls:0.04%
—
—
—
—
cases:1.38%
controls:0.01%
cases:0.91%
controls:0.03%
cases:1.68%
controls:0.11%
28
42
6717
67335
66
25
6683
67389
—
—
90
6
6438
67210
55
22
5962
64532
74
56
4341
50730
Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29723-4 [3037875]
29723-4 [3037875]
1.9e+00
3.3e+00
—
—
5.1e+00
3.3e+00
2.6e+00
cases:0.42%
controls:0.06%
cases:1.01%
controls:0.04%
—
—
—
—
cases:1.39%
controls:0.01%
cases:0.91%
controls:0.04%
cases:1.68%
controls:0.12%
28
42
6717
67335
68
25
6681
67389
—
—
91
6
6437
67210
55
23
5962
64531
74
62
4341
50724
Sarcoidosis of lung
D86.0 [45576422]
D86.0 [45576422]
1.5e+00
2.2e+00
3.0e+00
1.0e+50
3.4e+00
3.0e+00
2.9e+00
cases:0.47%
controls:0.11%
cases:0.52%
controls:0.06%
cases:0.18%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.28%
controls:0.01%
cases:1.03%
controls:0.05%
cases:1.54%
controls:0.09%
32
74
6713
67303
35
38
6714
67376
12
6
6737
67408
13
0
6736
67414
18
6
6510
67210
62
33
5955
64521
68
44
4347
50742
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
3.7e-01
1.2e+00
3.0e+00
5.4e+00
3.1e+00
1.7e+00
1.1e+00
cases:3.62%
controls:2.52%
cases:3.81%
controls:1.16%
cases:2.22%
controls:0.11%
cases:2.80%
controls:0.01%
cases:2.90%
controls:0.13%
cases:6.07%
controls:1.12%
cases:12.10%
controls:4.24%
244
1700
6501
65677
257
782
6492
66632
150
75
6599
67339
189
9
6560
67405
189
88
6339
67128
365
725
5652
63829
534
2153
3881
48633
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
3.7e-01
1.2e+00
3.0e+00
5.4e+00
3.1e+00
1.7e+00
1.2e+00
cases:3.62%
controls:2.52%
cases:3.82%
controls:1.18%
cases:2.24%
controls:0.12%
cases:2.84%
controls:0.01%
cases:2.93%
controls:0.14%
cases:6.25%
controls:1.15%
cases:12.37%
controls:4.22%
244
1697
6501
65680
258
796
6491
66618
151
79
6598
67335
192
9
6557
67405
191
91
6337
67125
376
740
5641
63814
546
2143
3869
48643
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
3.7e-01
1.2e+00
3.0e+00
5.4e+00
3.1e+00
1.7e+00
1.2e+00
cases:3.62%
controls:2.52%
cases:3.82%
controls:1.18%
cases:2.24%
controls:0.12%
cases:2.86%
controls:0.01%
cases:2.93%
controls:0.14%
cases:6.25%
controls:1.15%
cases:12.37%
controls:4.22%
244
1697
6501
65680
258
797
6491
66617
151
79
6598
67335
193
9
6556
67405
191
92
6337
67124
376
740
5641
63814
546
2142
3869
48644
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
3.6e-01
1.2e+00
2.9e+00
5.8e+00
3.0e+00
1.6e+00
9.9e-01
cases:3.14%
controls:2.21%
cases:3.24%
controls:1.02%
cases:1.79%
controls:0.10%
cases:2.30%
controls:0.01%
cases:2.18%
controls:0.11%
cases:4.85%
controls:1.01%
cases:9.85%
controls:3.91%
212
1489
6533
65888
219
685
6530
66729
121
65
6628
67349
155
5
6594
67409
142
75
6386
67141
292
654
5725
63900
435
1985
3980
48801
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
3.5e-01
1.2e+00
3.0e+00
5.4e+00
3.1e+00
1.7e+00
1.2e+00
cases:3.54%
controls:2.52%
cases:3.79%
controls:1.18%
cases:2.16%
controls:0.11%
cases:2.79%
controls:0.01%
cases:2.80%
controls:0.13%
cases:6.00%
controls:1.15%
cases:12.34%
controls:4.24%
239
1697
6506
65680
256
797
6493
66617
146
77
6603
67337
188
9
6561
67405
183
88
6345
67128
361
743
5656
63811
545
2151
3870
48635
CR(E)ST syndrome
M34.1 [45582129]
M34.1 [45582129]
2.1e+00
2.4e+00
2.8e+00
1.0e+50
3.2e+00
2.7e+00
2.5e+00
cases:0.40%
controls:0.05%
cases:0.50%
controls:0.05%
cases:0.18%
controls:0.01%
cases:0.27%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.65%
controls:0.04%
cases:0.86%
controls:0.07%
27
33
6718
67344
34
32
6715
67382
12
7
6737
67407
18
0
6731
67414
14
6
6514
67210
39
28
5978
64526
38
36
4377
50750
Streptococcus pneumoniae Ag [Presence] in Urine
24027-5 [3011363]
24027-5 [3011363]
1.1e+00
2.6e+00
4.1e+00
—
4.2e+00
2.2e+00
1.5e+00
cases:0.34%
controls:0.11%
cases:0.70%
controls:0.05%
cases:0.43%
controls:0.01%
—
—
cases:0.58%
controls:0.01%
cases:0.53%
controls:0.06%
cases:1.04%
controls:0.23%
23
75
6722
67302
47
36
6702
67378
29
5
6720
67409
—
38
6
6490
67210
32
39
5985
64515
46
115
4369
50671
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
5.2e-01
1.2e+00
2.9e+00
5.0e+00
3.0e+00
1.7e+00
1.3e+00
cases:1.69%
controls:1.01%
cases:1.79%
controls:0.53%
cases:0.90%
controls:0.05%
cases:1.07%
controls:0.01%
cases:1.24%
controls:0.07%
cases:2.84%
controls:0.53%
cases:6.80%
controls:1.95%
114
679
6631
66698
121
357
6628
67057
61
33
6688
67381
72
5
6677
67409
81
44
6447
67172
171
340
5846
64214
300
989
4115
49797
Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49672-9 [3032699]
49672-9 [3032699]
1.6e+00
3.3e+00
—
—
5.1e+00
3.1e+00
2.3e+00
cases:0.42%
controls:0.08%
cases:1.08%
controls:0.04%
—
—
—
—
cases:1.42%
controls:0.01%
cases:0.96%
controls:0.04%
cases:1.72%
controls:0.17%
28
54
6717
67323
73
26
6676
67388
—
—
93
6
6435
67210
58
27
5959
64527
76
85
4339
50701
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
1.0e+00
2.3e+00
3.8e+00
—
3.3e+00
2.9e+00
2.3e+00
cases:1.48%
controls:0.55%
cases:3.24%
controls:0.33%
cases:1.73%
controls:0.04%
—
—
cases:0.75%
controls:0.03%
cases:5.47%
controls:0.33%
cases:8.72%
controls:0.98%
100
371
6645
67006
219
221
6530
67193
117
26
6632
67388
—
49
19
6479
67197
329
214
5688
64340
385
500
4030
50286
Mycobacterium sp identified in Specimen
40699-1 [3042631]
40699-1 [3042631]
1.4e+00
2.9e+00
—
—
5.6e+00
3.1e+00
2.4e+00
cases:1.20%
controls:0.30%
cases:1.90%
controls:0.10%
—
—
—
—
cases:2.83%
controls:0.01%
cases:2.16%
controls:0.10%
cases:3.15%
controls:0.30%
81
199
6664
67178
128
70
6621
67344
—
—
185
7
6343
67209
130
66
5887
64488
139
153
4276
50633
Pleural plaque with presence of asbestos
J92.0 [45567277]
J92.0 [45567277]
1.5e+00
2.0e+00
2.9e+00
—
3.5e+00
3.1e+00
2.4e+00
cases:1.82%
controls:0.42%
cases:1.36%
controls:0.19%
cases:0.62%
controls:0.03%
—
—
cases:1.23%
controls:0.04%
cases:3.69%
controls:0.17%
cases:4.62%
controls:0.43%
123
280
6622
67097
92
129
6657
67285
42
23
6707
67391
—
80
26
6448
67190
222
108
5795
64446
204
216
4211
50570
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
2742-5 [3034780]
7.6e-01
2.3e+00
4.6e+00
—
4.0e+00
2.3e+00
1.4e+00
cases:1.87%
controls:0.88%
cases:3.29%
controls:0.34%
cases:3.14%
controls:0.03%
—
—
cases:2.31%
controls:0.04%
cases:2.93%
controls:0.31%
cases:3.58%
controls:0.91%
126
593
6619
66784
222
228
6527
67186
212
21
6537
67393
—
151
30
6377
67186
176
203
5841
64351
158
461
4257
50325
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
2589-0 [3012110]
8.3e-01
2.2e+00
4.2e+00
1.0e+50
4.0e+00
2.3e+00
1.7e+00
cases:1.25%
controls:0.55%
cases:2.13%
controls:0.23%
cases:1.79%
controls:0.03%
cases:0.12%
controls:0.00%
cases:1.47%
controls:0.03%
cases:1.81%
controls:0.18%
cases:2.76%
controls:0.54%
84
369
6661
67008
144
155
6605
67259
121
18
6628
67396
8
0
6741
67414
96
18
6432
67198
109
114
5908
64440
122
275
4293
50511
Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
80721-4 [21493690]
80721-4 [21493690]
1.4e+00
2.3e+00
3.0e+00
—
3.8e+00
2.3e+00
2.5e+00
cases:0.43%
controls:0.11%
cases:0.52%
controls:0.05%
cases:0.15%
controls:0.01%
—
—
cases:0.41%
controls:0.01%
cases:0.81%
controls:0.08%
cases:1.61%
controls:0.14%
29
73
6716
67304
35
35
6714
67379
10
5
6739
67409
—
27
6
6501
67210
49
53
5968
64501
71
71
4344
50715
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
9.0e-01
2.1e+00
4.5e+00
1.0e+50
3.9e+00
2.3e+00
1.5e+00
cases:2.48%
controls:1.02%
cases:2.89%
controls:0.36%
cases:2.28%
controls:0.03%
cases:0.27%
controls:0.00%
cases:1.72%
controls:0.03%
cases:2.84%
controls:0.30%
cases:4.87%
controls:1.11%
167
689
6578
66688
195
244
6554
67170
154
17
6595
67397
18
0
6731
67414
112
23
6416
67193
171
193
5846
64361
215
563
4200
50223
Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
41005-0 [3040359]
41005-0 [3040359]
1.2e+00
2.4e+00
3.9e+00
1.0e+50
4.1e+00
1.9e+00
1.7e+00
cases:0.53%
controls:0.16%
cases:0.73%
controls:0.07%
cases:0.37%
controls:0.01%
cases:0.21%
controls:0.00%
cases:0.60%
controls:0.01%
cases:0.43%
controls:0.06%
cases:1.11%
controls:0.20%
36
111
6709
67266
49
46
6700
67368
25
5
6724
67409
14
0
6735
67414
39
7
6489
67209
26
40
5991
64514
49
103
4366
50683
Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
41003-5 [3041642]
41003-5 [3041642]
1.2e+00
2.4e+00
3.9e+00
1.0e+50
4.1e+00
1.9e+00
1.7e+00
cases:0.53%
controls:0.16%
cases:0.73%
controls:0.07%
cases:0.37%
controls:0.01%
cases:0.21%
controls:0.00%
cases:0.60%
controls:0.01%
cases:0.43%
controls:0.06%
cases:1.11%
controls:0.20%
36
111
6709
67266
49
46
6700
67368
25
5
6724
67409
14
0
6735
67414
39
7
6489
67209
26
40
5991
64514
49
103
4366
50683
Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
41009-2 [3038546]
41009-2 [3038546]
1.2e+00
2.4e+00
3.9e+00
1.0e+50
4.1e+00
1.9e+00
1.7e+00
cases:0.53%
controls:0.16%
cases:0.73%
controls:0.07%
cases:0.37%
controls:0.01%
cases:0.21%
controls:0.00%
cases:0.60%
controls:0.01%
cases:0.43%
controls:0.06%
cases:1.11%
controls:0.20%
36
111
6709
67266
49
46
6700
67368
25
5
6724
67409
14
0
6735
67414
39
7
6489
67209
26
40
5991
64514
49
103
4366
50683
Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53017-0 [3041067]
53017-0 [3041067]
1.3e+00
2.8e+00
5.5e+00
1.0e+50
—
3.3e+00
2.2e+00
cases:0.58%
controls:0.16%
cases:1.33%
controls:0.08%
cases:1.82%
controls:0.01%
cases:0.25%
controls:0.00%
—
—
cases:1.36%
controls:0.05%
cases:1.97%
controls:0.23%
39
111
6706
67266
90
56
6659
67358
123
5
6626
67409
17
0
6732
67414
—
82
32
5935
64522
87
115
4328
50671
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
1.3e+00
2.6e+00
—
1.0e+50
3.8e+00
4.2e+00
3.2e+00
cases:1.20%
controls:0.34%
cases:1.26%
controls:0.10%
—
—
cases:2.67%
controls:0.00%
cases:0.66%
controls:0.01%
cases:5.88%
controls:0.10%
cases:7.09%
controls:0.30%
81
231
6664
67146
85
65
6664
67349
—
180
0
6569
67414
43
10
6485
67206
354
62
5663
64492
313
153
4102
50633
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
6.7e-01
1.5e+00
2.9e+00
3.8e+00
2.7e+00
1.9e+00
1.5e+00
cases:15.73%
controls:8.74%
cases:18.70%
controls:5.05%
cases:16.98%
controls:1.07%
cases:2.53%
controls:0.06%
cases:12.55%
controls:0.98%
cases:26.62%
controls:5.23%
cases:36.44%
controls:11.40%
1061
5889
5684
61488
1262
3403
5487
64011
1146
722
5603
66692
171
39
6578
67375
819
660
5709
66556
1602
3379
4415
61175
1609
5788
2806
44998
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
5.7e-01
1.4e+00
3.0e+00
4.3e+00
2.8e+00
1.7e+00
1.2e+00
cases:8.26%
controls:4.85%
cases:9.71%
controls:2.64%
cases:8.53%
controls:0.48%
cases:1.17%
controls:0.02%
cases:6.83%
controls:0.44%
cases:13.59%
controls:2.69%
cases:19.50%
controls:6.96%
557
3265
6188
64112
655
1779
6094
65635
576
324
6173
67090
79
11
6670
67403
446
299
6082
66917
818
1737
5199
62817
861
3534
3554
47252
Haemoptysis
R04.2 [45577777]
R04.2 [45577777]
1.3e+00
2.6e+00
4.1e+00
1.0e+50
3.0e+00
2.4e+00
1.6e+00
cases:1.42%
controls:0.41%
cases:1.69%
controls:0.13%
cases:0.95%
controls:0.02%
cases:0.79%
controls:0.00%
cases:0.46%
controls:0.02%
cases:1.21%
controls:0.12%
cases:2.11%
controls:0.43%
96
277
6649
67100
114
87
6635
67327
64
11
6685
67403
53
0
6696
67414
30
15
6498
67201
73
75
5944
64479
93
219
4322
50567
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
5.2e-01
1.4e+00
3.1e+00
3.8e+00
2.7e+00
1.9e+00
1.4e+00
cases:20.28%
controls:13.12%
cases:26.02%
controls:7.71%
cases:24.42%
controls:1.50%
cases:3.36%
controls:0.07%
cases:17.45%
controls:1.44%
cases:37.09%
controls:7.96%
cases:48.45%
controls:18.27%
1368
8843
5377
58534
1756
5196
4993
62218
1648
1009
5101
66405
227
50
6522
67364
1139
966
5389
66250
2232
5136
3785
59418
2139
9279
2276
41507
Emphysema, unspecified
J43.9 [45567264]
J43.9 [45567264]
1.3e+00
2.0e+00
2.3e+00
1.0e+50
3.9e+00
3.0e+00
2.3e+00
cases:0.55%
controls:0.15%
cases:0.53%
controls:0.07%
cases:0.19%
controls:0.02%
cases:1.39%
controls:0.00%
cases:0.70%
controls:0.01%
cases:1.88%
controls:0.09%
cases:2.42%
controls:0.24%
37
101
6708
67276
36
47
6713
67367
13
13
6736
67401
94
0
6655
67414
46
10
6482
67206
113
59
5904
64495
107
121
4308
50665
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
5.3e-01
1.4e+00
3.1e+00
3.8e+00
2.7e+00
1.9e+00
1.4e+00
cases:21.29%
controls:13.76%
cases:26.91%
controls:8.03%
cases:25.28%
controls:1.57%
cases:3.47%
controls:0.08%
cases:18.11%
controls:1.52%
cases:38.14%
controls:8.24%
cases:49.33%
controls:18.87%
1436
9272
5309
58105
1816
5413
4933
62001
1706
1058
5043
66356
234
52
6515
67362
1182
1021
5346
66195
2295
5320
3722
59234
2178
9581
2237
41205
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
5.4e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:19.79%
controls:12.55%
cases:24.71%
controls:7.32%
cases:23.03%
controls:1.47%
cases:3.22%
controls:0.07%
cases:16.61%
controls:1.39%
cases:35.13%
controls:7.49%
cases:46.02%
controls:16.85%
1335
8453
5410
58924
1668
4935
5081
62479
1554
993
5195
66421
217
44
6532
67370
1084
935
5444
66281
2114
4832
3903
59722
2032
8555
2383
42231
CD3 cells/Lymphocytes in Blood
90304-7 [1175426]
90304-7 [1175426]
1.3e+00
2.3e+00
3.1e+00
—
3.5e+00
2.3e+00
2.5e+00
cases:0.40%
controls:0.11%
cases:0.52%
controls:0.05%
cases:0.19%
controls:0.01%
—
—
cases:0.43%
controls:0.01%
cases:0.83%
controls:0.09%
cases:1.65%
controls:0.14%
27
71
6718
67306
35
37
6714
67377
13
6
6736
67408
—
28
9
6500
67207
50
56
5967
64498
73
72
4342
50714
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
5.5e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:19.87%
controls:12.56%
cases:24.76%
controls:7.32%
cases:23.10%
controls:1.47%
cases:3.23%
controls:0.07%
cases:16.61%
controls:1.40%
cases:35.20%
controls:7.49%
cases:46.09%
controls:16.85%
1340
8465
5405
58912
1671
4936
5078
62478
1559
994
5190
66420
218
45
6531
67369
1084
939
5444
66277
2118
4832
3899
59722
2035
8559
2380
42227
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
5.2e-01
1.4e+00
3.1e+00
3.8e+00
2.7e+00
1.9e+00
1.4e+00
cases:20.34%
controls:13.21%
cases:26.00%
controls:7.75%
cases:24.42%
controls:1.50%
cases:3.36%
controls:0.07%
cases:17.45%
controls:1.44%
cases:37.08%
controls:7.99%
cases:48.52%
controls:18.37%
1372
8898
5373
58479
1755
5223
4994
62191
1648
1012
5101
66402
227
50
6522
67364
1139
970
5389
66246
2231
5157
3786
59397
2142
9328
2273
41458
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
5.4e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:19.70%
controls:12.48%
cases:24.67%
controls:7.30%
cases:23.13%
controls:1.47%
cases:3.23%
controls:0.07%
cases:16.53%
controls:1.40%
cases:35.17%
controls:7.48%
cases:45.96%
controls:16.87%
1329
8412
5416
58965
1665
4923
5084
62491
1561
992
5188
66422
218
45
6531
67369
1079
938
5449
66278
2116
4828
3901
59726
2029
8566
2386
42220
rituximab
L01FA01 [955167]
L01FA01 [955167]
1.7e+00
2.2e+00
2.9e+00
—
2.2e+00
2.9e+00
2.9e+00
cases:0.76%
controls:0.14%
cases:0.61%
controls:0.07%
cases:0.16%
controls:0.01%
—
—
cases:0.17%
controls:0.02%
cases:1.15%
controls:0.07%
cases:2.24%
controls:0.12%
51
94
6694
67283
41
46
6708
67368
11
6
6738
67408
—
11
12
6517
67204
69
43
5948
64511
99
61
4316
50725
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
5.0e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:20.74%
controls:13.71%
cases:26.33%
controls:8.04%
cases:24.45%
controls:1.54%
cases:3.41%
controls:0.07%
cases:17.54%
controls:1.50%
cases:37.23%
controls:8.27%
cases:48.63%
controls:18.89%
1399
9240
5346
58137
1777
5417
4972
61997
1650
1041
5099
66373
230
49
6519
67365
1145
1007
5383
66209
2240
5337
3777
59217
2147
9594
2268
41192
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
5.2e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:19.75%
controls:12.80%
cases:24.88%
controls:7.50%
cases:23.19%
controls:1.50%
cases:3.26%
controls:0.07%
cases:16.62%
controls:1.43%
cases:35.30%
controls:7.72%
cases:46.14%
controls:17.37%
1332
8626
5413
58751
1679
5059
5070
62355
1565
1010
5184
66404
220
45
6529
67369
1085
964
5443
66252
2124
4984
3893
59570
2037
8824
2378
41962
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
1.1e+00
2.1e+00
3.4e+00
—
3.1e+00
2.5e+00
2.5e+00
cases:1.42%
controls:0.47%
cases:1.07%
controls:0.13%
cases:0.74%
controls:0.03%
—
—
cases:0.51%
controls:0.02%
cases:1.33%
controls:0.11%
cases:2.72%
controls:0.23%
96
317
6649
67060
72
88
6677
67326
50
17
6699
67397
—
33
15
6495
67201
80
73
5937
64481
120
118
4295
50668
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
5.1e-01
1.4e+00
3.0e+00
3.9e+00
2.6e+00
1.9e+00
1.4e+00
cases:19.14%
controls:12.46%
cases:23.78%
controls:7.30%
cases:22.21%
controls:1.43%
cases:3.11%
controls:0.06%
cases:15.96%
controls:1.38%
cases:34.15%
controls:7.51%
cases:45.30%
controls:17.00%
1291
8392
5454
58985
1605
4918
5144
62496
1499
965
5250
66449
210
43
6539
67371
1042
929
5486
66287
2055
4845
3962
59709
2000
8633
2415
42153
CD3-CD16+CD56+ (Natural killer) cells/cells in Blood
8112-5 [3027831]
8112-5 [3027831]
1.4e+00
2.3e+00
2.8e+00
—
3.4e+00
2.2e+00
2.5e+00
cases:0.40%
controls:0.10%
cases:0.50%
controls:0.05%
cases:0.15%
controls:0.01%
—
—
cases:0.41%
controls:0.01%
cases:0.78%
controls:0.09%
cases:1.61%
controls:0.14%
27
68
6718
67309
34
35
6715
67379
10
6
6739
67408
—
27
9
6501
67207
47
55
5970
64499
71
69
4344
50717
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
4.8e-01
1.3e+00
2.9e+00
4.4e+00
2.9e+00
1.4e+00
1.1e+00
cases:2.19%
controls:1.38%
cases:2.87%
controls:0.79%
cases:1.82%
controls:0.10%
cases:0.74%
controls:0.01%
cases:2.34%
controls:0.13%
cases:3.52%
controls:0.86%
cases:6.70%
controls:2.29%
148
927
6597
66450
194
530
6555
66884
123
67
6626
67347
50
6
6699
67408
153
89
6375
67127
212
553
5805
64001
296
1162
4119
49624
CD3 cells [#/volume] in Blood
8122-4 [3011412]
8122-4 [3011412]
1.3e+00
2.2e+00
3.1e+00
—
3.3e+00
2.2e+00
2.4e+00
cases:0.58%
controls:0.17%
cases:0.76%
controls:0.08%
cases:0.24%
controls:0.01%
—
—
cases:0.46%
controls:0.02%
cases:0.95%
controls:0.11%
cases:1.83%
controls:0.17%
39
112
6706
67265
51
57
6698
67357
16
7
6733
67407
—
30
11
6498
67205
57
68
5960
64486
81
87
4334
50699
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
8.8e-01
2.2e+00
4.0e+00
1.0e+50
2.7e+00
2.6e+00
2.2e+00
cases:1.79%
controls:0.75%
cases:1.90%
controls:0.21%
cases:0.99%
controls:0.02%
cases:2.30%
controls:0.00%
cases:0.29%
controls:0.02%
cases:2.03%
controls:0.16%
cases:3.49%
controls:0.42%
121
508
6624
66869
128
142
6621
67272
67
13
6682
67401
155
0
6594
67414
19
13
6509
67203
122
102
5895
64452
154
211
4261
50575
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
4.9e-01
1.3e+00
2.9e+00
4.3e+00
2.9e+00
1.4e+00
1.1e+00
cases:2.24%
controls:1.38%
cases:2.89%
controls:0.81%
cases:1.91%
controls:0.10%
cases:0.76%
controls:0.01%
cases:2.39%
controls:0.14%
cases:3.61%
controls:0.89%
cases:6.93%
controls:2.37%
151
932
6594
66445
195
544
6554
66870
129
70
6620
67344
51
7
6698
67407
156
91
6372
67125
217
572
5800
63982
306
1206
4109
49580
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
18501-7 [3018559]
1.2e+00
2.7e+00
—
1.0e+50
5.8e+00
2.8e+00
1.8e+00
cases:0.87%
controls:0.26%
cases:1.50%
controls:0.10%
—
—
cases:0.34%
controls:0.00%
cases:2.71%
controls:0.01%
cases:1.21%
controls:0.07%
cases:1.86%
controls:0.30%
59
174
6686
67203
101
66
6648
67348
—
23
0
6726
67414
177
6
6351
67210
73
46
5944
64508
82
152
4333
50634
Sicca syndrome [Sjögren]
M35.0 [45562711]
M35.0 [45562711]
1.6e+00
2.0e+00
2.5e+00
—
3.2e+00
2.7e+00
2.4e+00
cases:1.04%
controls:0.22%
cases:0.93%
controls:0.13%
cases:0.34%
controls:0.03%
—
—
cases:0.55%
controls:0.02%
cases:1.96%
controls:0.14%
cases:2.47%
controls:0.23%
70
146
6675
67231
63
87
6686
67327
23
18
6726
67396
—
36
15
6492
67201
118
88
5899
64466
109
119
4306
50667
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
113016006 [4010399]
8.4e-01
2.0e+00
4.1e+00
—
2.8e+00
2.7e+00
1.9e+00
cases:5.66%
controls:2.53%
cases:6.21%
controls:0.88%
cases:4.64%
controls:0.08%
—
—
cases:1.29%
controls:0.08%
cases:10.47%
controls:0.80%
cases:15.31%
controls:2.68%
382
1706
6363
65671
419
591
6330
66823
313
52
6436
67362
—
84
55
6444
67161
630
515
5387
64039
676
1360
3739
49426
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
53027-9 [3041942]
6.1e-01
2.0e+00
4.5e+00
—
4.3e+00
1.9e+00
9.8e-01
cases:5.47%
controls:3.04%
cases:6.56%
controls:0.94%
cases:7.04%
controls:0.08%
—
—
cases:6.30%
controls:0.09%
cases:5.98%
controls:0.97%
cases:8.86%
controls:3.51%
369
2048
6376
65329
443
637
6306
66777
475
54
6274
67360
—
411
61
6117
67155
360
626
5657
63928
391
1782
4024
49004
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
1.0e+00
2.1e+00
4.0e+00
—
3.3e+00
2.2e+00
1.7e+00
cases:2.80%
controls:1.02%
cases:2.59%
controls:0.33%
cases:1.23%
controls:0.02%
—
—
cases:0.89%
controls:0.03%
cases:2.18%
controls:0.25%
cases:5.25%
controls:1.01%
189
688
6556
66689
175
222
6574
67192
83
15
6666
67399
—
58
23
6470
67193
131
160
5886
64394
232
512
4183
50274
Hemoglobin [Mass/volume] in Capillary blood
30352-9 [3006184]
30352-9 [3006184]
9.2e-01
1.8e+00
4.0e+00
1.0e+50
3.5e+00
2.1e+00
1.9e+00
cases:0.99%
controls:0.40%
cases:1.32%
controls:0.22%
cases:0.95%
controls:0.02%
cases:0.25%
controls:0.00%
cases:0.77%
controls:0.02%
cases:2.31%
controls:0.29%
cases:6.00%
controls:0.96%
67
268
6678
67109
89
146
6660
67268
64
12
6685
67402
17
0
6732
67414
50
15
6478
67201
139
186
5878
64368
265
487
4150
50299
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
4.7e-01
1.3e+00
2.8e+00
4.2e+00
2.8e+00
1.4e+00
1.2e+00
cases:2.15%
controls:1.35%
cases:2.55%
controls:0.70%
cases:1.48%
controls:0.09%
cases:0.61%
controls:0.01%
cases:1.91%
controls:0.12%
cases:2.97%
controls:0.73%
cases:6.09%
controls:1.96%
145
911
6600
66466
172
470
6577
66944
100
62
6649
67352
41
6
6708
67408
125
78
6403
67138
179
470
5838
64084
269
995
4146
49791
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
6.2e-01
1.3e+00
1.9e+00
5.7e+00
2.1e+00
1.6e+00
9.9e-01
cases:7.10%
controls:3.96%
cases:6.65%
controls:1.93%
cases:2.40%
controls:0.36%
cases:4.98%
controls:0.02%
cases:2.91%
controls:0.35%
cases:8.87%
controls:2.01%
cases:12.28%
controls:4.92%
479
2666
6266
64711
449
1303
6300
66111
162
241
6587
67173
336
12
6413
67402
190
235
6338
66981
534
1295
5483
63259
542
2501
3873
48285
Rheumatoid factor [Units/volume] in Serum or Plasma
11572-5 [3021614]
11572-5 [3021614]
5.4e-01
1.9e+00
4.6e+00
—
4.3e+00
1.9e+00
9.9e-01
cases:5.59%
controls:3.35%
cases:6.77%
controls:1.04%
cases:7.69%
controls:0.08%
—
—
cases:6.14%
controls:0.09%
cases:6.53%
controls:1.09%
cases:9.72%
controls:3.86%
377
2256
6368
65121
457
701
6292
66713
519
57
6230
67357
—
401
61
6127
67155
393
701
5624
63853
429
1962
3986
48824
Myeloperoxidase Ab [Units/volume] in Serum
6969-0 [3023150]
6969-0 [3023150]
1.0e+00
2.8e+00
5.5e+00
—
—
2.8e+00
2.0e+00
cases:0.85%
controls:0.31%
cases:1.88%
controls:0.11%
cases:1.72%
controls:0.01%
—
—
—
—
cases:1.68%
controls:0.10%
cases:2.58%
controls:0.36%
57
209
6688
67168
127
77
6622
67337
116
5
6633
67409
—
—
101
65
5916
64489
114
183
4301
50603
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
4.6e-01
1.2e+00
2.9e+00
4.2e+00
2.6e+00
1.5e+00
1.1e+00
cases:1.72%
controls:1.09%
cases:1.91%
controls:0.57%
cases:1.35%
controls:0.08%
cases:0.50%
controls:0.01%
cases:1.39%
controls:0.11%
cases:2.59%
controls:0.58%
cases:4.48%
controls:1.52%
116
733
6629
66644
129
386
6620
67028
91
51
6658
67363
34
5
6715
67409
91
72
6437
67144
156
376
5861
64178
198
770
4217
50016
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
5.8e-01
1.1e+00
1.6e+00
6.2e+00
2.0e+00
1.5e+00
1.0e+00
cases:4.98%
controls:2.85%
cases:4.82%
controls:1.73%
cases:1.87%
controls:0.36%
cases:4.82%
controls:0.01%
cases:2.53%
controls:0.36%
cases:7.68%
controls:1.81%
cases:9.58%
controls:3.63%
336
1918
6409
65459
325
1163
6424
66251
126
246
6623
67168
325
7
6424
67407
165
239
6363
66977
462
1166
5555
63388
423
1842
3992
48944
Bronchial lavation
TGC00 [2001303585]
TGC00 [2001303585]
2.2e+00
4.1e+00
—
—
—
4.4e+00
3.3e+00
cases:1.53%
controls:0.17%
cases:3.90%
controls:0.07%
—
—
—
—
—
—
cases:3.19%
controls:0.04%
cases:3.87%
controls:0.15%
103
117
6642
67260
263
45
6486
67369
—
—
—
192
26
5825
64528
171
78
4244
50708
Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot
56731-3 [40759850]
56731-3 [40759850]
1.5e+00
2.3e+00
—
—
4.5e+00
3.9e+00
1.7e+00
cases:0.46%
controls:0.10%
cases:0.43%
controls:0.04%
—
—
—
—
cases:0.66%
controls:0.01%
cases:1.20%
controls:0.02%
cases:1.06%
controls:0.19%
31
66
6714
67311
29
29
6720
67385
—
—
43
5
6485
67211
72
16
5945
64538
47
97
4368
50689
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
72493-0 [43055120]
1.1e+00
2.0e+00
2.8e+00
—
3.7e+00
2.3e+00
2.1e+00
cases:1.04%
controls:0.36%
cases:1.32%
controls:0.18%
cases:0.80%
controls:0.05%
—
—
cases:1.75%
controls:0.04%
cases:1.71%
controls:0.17%
cases:3.96%
controls:0.50%
70
241
6675
67136
89
124
6660
67290
54
33
6695
67381
—
114
30
6414
67186
103
112
5914
64442
175
254
4240
50532
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
1.0e+00
2.0e+00
3.3e+00
—
2.9e+00
2.4e+00
2.2e+00
cases:1.54%
controls:0.55%
cases:1.14%
controls:0.15%
cases:0.80%
controls:0.03%
—
—
cases:0.55%
controls:0.03%
cases:1.46%
controls:0.13%
cases:2.85%
controls:0.33%
104
368
6641
67009
77
104
6672
67310
54
20
6695
67394
—
36
20
6492
67196
88
85
5929
64469
126
167
4289
50619
Ribosomal P Ab [Presence] in Serum
31592-9 [3018333]
31592-9 [3018333]
1.6e+00
2.3e+00
1.0e+50
—
4.3e+00
3.9e+00
1.8e+00
cases:0.44%
controls:0.09%
cases:0.40%
controls:0.04%
cases:0.33%
controls:0.00%
—
—
cases:0.54%
controls:0.01%
cases:1.05%
controls:0.02%
cases:0.95%
controls:0.16%
30
63
6715
67314
27
27
6722
67387
22
0
6727
67414
—
35
5
6493
67211
63
14
5954
64540
42
82
4373
50704
Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
56723-0 [40759842]
56723-0 [40759842]
1.5e+00
2.3e+00
1.0e+50
—
4.3e+00
3.9e+00
1.7e+00
cases:0.44%
controls:0.10%
cases:0.40%
controls:0.04%
cases:0.33%
controls:0.00%
—
—
cases:0.55%
controls:0.01%
cases:1.06%
controls:0.02%
cases:0.95%
controls:0.17%
30
65
6715
67312
27
27
6722
67387
22
0
6727
67414
—
36
5
6492
67211
64
14
5953
64540
42
87
4373
50699
Occupatioal Medicine
901 [44777713]
901 [44777713]
1.5e+00
1.9e+00
2.4e+00
—
3.6e+00
2.9e+00
1.4e+00
cases:1.14%
controls:0.25%
cases:0.67%
controls:0.10%
cases:0.15%
controls:0.01%
—
—
cases:0.44%
controls:0.01%
cases:1.68%
controls:0.09%
cases:1.40%
controls:0.36%
77
168
6668
67209
45
70
6704
67344
10
9
6739
67405
—
29
8
6499
67208
101
59
5916
64495
62
183
4353
50603
Histone Ab [Presence] in Serum by Immunoblot
56717-2 [40759836]
56717-2 [40759836]
1.6e+00
2.3e+00
—
—
4.3e+00
3.8e+00
1.7e+00
cases:0.46%
controls:0.09%
cases:0.43%
controls:0.04%
—
—
—
—
cases:0.57%
controls:0.01%
cases:1.11%
controls:0.02%
cases:0.97%
controls:0.18%
31
64
6714
67313
29
29
6720
67385
—
—
37
5
6491
67211
67
16
5950
64538
43
93
4372
50693
Myosin Ab [Presence] in Serum or Plasma by Immunoblot
72458-3 [43055089]
72458-3 [43055089]
1.8e+00
4.0e+00
—
1.0e+50
—
4.6e+00
3.2e+00
cases:0.39%
controls:0.06%
cases:1.08%
controls:0.02%
—
—
cases:0.27%
controls:0.00%
—
—
cases:2.29%
controls:0.02%
cases:2.42%
controls:0.10%
26
43
6719
67334
73
13
6676
67401
—
18
0
6731
67414
—
138
16
5879
64538
107
49
4308
50737
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
88518-6 [36304997]
8.8e-01
2.0e+00
3.6e+00
—
3.4e+00
2.4e+00
1.4e+00
cases:1.23%
controls:0.51%
cases:1.54%
controls:0.20%
cases:0.52%
controls:0.01%
—
—
cases:0.69%
controls:0.02%
cases:1.46%
controls:0.14%
cases:2.38%
controls:0.63%
83
346
6662
67031
104
138
6645
67276
35
10
6714
67404
—
45
15
6483
67201
88
89
5929
64465
105
318
4310
50468
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.0e-01
1.0e+00
2.0e+00
4.7e+00
2.7e+00
1.7e+00
1.1e+00
cases:13.02%
controls:9.16%
cases:6.45%
controls:2.47%
cases:2.15%
controls:0.30%
cases:1.64%
controls:0.01%
cases:4.66%
controls:0.31%
cases:10.69%
controls:2.24%
cases:16.92%
controls:6.42%
878
6170
5867
61207
435
1662
6314
65752
145
199
6604
67215
111
10
6638
67404
304
210
6224
67006
643
1449
5374
63105
747
3262
3668
47524
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
3.8e-01
1.2e+00
2.8e+00
5.2e+00
2.2e+00
1.0e+00
8.0e-01
cases:9.01%
controls:6.32%
cases:10.05%
controls:3.18%
cases:6.16%
controls:0.40%
cases:4.61%
controls:0.03%
cases:4.06%
controls:0.48%
cases:9.32%
controls:3.57%
cases:21.43%
controls:10.90%
608
4258
6137
63119
678
2147
6071
65267
416
268
6333
67146
311
18
6438
67396
265
320
6263
66896
561
2307
5456
62247
946
5537
3469
45249
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
2472-9 [3028026]
1.1e+00
1.8e+00
3.0e+00
—
3.4e+00
2.3e+00
1.9e+00
cases:3.26%
controls:1.07%
cases:2.82%
controls:0.47%
cases:1.02%
controls:0.05%
—
—
cases:1.55%
controls:0.05%
cases:4.12%
controls:0.43%
cases:7.43%
controls:1.23%
220
719
6525
66658
190
318
6559
67096
69
33
6680
67381
—
101
35
6427
67181
248
279
5769
64275
328
626
4087
50160
MDA5 Ab [Presence] in Serum by Line blot
82424-3 [42529582]
82424-3 [42529582]
1.5e+00
3.8e+00
—
1.0e+50
—
4.5e+00
3.7e+00
cases:0.15%
controls:0.03%
cases:0.52%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
—
—
cases:1.26%
controls:0.01%
cases:1.47%
controls:0.04%
10
22
6735
67355
35
8
6714
67406
—
5
0
6744
67414
—
76
9
5941
64545
65
19
4350
50767
Mi-2 Ab [Presence] in Serum
18485-3 [3013637]
18485-3 [3013637]
1.5e+00
3.8e+00
—
1.0e+50
—
4.5e+00
3.7e+00
cases:0.15%
controls:0.03%
cases:0.52%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
—
—
cases:1.26%
controls:0.01%
cases:1.47%
controls:0.04%
10
22
6735
67355
35
8
6714
67406
—
5
0
6744
67414
—
76
9
5941
64545
65
19
4350
50767
SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
82440-9 [42529598]
82440-9 [42529598]
1.5e+00
3.8e+00
—
1.0e+50
—
4.5e+00
3.7e+00
cases:0.15%
controls:0.03%
cases:0.52%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
—
—
cases:1.26%
controls:0.01%
cases:1.47%
controls:0.04%
10
22
6735
67355
35
8
6714
67406
—
5
0
6744
67414
—
76
9
5941
64545
65
19
4350
50767
TIF1-gamma Ab [Presence] in Serum by Line blot
82448-2 [42528593]
82448-2 [42528593]
1.5e+00
3.8e+00
—
1.0e+50
—
4.5e+00
3.7e+00
cases:0.15%
controls:0.03%
cases:0.52%
controls:0.01%
—
—
cases:0.07%
controls:0.00%
—
—
cases:1.26%
controls:0.01%
cases:1.47%
controls:0.04%
10
22
6735
67355
35
8
6714
67406
—
5
0
6744
67414
—
76
9
5941
64545
65
19
4350
50767
Extensive high resolution CT examination of lungs
GD1ED [2001303637]
GD1ED [2001303637]
1.6e+00
3.4e+00
—
—
—
4.3e+00
4.2e+00
cases:1.53%
controls:0.32%
cases:2.53%
controls:0.08%
—
—
—
—
—
—
cases:4.22%
controls:0.06%
cases:6.86%
controls:0.11%
103
218
6642
67159
171
56
6578
67358
—
—
—
254
38
5763
64516
303
58
4112
50728
U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
59026-5 [40762119]
59026-5 [40762119]
1.1e+00
2.6e+00
—
1.0e+50
5.0e+00
3.0e+00
1.8e+00
cases:0.64%
controls:0.22%
cases:1.41%
controls:0.10%
—
—
cases:0.19%
controls:0.00%
cases:1.04%
controls:0.01%
cases:1.30%
controls:0.07%
cases:2.02%
controls:0.32%
43
145
6702
67232
95
69
6654
67345
—
13
0
6736
67414
68
5
6460
67211
78
44
5939
64510
89
165
4326
50621
Systemic sclerosis, unspecified
M34.9 [45533828]
M34.9 [45533828]
2.9e+00
3.4e+00
—
—
—
3.7e+00
3.4e+00
cases:0.44%
controls:0.02%
cases:0.43%
controls:0.01%
—
—
—
—
—
—
cases:0.58%
controls:0.01%
cases:0.77%
controls:0.03%
30
16
6715
67361
29
10
6720
67404
—
—
—
35
9
5982
64545
34
13
4381
50773
Needle biopsy of the lungs in bronchoscopy
TGD04 [2001303751]
TGD04 [2001303751]
1.8e+00
3.2e+00
—
1.0e+50
—
4.7e+00
3.7e+00
cases:0.16%
controls:0.03%
cases:0.36%
controls:0.01%
—
—
cases:0.18%
controls:0.00%
—
—
cases:0.83%
controls:0.01%
cases:2.17%
controls:0.05%
11
18
6734
67359
24
10
6725
67404
—
12
0
6737
67414
—
50
5
5967
64549
96
27
4319
50759
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
4.3e-01
1.2e+00
2.6e+00
3.8e+00
2.2e+00
1.7e+00
1.3e+00
cases:22.40%
controls:15.78%
cases:27.19%
controls:9.74%
cases:24.95%
controls:2.31%
cases:4.13%
controls:0.10%
cases:17.78%
controls:2.25%
cases:37.69%
controls:9.61%
cases:50.17%
controls:21.09%
1511
10633
5234
56744
1835
6568
4914
60846
1684
1557
5065
65857
279
68
6470
67346
1161
1512
5367
65704
2268
6206
3749
58348
2215
10713
2200
40073
Other bronchoscopic procedure on bronchus
GCA98 [2001303606]
GCA98 [2001303606]
1.7e+00
4.1e+00
—
1.0e+50
1.0e+50
4.7e+00
2.9e+00
cases:0.18%
controls:0.03%
cases:0.73%
controls:0.01%
—
—
cases:0.81%
controls:0.00%
cases:1.56%
controls:0.00%
cases:0.85%
controls:0.01%
cases:0.82%
controls:0.05%
12
23
6733
67354
49
8
6700
67406
—
55
0
6694
67414
102
0
6426
67216
51
5
5966
64549
36
23
4379
50763
Centromere protein B Ab [Units/volume] in Serum
53982-5 [3039162]
53982-5 [3039162]
1.1e+00
2.6e+00
—
1.0e+50
4.7e+00
3.2e+00
1.8e+00
cases:0.55%
controls:0.18%
cases:1.01%
controls:0.08%
—
—
cases:0.10%
controls:0.00%
cases:0.98%
controls:0.01%
cases:1.46%
controls:0.06%
cases:1.74%
controls:0.30%
37
122
6708
67255
68
51
6681
67363
—
7
0
6742
67414
64
6
6464
67210
88
40
5929
64514
77
152
4338
50634
Pneumonia due to Pneumocystis carinii
J17.3*B59 [2000502585]
J17.3*B59 [2000502585]
2.3e+00
3.2e+00
1.0e+50
1.0e+50
—
4.6e+00
3.2e+00
cases:0.19%
controls:0.02%
cases:0.28%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.36%
controls:0.00%
—
—
cases:0.80%
controls:0.01%
cases:0.70%
controls:0.03%
13
13
6732
67364
19
8
6730
67406
9
0
6740
67414
24
0
6725
67414
—
48
5
5969
64549
31
14
4384
50772
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
5.4e-01
1.4e+00
3.1e+00
4.6e+00
1.5e+00
1.3e+00
9.0e-01
cases:3.05%
controls:1.81%
cases:2.65%
controls:0.68%
cases:1.62%
controls:0.07%
cases:0.87%
controls:0.01%
cases:0.44%
controls:0.10%
cases:2.59%
controls:0.69%
cases:5.78%
controls:2.44%
206
1220
6539
66157
179
456
6570
66958
109
48
6640
67366
59
6
6690
67408
29
70
6499
67146
156
445
5861
64109
255
1238
4160
49548
Aldolase [Enzymatic activity/volume] in Serum or Plasma
1761-6 [3027953]
1761-6 [3027953]
1.3e-01
2.1e+00
2.8e+00
—
3.2e+00
3.1e+00
2.2e+00
cases:0.15%
controls:0.13%
cases:0.30%
controls:0.04%
cases:0.12%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.88%
controls:0.04%
cases:1.04%
controls:0.12%
10
88
6735
67289
20
24
6729
67390
8
5
6741
67409
—
14
6
6514
67210
53
27
5964
64527
46
59
4369
50727
Nuclear Ab [Presence] in Serum
8061-4 [3004616]
8061-4 [3004616]
8.3e-01
2.5e+00
5.1e+00
1.0e+50
—
2.8e+00
2.1e+00
cases:0.53%
controls:0.23%
cases:1.30%
controls:0.11%
cases:1.69%
controls:0.01%
cases:0.24%
controls:0.00%
—
—
cases:1.08%
controls:0.07%
cases:1.77%
controls:0.21%
36
157
6709
67220
88
72
6661
67342
114
7
6635
67407
16
0
6733
67414
—
65
45
5952
64509
78
109
4337
50677
Bronchiectasis
J47 [45605889]
J47 [45605889]
1.4e+00
1.7e+00
2.8e+00
1.0e+50
3.0e+00
2.4e+00
2.1e+00
cases:1.11%
controls:0.28%
cases:0.99%
controls:0.19%
cases:0.58%
controls:0.04%
cases:1.44%
controls:0.00%
cases:0.93%
controls:0.05%
cases:2.11%
controls:0.20%
cases:2.74%
controls:0.34%
75
191
6670
67186
67
129
6682
67285
39
25
6710
67389
97
0
6652
67414
61
32
6467
67184
127
132
5890
64422
121
174
4294
50612
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
48065-7 [3051714]
3.8e-01
1.2e+00
2.8e+00
4.9e+00
2.0e+00
1.1e+00
7.5e-01
cases:6.49%
controls:4.55%
cases:5.42%
controls:1.67%
cases:2.27%
controls:0.13%
cases:0.99%
controls:0.01%
cases:1.15%
controls:0.16%
cases:4.92%
controls:1.65%
cases:12.12%
controls:6.11%
438
3068
6307
64309
366
1127
6383
66287
153
91
6596
67323
67
5
6682
67409
75
109
6453
67107
296
1067
5721
63487
535
3103
3880
47683
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
1.0e+00
2.2e+00
3.6e+00
—
3.3e+00
1.8e+00
1.3e+00
cases:2.85%
controls:1.04%
cases:3.11%
controls:0.35%
cases:1.93%
controls:0.06%
—
—
cases:1.12%
controls:0.04%
cases:2.28%
controls:0.37%
cases:5.32%
controls:1.50%
192
702
6553
66675
210
237
6539
67177
130
38
6619
67376
—
73
29
6455
67187
137
241
5880
64313
235
763
4180
50023
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
3.5e-01
1.1e+00
3.0e+00
3.7e+00
2.3e+00
1.6e+00
1.0e+00
cases:30.78%
controls:23.90%
cases:29.63%
controls:12.08%
cases:24.14%
controls:1.60%
cases:2.31%
controls:0.06%
cases:14.74%
controls:1.63%
cases:40.30%
controls:11.87%
cases:54.77%
controls:29.79%
2076
16101
4669
51276
2000
8145
4749
59269
1629
1081
5120
66333
156
39
6593
67375
962
1095
5566
66121
2425
7665
3592
56889
2418
15130
1997
35656
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
43730-1 [3043849]
1.0e+00
1.9e+00
2.8e+00
1.0e+50
3.4e+00
1.8e+00
2.2e+00
cases:0.74%
controls:0.27%
cases:0.87%
controls:0.13%
cases:0.40%
controls:0.03%
cases:0.16%
controls:0.00%
cases:0.64%
controls:0.02%
cases:0.83%
controls:0.14%
cases:3.35%
controls:0.38%
50
180
6695
67197
59
88
6690
67326
27
17
6722
67397
11
0
6738
67414
42
15
6486
67201
50
89
5967
64465
148
193
4267
50593
IgG subclass 2 [Mass/volume] in Serum
2467-9 [3028192]
2467-9 [3028192]
1.1e+00
2.9e+00
—
—
4.2e+00
2.8e+00
2.0e+00
cases:0.53%
controls:0.18%
cases:0.93%
controls:0.05%
—
—
—
—
cases:0.51%
controls:0.01%
cases:1.05%
controls:0.07%
cases:1.43%
controls:0.19%
36
120
6709
67257
63
36
6686
67378
—
—
33
5
6495
67211
63
42
5954
64512
63
97
4352
50689
IgG subclass 3 [Mass/volume] in Serum
2468-7 [3024139]
2468-7 [3024139]
1.1e+00
2.9e+00
—
—
4.2e+00
2.8e+00
2.0e+00
cases:0.53%
controls:0.18%
cases:0.93%
controls:0.05%
—
—
—
—
cases:0.51%
controls:0.01%
cases:1.05%
controls:0.07%
cases:1.43%
controls:0.19%
36
120
6709
67257
63
36
6686
67378
—
—
33
5
6495
67211
63
42
5954
64512
63
97
4352
50689
IgG subclass 1 [Mass/volume] in Serum
2466-1 [3027135]
2466-1 [3027135]
1.1e+00
2.9e+00
—
—
4.2e+00
2.8e+00
2.0e+00
cases:0.53%
controls:0.18%
cases:0.93%
controls:0.05%
—
—
—
—
cases:0.51%
controls:0.01%
cases:1.05%
controls:0.07%
cases:1.43%
controls:0.19%
36
120
6709
67257
63
36
6686
67378
—
—
33
5
6495
67211
63
42
5954
64512
63
97
4352
50689
CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14135-8 [3001405]
14135-8 [3001405]
9.5e-01
2.0e+00
2.9e+00
—
3.0e+00
1.9e+00
2.2e+00
cases:0.34%
controls:0.13%
cases:0.47%
controls:0.07%
cases:0.13%
controls:0.01%
—
—
cases:0.26%
controls:0.01%
cases:0.45%
controls:0.07%
cases:1.00%
controls:0.11%
23
89
6722
67288
32
44
6717
67370
9
5
6740
67409
—
17
9
6511
67207
27
45
5990
64509
44
54
4371
50732
Clinical & Laboratory Immunology (Internal Medicine) Physician
207RI0001X [38003875]
207RI0001X [38003875]
1.4e+00
2.5e+00
2.6e+00
1.0e+50
—
3.5e+00
2.8e+00
cases:0.31%
controls:0.08%
cases:0.33%
controls:0.03%
cases:0.10%
controls:0.01%
cases:0.61%
controls:0.00%
—
—
cases:0.88%
controls:0.03%
cases:0.95%
controls:0.06%
21
51
6724
67326
22
18
6727
67396
7
5
6742
67409
41
0
6708
67414
—
53
17
5964
64537
42
29
4373
50757
Immunoglobulin typing, IgG
1712009 [4062490]
1712009 [4062490]
1.0e+00
2.8e+00
—
—
4.2e+00
2.8e+00
2.0e+00
cases:0.50%
controls:0.18%
cases:0.93%
controls:0.05%
—
—
—
—
cases:0.51%
controls:0.01%
cases:1.05%
controls:0.07%
cases:1.38%
controls:0.19%
34
121
6711
67256
63
37
6686
67377
—
—
33
5
6495
67211
63
42
5954
64512
61
95
4354
50691
CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
9728-7 [3025271]
9728-7 [3025271]
9.2e-01
1.9e+00
2.9e+00
—
3.0e+00
2.0e+00
2.2e+00
cases:0.31%
controls:0.12%
cases:0.46%
controls:0.07%
cases:0.13%
controls:0.01%
—
—
cases:0.28%
controls:0.01%
cases:0.52%
controls:0.07%
cases:1.06%
controls:0.12%
21
84
6724
67293
31
46
6718
67368
9
5
6740
67409
—
18
9
6510
67207
31
47
5986
64507
47
63
4368
50723
Chronic respiratory failure
J96.1 [45557632]
J96.1 [45557632]
1.0e+00
1.5e+00
2.6e+00
—
2.8e+00
2.4e+00
2.4e+00
cases:0.55%
controls:0.19%
cases:0.84%
controls:0.18%
cases:0.44%
controls:0.03%
—
—
cases:0.57%
controls:0.04%
cases:2.13%
controls:0.20%
cases:3.69%
controls:0.35%
37
131
6708
67246
57
122
6692
67292
30
22
6719
67392
—
37
24
6491
67192
128
129
5889
64425
163
179
4252
50607
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
1.4e+00
1.9e+00
2.3e+00
1.0e+50
2.4e+00
2.5e+00
2.2e+00
cases:3.26%
controls:0.79%
cases:1.82%
controls:0.27%
cases:0.33%
controls:0.03%
cases:0.09%
controls:0.00%
cases:0.26%
controls:0.02%
cases:2.39%
controls:0.19%
cases:4.69%
controls:0.55%
220
535
6525
66842
123
183
6626
67231
22
23
6727
67391
6
0
6743
67414
17
16
6511
67200
144
125
5873
64429
207
281
4208
50505
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
64799-0 [40767503]
9.5e-01
1.8e+00
3.6e+00
—
3.3e+00
1.5e+00
1.5e+00
cases:0.96%
controls:0.37%
cases:1.27%
controls:0.22%
cases:0.73%
controls:0.02%
—
—
cases:0.86%
controls:0.03%
cases:1.05%
controls:0.23%
cases:2.90%
controls:0.68%
65
252
6680
67125
86
150
6663
67264
49
13
6700
67401
—
56
21
6472
67195
63
151
5954
64403
128
343
4287
50443
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
2715-1 [3022806]
1.0e+00
1.7e+00
3.8e+00
—
2.5e+00
1.8e+00
1.7e+00
cases:0.77%
controls:0.28%
cases:0.61%
controls:0.11%
cases:0.39%
controls:0.01%
—
—
cases:0.20%
controls:0.02%
cases:0.45%
controls:0.08%
cases:1.43%
controls:0.26%
52
186
6693
67191
41
73
6708
67341
26
6
6723
67408
—
13
11
6515
67205
27
49
5990
64505
63
131
4352
50655
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
FB1BD [2001302407]
7.6e-01
2.1e+00
4.0e+00
—
2.1e+00
1.9e+00
1.6e+00
cases:2.13%
controls:1.01%
cases:2.36%
controls:0.29%
cases:1.27%
controls:0.02%
—
—
cases:0.26%
controls:0.03%
cases:1.81%
controls:0.27%
cases:4.48%
controls:0.98%
144
681
6601
66696
159
196
6590
67218
86
16
6663
67398
—
17
21
6511
67195
109
173
5908
64381
198
497
4217
50289
abatacept; parenteral
L04AA24 [21603905]
L04AA24 [21603905]
1.9e+00
2.1e+00
—
—
2.5e+00
2.8e+00
3.2e+00
cases:0.19%
controls:0.03%
cases:0.13%
controls:0.02%
—
—
—
—
cases:0.12%
controls:0.01%
cases:0.40%
controls:0.02%
cases:0.61%
controls:0.03%
13
20
6732
67357
9
11
6740
67403
—
—
8
7
6520
67209
24
15
5993
64539
27
13
4388
50773
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
19239-3 [3028271]
1.0e+00
1.8e+00
3.8e+00
—
2.8e+00
1.5e+00
1.6e+00
cases:0.85%
controls:0.31%
cases:0.83%
controls:0.14%
cases:0.50%
controls:0.01%
—
—
cases:0.38%
controls:0.02%
cases:0.60%
controls:0.13%
cases:1.95%
controls:0.41%
57
208
6688
67169
56
96
6693
67318
34
8
6715
67406
—
25
15
6503
67201
36
87
5981
64467
86
207
4329
50579
Spirometry study
18759-1 [3000492]
18759-1 [3000492]
7.8e-01
1.9e+00
3.1e+00
1.0e+50
2.2e+00
2.5e+00
2.1e+00
cases:4.03%
controls:1.89%
cases:3.76%
controls:0.59%
cases:1.26%
controls:0.06%
cases:0.46%
controls:0.00%
cases:0.35%
controls:0.04%
cases:6.00%
controls:0.54%
cases:11.98%
controls:1.69%
272
1276
6473
66101
254
398
6495
67016
85
40
6664
67374
31
0
6718
67414
23
27
6505
67189
361
349
5656
64205
529
856
3886
49930
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
4.8e-01
9.8e-01
2.6e+00
4.3e+00
2.4e+00
1.1e+00
6.6e-01
cases:2.52%
controls:1.58%
cases:2.10%
controls:0.80%
cases:0.99%
controls:0.08%
cases:0.74%
controls:0.01%
cases:1.15%
controls:0.10%
cases:2.46%
controls:0.87%
cases:6.43%
controls:3.43%
170
1066
6575
66311
142
538
6607
66876
67
52
6682
67362
50
7
6699
67407
75
70
6453
67146
148
563
5869
63991
284
1742
4131
49044
Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
17792-3 [3023939]
17792-3 [3023939]
1.0e+00
2.5e+00
—
1.0e+50
4.6e+00
2.8e+00
1.5e+00
cases:0.83%
controls:0.30%
cases:1.23%
controls:0.10%
—
—
cases:0.18%
controls:0.00%
cases:1.56%
controls:0.02%
cases:1.73%
controls:0.11%
cases:2.17%
controls:0.49%
56
204
6689
67173
83
69
6666
67345
—
12
0
6737
67414
102
11
6426
67205
104
69
5913
64485
96
249
4319
50537
Pulmonary eosinophilia, not elsewhere classified
J82 [45548123]
J82 [45548123]
1.8e+00
3.4e+00
—
1.0e+50
—
3.7e+00
3.3e+00
cases:0.18%
controls:0.03%
cases:0.46%
controls:0.01%
—
—
cases:0.12%
controls:0.00%
—
—
cases:0.76%
controls:0.02%
cases:0.79%
controls:0.03%
12
19
6733
67358
31
10
6718
67404
—
8
0
6741
67414
—
46
12
5971
64542
35
15
4380
50771
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
3.2e-01
1.0e+00
1.5e+00
5.3e+00
1.7e+00
1.4e+00
1.1e+00
cases:8.14%
controls:6.05%
cases:5.45%
controls:2.09%
cases:1.13%
controls:0.26%
cases:1.72%
controls:0.01%
cases:1.42%
controls:0.26%
cases:7.38%
controls:1.87%
cases:15.24%
controls:5.75%
549
4079
6196
63298
368
1407
6381
66007
76
173
6673
67241
116
6
6633
67408
93
178
6435
67038
444
1206
5573
63348
673
2919
3742
47867
Pneumoconiosis due to asbestos and other mineral fibres
J61 [45581861]
J61 [45581861]
1.7e+00
2.3e+00
—
1.0e+50
2.7e+00
3.1e+00
2.5e+00
cases:0.61%
controls:0.12%
cases:0.62%
controls:0.06%
—
—
cases:0.27%
controls:0.00%
cases:0.21%
controls:0.01%
cases:1.33%
controls:0.06%
cases:1.54%
controls:0.13%
41
78
6704
67299
42
42
6707
67372
—
18
0
6731
67414
14
10
6514
67206
80
38
5937
64516
68
65
4347
50721
Heart failure, unspecified
I50.9 [45576879]
I50.9 [45576879]
5.0e-01
1.2e+00
1.8e+00
5.4e+00
1.6e+00
1.1e+00
6.6e-01
cases:4.83%
controls:2.98%
cases:5.56%
controls:1.70%
cases:2.09%
controls:0.35%
cases:2.50%
controls:0.01%
cases:1.82%
controls:0.39%
cases:6.03%
controls:2.02%
cases:9.81%
controls:5.31%
326
2009
6419
65368
375
1149
6374
66265
141
237
6608
67177
169
8
6580
67406
119
259
6409
66957
363
1307
5654
63247
433
2695
3982
48091
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
33762-6 [3029187]
3.9e-01
1.2e+00
2.3e+00
4.6e+00
1.9e+00
1.1e+00
7.5e-01
cases:11.99%
controls:8.46%
cases:13.99%
controls:4.77%
cases:6.30%
controls:0.65%
cases:1.72%
controls:0.02%
cases:4.87%
controls:0.73%
cases:13.51%
controls:5.18%
cases:26.25%
controls:14.45%
809
5697
5936
61680
944
3214
5805
64200
425
435
6324
66979
116
12
6633
67402
318
491
6210
66725
813
3344
5204
61210
1159
7341
3256
43445
Seropositive rheumatoid arthritis, unspecified
M05.9 [45553050]
M05.9 [45553050]
1.4e+00
1.9e+00
2.4e+00
1.0e+50
2.7e+00
2.0e+00
1.8e+00
cases:1.01%
controls:0.26%
cases:0.70%
controls:0.11%
cases:0.16%
controls:0.01%
cases:0.33%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.95%
controls:0.12%
cases:1.65%
controls:0.29%
68
172
6677
67205
47
73
6702
67341
11
10
6738
67404
22
0
6727
67414
21
14
6507
67202
57
80
5960
64474
73
146
4342
50640
CD19 cells [#/volume] in Blood
8116-6 [3010503]
8116-6 [3010503]
1.5e+00
2.4e+00
—
—
3.7e+00
2.3e+00
2.4e+00
cases:0.49%
controls:0.11%
cases:0.58%
controls:0.05%
—
—
—
—
cases:0.29%
controls:0.01%
cases:0.66%
controls:0.07%
cases:1.27%
controls:0.12%
33
75
6712
67302
39
36
6710
67378
—
—
19
5
6509
67211
40
44
5977
64510
56
62
4359
50724
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
6.6e-01
1.7e+00
3.4e+00
—
3.8e+00
1.7e+00
9.9e-01
cases:1.26%
controls:0.66%
cases:1.78%
controls:0.34%
cases:1.10%
controls:0.04%
—
—
cases:2.13%
controls:0.05%
cases:1.84%
controls:0.35%
cases:4.26%
controls:1.62%
85
443
6660
66934
120
226
6629
67188
74
26
6675
67388
—
139
33
6389
67183
111
225
5906
64329
188
823
4227
49963
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
NK4XE [2001308469]
1.3e+00
1.8e+00
2.1e+00
—
2.4e+00
2.5e+00
2.2e+00
cases:3.28%
controls:0.94%
cases:2.13%
controls:0.36%
cases:0.36%
controls:0.04%
—
—
cases:0.35%
controls:0.03%
cases:3.47%
controls:0.31%
cases:5.75%
controls:0.69%
221
635
6524
66742
144
246
6605
67168
24
30
6725
67384
—
23
22
6505
67194
209
197
5808
64357
254
352
4161
50434
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
22246-3 [3017918]
7.5e-01
1.5e+00
2.4e+00
—
3.2e+00
2.2e+00
2.1e+00
cases:0.73%
controls:0.35%
cases:0.64%
controls:0.14%
cases:0.18%
controls:0.02%
—
—
cases:0.40%
controls:0.02%
cases:1.16%
controls:0.13%
cases:2.47%
controls:0.32%
49
233
6696
67144
43
96
6706
67318
12
11
6737
67403
—
26
11
6502
67205
70
83
5947
64471
109
163
4306
50623
Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7993-9 [3025023]
7993-9 [3025023]
1.2e+00
2.6e+00
3.9e+00
1.0e+50
—
2.4e+00
2.0e+00
cases:0.58%
controls:0.18%
cases:0.90%
controls:0.07%
cases:0.43%
controls:0.01%
cases:0.15%
controls:0.00%
—
—
cases:0.68%
controls:0.06%
cases:1.52%
controls:0.20%
39
120
6706
67257
61
46
6688
67368
29
6
6720
67408
10
0
6739
67414
—
41
39
5976
64515
67
104
4348
50682
Inpatient Hospital
21 [8717]
21 [8717]
2.9e-01
9.1e-01
1.9e+00
5.5e+00
1.8e+00
1.0e+00
6.9e-01
cases:41.05%
controls:34.28%
cases:24.51%
controls:11.57%
cases:10.67%
controls:1.79%
cases:16.03%
controls:0.08%
cases:9.70%
controls:1.75%
cases:24.75%
controls:10.57%
cases:39.75%
controls:24.82%
2769
23097
3976
44280
1654
7802
5095
59612
720
1208
6029
66206
1082
52
5667
67362
633
1177
5895
66039
1489
6826
4528
57728
1755
12607
2660
38179
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
8.7e-01
1.7e+00
2.7e+00
—
3.4e+00
1.8e+00
1.7e+00
cases:1.29%
controls:0.54%
cases:1.26%
controls:0.24%
cases:0.58%
controls:0.04%
—
—
cases:1.01%
controls:0.04%
cases:1.26%
controls:0.21%
cases:2.72%
controls:0.50%
87
367
6658
67010
85
159
6664
67255
39
27
6710
67387
—
66
24
6462
67192
76
138
5941
64416
120
255
4295
50531
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
8.3e-01
1.7e+00
2.7e+00
—
3.4e+00
1.8e+00
1.7e+00
cases:1.25%
controls:0.54%
cases:1.24%
controls:0.24%
cases:0.58%
controls:0.04%
—
—
cases:1.01%
controls:0.04%
cases:1.26%
controls:0.21%
cases:2.72%
controls:0.50%
84
367
6661
67010
84
160
6665
67254
39
27
6710
67387
—
66
24
6462
67192
76
137
5941
64417
120
253
4295
50533
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
8.3e-01
1.7e+00
2.7e+00
—
3.4e+00
1.8e+00
1.7e+00
cases:1.25%
controls:0.54%
cases:1.24%
controls:0.24%
cases:0.58%
controls:0.04%
—
—
cases:1.01%
controls:0.04%
cases:1.26%
controls:0.21%
cases:2.72%
controls:0.50%
84
367
6661
67010
84
160
6665
67254
39
27
6710
67387
—
66
24
6462
67192
76
137
5941
64417
120
253
4295
50533
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
5.7e-01
1.1e+00
1.8e+00
4.4e+00
2.1e+00
1.1e+00
9.9e-01
cases:4.89%
controls:2.83%
cases:3.67%
controls:1.31%
cases:1.21%
controls:0.20%
cases:1.08%
controls:0.01%
cases:1.46%
controls:0.18%
cases:3.46%
controls:1.22%
cases:8.38%
controls:3.29%
330
1908
6415
65469
248
885
6501
66529
82
133
6667
67281
73
9
6676
67405
95
119
6433
67097
208
785
5809
63769
370
1671
4045
49115
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
D38.1 [45605357]
1.2e+00
1.7e+00
3.3e+00
—
2.7e+00
2.0e+00
1.2e+00
cases:0.80%
controls:0.24%
cases:0.71%
controls:0.13%
cases:0.53%
controls:0.02%
—
—
cases:0.32%
controls:0.02%
cases:0.76%
controls:0.11%
cases:1.13%
controls:0.34%
54
164
6691
67213
48
91
6701
67323
36
13
6713
67401
—
21
15
6507
67201
46
70
5971
64484
50
175
4365
50611
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7853-5 [3015635]
7.5e-01
1.5e+00
2.3e+00
—
3.2e+00
2.2e+00
2.1e+00
cases:0.73%
controls:0.34%
cases:0.64%
controls:0.14%
cases:0.16%
controls:0.02%
—
—
cases:0.38%
controls:0.02%
cases:1.13%
controls:0.12%
cases:2.36%
controls:0.31%
49
232
6696
67145
43
96
6706
67318
11
11
6738
67403
—
25
11
6503
67205
68
80
5949
64474
104
157
4311
50629
Legionella sp identified in Specimen by Organism specific culture
593-4 [3037692]
593-4 [3037692]
1.6e+00
3.5e+00
1.0e+50
—
—
3.5e+00
3.3e+00
cases:0.33%
controls:0.06%
cases:0.89%
controls:0.03%
cases:0.55%
controls:0.00%
—
—
—
—
cases:0.71%
controls:0.02%
cases:1.45%
controls:0.05%
22
43
6723
67334
60
18
6689
67396
37
0
6712
67414
—
—
43
14
5974
64540
64
27
4351
50759
Other overlap syndromes
M35.1 [45553172]
M35.1 [45553172]
2.2e+00
2.9e+00
—
1.0e+50
—
3.5e+00
3.3e+00
cases:0.28%
controls:0.03%
cases:0.40%
controls:0.02%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.75%
controls:0.02%
cases:0.91%
controls:0.03%
19
21
6726
67356
27
15
6722
67399
—
23
0
6726
67414
—
45
14
5972
64540
40
17
4375
50769
Overnight pulse oximetry
252568001 [4091874]
252568001 [4091874]
3.5e-01
1.5e+00
3.2e+00
—
3.0e+00
2.3e+00
2.1e+00
cases:0.59%
controls:0.42%
cases:0.55%
controls:0.13%
cases:0.21%
controls:0.01%
—
—
cases:0.23%
controls:0.01%
cases:1.18%
controls:0.12%
cases:2.22%
controls:0.28%
40
282
6705
67095
37
86
6712
67328
14
6
6735
67408
—
15
8
6513
67208
71
78
5946
64476
98
144
4317
50642
Internal Medicine
11 [38004456]
11 [38004456]
4.0e-01
1.1e+00
1.9e+00
5.2e+00
1.5e+00
1.0e+00
8.1e-01
cases:34.62%
controls:26.18%
cases:25.03%
controls:10.35%
cases:11.04%
controls:1.74%
cases:9.78%
controls:0.06%
cases:7.51%
controls:1.70%
cases:23.83%
controls:10.17%
cases:41.72%
controls:24.22%
2335
17640
4410
49737
1689
6975
5060
60439
745
1172
6004
66242
660
42
6089
67372
490
1142
6038
66074
1434
6564
4583
57990
1842
12299
2573
38487
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
7.2e-01
1.7e+00
2.7e+00
1.0e+50
3.6e+00
1.7e+00
1.5e+00
cases:0.92%
controls:0.45%
cases:1.38%
controls:0.26%
cases:0.65%
controls:0.05%
cases:0.39%
controls:0.00%
cases:1.59%
controls:0.04%
cases:1.58%
controls:0.29%
cases:3.44%
controls:0.77%
62
304
6683
67073
93
174
6656
67240
44
31
6705
67383
26
0
6723
67414
104
29
6424
67187
95
188
5922
64366
152
393
4263
50393
Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29591-5 [3016881]
29591-5 [3016881]
1.2e+00
2.5e+00
3.9e+00
1.0e+50
—
2.4e+00
2.0e+00
cases:0.61%
controls:0.19%
cases:0.90%
controls:0.08%
cases:0.44%
controls:0.01%
cases:0.15%
controls:0.00%
—
—
cases:0.68%
controls:0.07%
cases:1.54%
controls:0.22%
41
130
6704
67247
61
51
6688
67363
30
6
6719
67408
10
0
6739
67414
—
41
42
5976
64512
68
111
4347
50675
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
3.2e-01
1.3e+00
3.1e+00
—
3.6e+00
2.0e+00
1.5e+00
cases:2.21%
controls:1.61%
cases:2.40%
controls:0.65%
cases:1.47%
controls:0.07%
—
—
cases:2.33%
controls:0.06%
cases:4.65%
controls:0.64%
cases:8.70%
controls:2.10%
149
1088
6596
66289
162
437
6587
66977
99
47
6650
67367
—
152
42
6376
67174
280
410
5737
64144
384
1067
4031
49719
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
D86.2 [45586127]
1.3e+00
2.0e+00
3.0e+00
—
—
2.8e+00
2.7e+00
cases:0.27%
controls:0.07%
cases:0.33%
controls:0.04%
cases:0.15%
controls:0.01%
—
—
—
—
cases:0.68%
controls:0.04%
cases:0.93%
controls:0.06%
18
47
6727
67330
22
29
6727
67385
10
5
6739
67409
—
—
41
26
5976
64528
41
33
4374
50753
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
87975-9 [36305247]
7.9e-01
1.4e+00
3.1e+00
1.0e+50
3.8e+00
1.6e+00
1.3e+00
cases:1.11%
controls:0.51%
cases:0.93%
controls:0.24%
cases:0.56%
controls:0.03%
cases:0.19%
controls:0.00%
cases:1.19%
controls:0.03%
cases:1.15%
controls:0.24%
cases:2.56%
controls:0.73%
75
341
6670
67036
63
162
6686
67252
38
18
6711
67396
13
0
6736
67414
78
18
6450
67198
69
158
5948
64396
113
370
4302
50416
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
6.9e-01
1.5e+00
3.1e+00
—
3.8e+00
1.5e+00
1.3e+00
cases:0.59%
controls:0.30%
cases:0.99%
controls:0.22%
cases:0.59%
controls:0.03%
—
—
cases:1.07%
controls:0.03%
cases:1.25%
controls:0.29%
cases:3.17%
controls:0.88%
40
202
6705
67175
67
148
6682
67266
40
18
6709
67396
—
70
17
6458
67199
75
189
5942
64365
140
447
4275
50339
B-cell lymphoma in marginal zone
C83.80 [2000501237]
C83.80 [2000501237]
1.4e+00
1.7e+00
2.6e+00
1.0e+50
2.6e+00
2.0e+00
1.6e+00
cases:0.21%
controls:0.05%
cases:0.19%
controls:0.04%
cases:0.13%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.12%
controls:0.01%
cases:0.25%
controls:0.03%
cases:0.29%
controls:0.06%
14
35
6731
67342
13
24
6736
67390
9
7
6740
67407
6
0
6743
67414
8
6
6520
67210
15
22
6002
64532
13
31
4402
50755
Jo-1 extractable nuclear Ab [Units/volume] in Serum
11565-9 [3015302]
11565-9 [3015302]
1.9e+00
3.6e+00
—
—
—
3.9e+00
2.4e+00
cases:0.15%
controls:0.02%
cases:0.33%
controls:0.01%
—
—
—
—
—
—
cases:0.37%
controls:0.01%
cases:0.36%
controls:0.03%
10
15
6735
67362
22
6
6727
67408
—
—
—
22
5
5995
64549
16
16
4399
50770
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
4.2e-01
9.4e-01
2.3e+00
3.8e+00
2.1e+00
1.2e+00
1.0e+00
cases:16.26%
controls:11.27%
cases:20.25%
controls:9.01%
cases:18.03%
controls:2.07%
cases:4.47%
controls:0.11%
cases:14.54%
controls:2.05%
cases:27.36%
controls:9.84%
cases:37.60%
controls:18.12%
1097
7593
5648
59784
1367
6073
5382
61341
1217
1394
5532
66020
302
74
6447
67340
949
1381
5579
65835
1646
6351
4371
58203
1660
9202
2755
41584
Pneumonia
R81 [2002000949]
R81 [2002000949]
9.8e-01
2.3e+00
3.9e+00
—
2.0e+00
1.6e+00
1.0e+00
cases:1.01%
controls:0.38%
cases:1.19%
controls:0.12%
cases:0.81%
controls:0.02%
—
—
cases:0.11%
controls:0.01%
cases:0.71%
controls:0.14%
cases:1.54%
controls:0.55%
68
256
6677
67121
80
84
6669
67330
55
11
6694
67403
—
7
10
6521
67206
43
93
5974
64461
68
278
4347
50508
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.4e-01
9.8e-01
2.1e+00
5.5e+00
1.7e+00
7.6e-01
5.1e-01
cases:8.29%
controls:6.62%
cases:10.05%
controls:4.04%
cases:4.53%
controls:0.56%
cases:6.50%
controls:0.03%
cases:2.93%
controls:0.57%
cases:9.72%
controls:4.78%
cases:22.85%
controls:15.13%
559
4461
6186
62916
678
2723
6071
64691
306
379
6443
67035
439
19
6310
67395
191
381
6337
66835
585
3087
5432
61467
1009
7684
3406
43102
erdosteine; oral
R05CB15 [21603394]
R05CB15 [21603394]
6.6e-01
1.3e+00
1.8e+00
3.5e+00
2.2e+00
1.2e+00
1.1e+00
cases:6.32%
controls:3.37%
cases:5.19%
controls:1.45%
cases:1.24%
controls:0.21%
cases:0.25%
controls:0.01%
cases:1.47%
controls:0.17%
cases:4.80%
controls:1.50%
cases:13.39%
controls:4.79%
426
2273
6319
65104
350
975
6399
66439
84
141
6665
67273
17
5
6732
67409
96
114
6432
67102
289
970
5728
63584
591
2433
3824
48353
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
5.7e-01
1.0e+00
2.0e+00
4.1e+00
2.2e+00
1.1e+00
7.5e-01
cases:2.79%
controls:1.60%
cases:2.67%
controls:0.98%
cases:0.98%
controls:0.14%
cases:0.64%
controls:0.01%
cases:1.41%
controls:0.16%
cases:3.06%
controls:1.03%
cases:6.89%
controls:3.38%
188
1078
6557
66299
180
664
6569
66750
66
92
6683
67322
43
7
6706
67407
92
105
6436
67111
184
667
5833
63887
304
1719
4111
49067
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 [40763082]
60022-1 [40763082]
1.3e+00
1.2e+00
3.1e+00
1.0e+50
3.8e+00
1.4e+00
9.2e-01
cases:0.43%
controls:0.12%
cases:0.27%
controls:0.08%
cases:0.19%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.46%
controls:0.01%
cases:0.35%
controls:0.08%
cases:0.95%
controls:0.38%
29
81
6716
67296
18
53
6731
67361
13
6
6736
67408
5
0
6744
67414
30
7
6498
67209
21
53
5996
64501
42
193
4373
50593
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
3.2e-01
8.1e-01
2.0e+00
4.6e+00
2.2e+00
1.0e+00
6.8e-01
cases:3.66%
controls:2.69%
cases:3.35%
controls:1.52%
cases:1.39%
controls:0.19%
cases:1.53%
controls:0.01%
cases:1.78%
controls:0.21%
cases:4.24%
controls:1.53%
cases:10.17%
controls:5.42%
247
1810
6498
65567
226
1028
6523
66386
94
125
6655
67289
103
10
6646
67404
116
138
6412
67078
255
985
5762
63569
449
2754
3966
48032
azathioprine; oral, parenteral
L04AX01 [21603927]
L04AX01 [21603927]
1.0e+00
1.4e+00
1.7e+00
—
2.0e+00
2.7e+00
2.9e+00
cases:1.47%
controls:0.54%
cases:1.51%
controls:0.37%
cases:0.52%
controls:0.10%
—
—
cases:0.90%
controls:0.12%
cases:4.89%
controls:0.34%
cases:7.16%
controls:0.42%
99
365
6646
67012
102
247
6647
67167
35
67
6714
67347
—
59
84
6469
67132
294
220
5723
64334
316
214
4099
50572
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
6.3e-01
1.4e+00
3.4e+00
—
3.6e+00
1.6e+00
1.1e+00
cases:0.76%
controls:0.40%
cases:1.35%
controls:0.32%
cases:0.96%
controls:0.03%
—
—
cases:1.32%
controls:0.04%
cases:1.89%
controls:0.40%
cases:3.85%
controls:1.36%
51
271
6694
67106
91
218
6658
67196
65
22
6684
67392
—
86
25
6442
67191
114
260
5903
64294
170
690
4245
50096
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
7852-7 [3010130]
6.3e-01
1.4e+00
2.2e+00
—
3.1e+00
2.3e+00
2.1e+00
cases:0.61%
controls:0.33%
cases:0.58%
controls:0.14%
cases:0.15%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:1.06%
controls:0.11%
cases:2.29%
controls:0.30%
41
219
6704
67158
39
92
6710
67322
10
11
6739
67403
—
23
11
6505
67205
64
73
5953
64481
101
150
4314
50636
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
9.4e-01
1.6e+00
3.1e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:3.13%
controls:1.25%
cases:4.82%
controls:1.05%
cases:4.15%
controls:0.19%
—
—
cases:3.29%
controls:0.21%
cases:7.00%
controls:1.10%
cases:10.85%
controls:3.02%
211
840
6534
66537
325
707
6424
66707
280
130
6469
67284
—
215
143
6313
67073
421
707
5596
63847
479
1536
3936
49250
Emergency Room Visit
ER [9203]
ER [9203]
2.9e-01
9.8e-01
2.0e+00
5.5e+00
1.3e+00
8.7e-01
6.8e-01
cases:43.32%
controls:36.47%
cases:28.45%
controls:12.95%
cases:11.36%
controls:1.69%
cases:11.93%
controls:0.06%
cases:5.87%
controls:1.69%
cases:25.13%
controls:12.37%
cases:48.56%
controls:32.41%
2922
24571
3823
42806
1920
8728
4829
58686
767
1137
5982
66277
805
38
5944
67376
383
1139
6145
66077
1512
7986
4505
56568
2144
16460
2271
34326
Outpatient Hospital
22 [8756]
22 [8756]
2.2e-01
7.9e-01
1.7e+00
5.3e+00
1.8e+00
1.1e+00
6.4e-01
cases:32.66%
controls:27.96%
cases:16.39%
controls:8.13%
cases:5.36%
controls:1.05%
cases:8.89%
controls:0.05%
cases:6.20%
controls:1.04%
cases:17.82%
controls:7.01%
cases:30.42%
controls:18.68%
2203
18836
4542
48541
1106
5482
5643
61932
362
705
6387
66709
600
32
6149
67382
405
702
6123
66514
1072
4526
4945
60028
1343
9485
3072
41301
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
8.8e-01
1.5e+00
3.0e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:3.45%
controls:1.46%
cases:4.92%
controls:1.12%
cases:4.13%
controls:0.20%
—
—
cases:3.37%
controls:0.21%
cases:7.15%
controls:1.14%
cases:11.53%
controls:3.09%
233
982
6512
66395
332
754
6417
66660
279
138
6470
67276
—
220
144
6308
67072
430
734
5587
63820
509
1567
3906
49219
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
8.5e-01
1.5e+00
3.0e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:3.01%
controls:1.31%
cases:4.50%
controls:1.05%
cases:3.87%
controls:0.19%
—
—
cases:3.16%
controls:0.20%
cases:6.75%
controls:1.04%
cases:10.92%
controls:2.86%
203
884
6542
66493
304
707
6445
66707
261
130
6488
67284
—
206
132
6322
67084
406
673
5611
63881
482
1452
3933
49334
Rheumatoid arthritis, unspecified
M06.9 [45533705]
M06.9 [45533705]
1.2e+00
1.9e+00
2.0e+00
—
3.0e+00
2.0e+00
1.5e+00
cases:1.11%
controls:0.35%
cases:0.67%
controls:0.10%
cases:0.18%
controls:0.02%
—
—
cases:0.35%
controls:0.02%
cases:0.85%
controls:0.12%
cases:1.74%
controls:0.39%
75
237
6670
67140
45
69
6704
67345
12
16
6737
67398
—
23
12
6505
67204
51
76
5966
64478
77
200
4338
50586
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
8.9e-01
1.5e+00
3.0e+00
—
2.8e+00
1.9e+00
1.4e+00
cases:3.34%
controls:1.39%
cases:4.77%
controls:1.07%
cases:4.03%
controls:0.20%
—
—
cases:3.19%
controls:0.21%
cases:6.85%
controls:1.10%
cases:10.87%
controls:2.97%
225
937
6520
66440
322
722
6427
66692
272
134
6477
67280
—
208
141
6320
67075
412
710
5605
63844
480
1509
3935
49277
Polymyositis
M33.2 [45567548]
M33.2 [45567548]
2.2e+00
2.3e+00
—
1.0e+50
—
3.1e+00
3.9e+00
cases:0.12%
controls:0.01%
cases:0.12%
controls:0.01%
—
—
cases:0.16%
controls:0.00%
—
—
cases:0.32%
controls:0.01%
cases:0.66%
controls:0.01%
8
9
6737
67368
8
8
6741
67406
—
11
0
6738
67414
—
19
9
5998
64545
29
7
4386
50779
Inpatient Visit
IP [9201]
IP [9201]
2.5e-01
6.6e-01
1.5e+00
5.8e+00
1.9e+00
7.9e-01
5.5e-01
cases:10.73%
controls:8.54%
cases:7.36%
controls:3.93%
cases:1.88%
controls:0.43%
cases:4.03%
controls:0.01%
cases:3.13%
controls:0.49%
cases:8.31%
controls:3.95%
cases:20.70%
controls:13.14%
724
5757
6021
61620
497
2649
6252
64765
127
290
6622
67124
272
9
6477
67405
204
330
6324
66886
500
2548
5517
62006
914
6675
3501
44111
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
2.3e-01
7.3e-01
1.7e+00
5.3e+00
1.8e+00
8.7e-01
7.4e-01
cases:9.31%
controls:7.54%
cases:8.25%
controls:4.16%
cases:3.44%
controls:0.63%
cases:1.42%
controls:0.01%
cases:3.65%
controls:0.62%
cases:10.02%
controls:4.44%
cases:21.97%
controls:11.83%
628
5077
6117
62300
557
2803
6192
64611
232
422
6517
66992
96
5
6653
67409
238
418
6290
66798
603
2868
5414
61686
970
6007
3445
44779
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 [3036428]
35704-6 [3036428]
1.1e+00
1.4e+00
3.0e+00
1.0e+50
3.7e+00
1.3e+00
9.3e-01
cases:0.33%
controls:0.11%
cases:0.22%
controls:0.06%
cases:0.18%
controls:0.01%
cases:0.07%
controls:0.00%
cases:0.41%
controls:0.01%
cases:0.28%
controls:0.08%
cases:0.66%
controls:0.26%
22
74
6723
67303
15
38
6734
67376
12
6
6737
67408
5
0
6744
67414
27
7
6501
67209
17
50
6000
64504
29
132
4386
50654
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
2.7e-01
7.8e-01
1.8e+00
5.0e+00
1.8e+00
9.1e-01
8.0e-01
cases:9.24%
controls:7.18%
cases:8.00%
controls:3.85%
cases:3.26%
controls:0.56%
cases:1.30%
controls:0.01%
cases:3.42%
controls:0.57%
cases:9.51%
controls:4.06%
cases:21.34%
controls:10.90%
623
4841
6122
62536
540
2593
6209
64821
220
376
6529
67038
88
6
6661
67408
223
381
6305
66835
572
2624
5445
61930
942
5535
3473
45251
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
6.5e-01
1.4e+00
3.1e+00
—
3.4e+00
1.4e+00
1.3e+00
cases:0.71%
controls:0.37%
cases:1.17%
controls:0.29%
cases:0.65%
controls:0.03%
—
—
cases:1.15%
controls:0.04%
cases:1.40%
controls:0.34%
cases:3.44%
controls:0.97%
48
251
6697
67126
79
195
6670
67219
44
20
6705
67394
—
75
25
6453
67191
84
217
5933
64337
152
491
4263
50295
Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5000-5 [3020229]
5000-5 [3020229]
1.7e+00
3.2e+00
1.0e+50
1.0e+50
—
3.5e+00
2.8e+00
cases:0.15%
controls:0.03%
cases:0.50%
controls:0.02%
cases:0.53%
controls:0.00%
cases:0.16%
controls:0.00%
—
—
cases:0.53%
controls:0.02%
cases:0.84%
controls:0.05%
10
18
6735
67359
34
14
6715
67400
36
0
6713
67414
11
0
6738
67414
—
32
10
5985
64544
37
25
4378
50761
Erythrocyte sedimentation rate above reference range
165468009 [4013526]
165468009 [4013526]
9.4e-01
2.0e+00
3.0e+00
1.0e+50
3.2e+00
1.1e+00
1.0e+00
cases:0.53%
controls:0.21%
cases:0.62%
controls:0.09%
cases:0.30%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.18%
controls:0.01%
cases:0.28%
controls:0.09%
cases:0.66%
controls:0.23%
36
141
6709
67236
42
59
6707
67355
20
10
6729
67404
15
0
6734
67414
12
5
6516
67211
17
59
6000
64495
29
119
4386
50667
Pleura Pathology biopsy report
66123-1 [40768806]
66123-1 [40768806]
1.0e+00
1.5e+00
2.9e+00
1.0e+50
3.7e+00
1.1e+00
1.0e+00
cases:0.44%
controls:0.16%
cases:0.41%
controls:0.09%
cases:0.19%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.49%
controls:0.01%
cases:0.30%
controls:0.10%
cases:1.00%
controls:0.37%
30
107
6715
67270
28
64
6721
67350
13
7
6736
67407
6
0
6743
67414
32
8
6496
67208
18
67
5999
64487
44
187
4371
50599
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
FM1EE [2001303307]
3.4e-01
9.3e-01
1.7e+00
4.6e+00
1.6e+00
1.2e+00
8.7e-01
cases:8.11%
controls:5.91%
cases:6.15%
controls:2.52%
cases:1.51%
controls:0.28%
cases:0.87%
controls:0.01%
cases:1.26%
controls:0.26%
cases:7.58%
controls:2.44%
cases:14.63%
controls:6.73%
547
3985
6198
63392
415
1701
6334
65713
102
188
6647
67226
59
6
6690
67408
82
177
6446
67039
456
1572
5561
62982
646
3418
3769
47368
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
L04AA06 [21603896]
9.4e-01
1.2e+00
1.4e+00
—
2.3e+00
2.4e+00
3.0e+00
cases:0.70%
controls:0.27%
cases:0.84%
controls:0.27%
cases:0.36%
controls:0.09%
—
—
cases:0.70%
controls:0.07%
cases:3.01%
controls:0.27%
cases:6.09%
controls:0.32%
47
185
6698
67192
57
180
6692
67234
24
62
6725
67352
—
46
50
6482
67166
181
173
5836
64381
269
164
4146
50622
Fungus identified in Specimen by Culture
580-1 [3000494]
580-1 [3000494]
4.6e-01
1.3e+00
2.9e+00
—
3.8e+00
1.5e+00
1.2e+00
cases:3.88%
controls:2.50%
cases:3.39%
controls:0.90%
cases:1.63%
controls:0.09%
—
—
cases:3.52%
controls:0.08%
cases:3.77%
controls:0.91%
cases:8.43%
controls:2.82%
262
1682
6483
65695
229
609
6520
66805
110
64
6639
67350
—
230
53
6298
67163
227
586
5790
63968
372
1431
4043
49355
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
3255-7 [3016407]
6.1e-01
1.2e+00
2.6e+00
—
3.2e+00
1.9e+00
1.5e+00
cases:1.01%
controls:0.55%
cases:0.83%
controls:0.24%
cases:0.27%
controls:0.02%
—
—
cases:0.44%
controls:0.02%
cases:1.28%
controls:0.19%
cases:2.88%
controls:0.65%
68
372
6677
67005
56
163
6693
67251
18
13
6731
67401
—
29
12
6499
67204
77
124
5940
64430
127
332
4288
50454
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
6.0e-01
1.5e+00
3.2e+00
—
3.3e+00
1.4e+00
1.1e+00
cases:3.41%
controls:1.90%
cases:4.93%
controls:1.14%
cases:3.26%
controls:0.14%
—
—
cases:3.88%
controls:0.14%
cases:5.19%
controls:1.30%
cases:12.46%
controls:4.69%
230
1281
6515
66096
333
766
6416
66648
220
97
6529
67317
—
253
95
6275
67121
312
838
5705
63716
550
2381
3865
48405
Osmolality of Urine
2695-5 [3026782]
2695-5 [3026782]
2.1e-01
7.6e-01
1.8e+00
4.9e+00
1.8e+00
9.0e-01
7.7e-01
cases:7.50%
controls:6.16%
cases:5.60%
controls:2.70%
cases:2.16%
controls:0.38%
cases:0.96%
controls:0.01%
cases:2.27%
controls:0.38%
cases:6.23%
controls:2.62%
cases:13.75%
controls:6.88%
506
4149
6239
63228
378
1822
6371
65592
146
253
6603
67161
65
5
6684
67409
148
258
6380
66958
375
1691
5642
62863
607
3493
3808
47293
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
6.0e-01
1.4e+00
2.7e+00
—
3.7e+00
1.6e+00
1.1e+00
cases:3.87%
controls:2.16%
cases:3.85%
controls:0.95%
cases:1.50%
controls:0.11%
—
—
cases:3.19%
controls:0.08%
cases:3.97%
controls:0.83%
cases:7.18%
controls:2.54%
261
1454
6484
65923
260
642
6489
66772
101
71
6648
67343
—
208
55
6320
67161
239
536
5778
64018
317
1292
4098
49494
Outpatient Visit
OP [9202]
OP [9202]
4.2e-01
6.9e-01
9.8e-01
4.9e+00
1.4e+00
1.4e+00
1.2e+00
cases:84.85%
controls:78.65%
cases:74.87%
controls:59.85%
cases:26.85%
controls:12.11%
cases:41.13%
controls:0.50%
cases:36.99%
controls:12.27%
cases:85.74%
controls:58.62%
cases:94.27%
controls:83.77%
5723
52989
1022
14388
5053
40345
1696
27069
1812
8167
4937
59247
2776
339
3973
67075
2415
8247
4113
58969
5159
37839
858
26715
4162
42541
253
8245
Systemic lupus erythematosus, unspecified
M32.9 [45553167]
M32.9 [45553167]
1.8e+00
1.9e+00
2.1e+00
1.0e+50
2.5e+00
2.4e+00
2.4e+00
cases:0.36%
controls:0.06%
cases:0.27%
controls:0.04%
cases:0.07%
controls:0.01%
cases:0.18%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.40%
controls:0.04%
cases:0.66%
controls:0.06%
24
40
6721
67337
18
26
6731
67388
5
6
6744
67408
12
0
6737
67414
11
9
6517
67207
24
24
5993
64530
29
31
4386
50755
Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5159-9 [3007844]
5159-9 [3007844]
7.0e-01
1.4e+00
2.1e+00
—
2.9e+00
2.0e+00
1.9e+00
cases:0.64%
controls:0.32%
cases:0.49%
controls:0.12%
cases:0.12%
controls:0.01%
—
—
cases:0.21%
controls:0.01%
cases:0.68%
controls:0.10%
cases:2.02%
controls:0.29%
43
214
6702
67163
33
79
6716
67335
8
10
6741
67404
—
14
8
6514
67208
41
62
5976
64492
89
149
4326
50637
CD4 cells/Lymphocytes in Specimen
80223-1 [21494815]
80223-1 [21494815]
1.3e+00
2.0e+00
—
—
3.4e+00
2.2e+00
2.1e+00
cases:0.52%
controls:0.15%
cases:0.53%
controls:0.07%
—
—
—
—
cases:0.28%
controls:0.01%
cases:0.90%
controls:0.10%
cases:1.65%
controls:0.20%
35
100
6710
67277
36
49
6713
67365
—
—
18
6
6510
67210
54
66
5963
64488
73
102
4342
50684
Glucose [Moles/volume] in Pleural fluid
14747-0 [3036782]
14747-0 [3036782]
1.1e+00
1.4e+00
2.6e+00
1.0e+50
3.2e+00
1.5e+00
1.1e+00
cases:0.40%
controls:0.13%
cases:0.30%
controls:0.07%
cases:0.19%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.37%
controls:0.01%
cases:0.37%
controls:0.08%
cases:1.02%
controls:0.35%
27
86
6718
67291
20
47
6729
67367
13
10
6736
67404
6
0
6743
67414
24
10
6504
67206
22
53
5995
64501
45
178
4370
50608
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
7.2e-01
1.2e+00
1.9e+00
3.1e+00
2.0e+00
1.0e+00
1.0e+00
cases:4.00%
controls:1.99%
cases:3.45%
controls:1.09%
cases:1.10%
controls:0.17%
cases:0.24%
controls:0.01%
cases:1.38%
controls:0.19%
cases:2.89%
controls:1.09%
cases:7.79%
controls:2.99%
270
1344
6475
66033
233
736
6516
66678
74
114
6675
67300
16
7
6733
67407
90
125
6438
67091
174
703
5843
63851
344
1519
4071
49267
Paranasal sinuses X-ray examination in one projection
DM1QA [2001301761]
DM1QA [2001301761]
1.0e+00
2.0e+00
—
1.0e+50
3.1e+00
2.4e+00
2.4e+00
cases:1.11%
controls:0.41%
cases:0.87%
controls:0.12%
—
—
cases:0.43%
controls:0.00%
cases:0.17%
controls:0.01%
cases:1.06%
controls:0.10%
cases:3.35%
controls:0.31%
75
277
6670
67100
59
81
6690
67333
—
29
0
6720
67414
11
5
6517
67211
64
63
5953
64491
148
159
4267
50627
Seropositive rheumatoid arthritis
M05 [45606038]
M05 [45606038]
2.1e+00
2.1e+00
2.8e+00
—
—
2.1e+00
1.8e+00
cases:1.30%
controls:0.17%
cases:0.61%
controls:0.07%
cases:0.12%
controls:0.01%
—
—
—
—
cases:0.55%
controls:0.07%
cases:1.11%
controls:0.19%
88
113
6657
67264
41
48
6708
67366
8
5
6741
67409
—
—
33
42
5984
64512
49
95
4366
50691
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.5e-01
9.1e-01
2.2e+00
3.3e+00
1.9e+00
1.3e+00
9.5e-01
cases:30.60%
controls:25.51%
cases:31.25%
controls:15.42%
cases:21.37%
controls:2.93%
cases:3.30%
controls:0.12%
cases:16.59%
controls:2.96%
cases:41.70%
controls:15.89%
cases:56.72%
controls:33.72%
2064
17185
4681
50192
2109
10398
4640
57016
1442
1975
5307
65439
223
84
6526
67330
1083
1991
5445
65225
2509
10260
3508
54294
2504
17123
1911
33663
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
7.7e-01
1.5e+00
2.4e+00
—
3.1e+00
1.6e+00
1.3e+00
cases:1.33%
controls:0.62%
cases:1.45%
controls:0.31%
cases:0.70%
controls:0.06%
—
—
cases:1.12%
controls:0.05%
cases:1.53%
controls:0.32%
cases:3.49%
controls:0.94%
90
419
6655
66958
98
211
6651
67203
47
41
6702
67373
—
73
33
6455
67183
92
207
5925
64347
154
477
4261
50309
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
1.9e-01
9.2e-01
2.3e+00
3.7e+00
1.9e+00
1.2e+00
6.5e-01
cases:41.22%
controls:36.68%
cases:44.36%
controls:24.17%
cases:34.94%
controls:4.91%
cases:12.83%
controls:0.38%
cases:24.75%
controls:4.90%
cases:51.69%
controls:24.68%
cases:64.46%
controls:48.68%
2780
24712
3965
42665
2994
16295
3755
51119
2358
3310
4391
64104
866
253
5883
67161
1616
3294
4912
63922
3110
15934
2907
48620
2846
24724
1569
26062
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
4.2e-01
9.0e-01
1.8e+00
4.3e+00
2.0e+00
8.3e-01
4.8e-01
cases:2.94%
controls:1.94%
cases:3.08%
controls:1.28%
cases:1.20%
controls:0.19%
cases:0.68%
controls:0.01%
cases:1.59%
controls:0.22%
cases:3.31%
controls:1.47%
cases:7.25%
controls:4.63%
198
1308
6547
66069
208
863
6541
66551
81
131
6668
67283
46
6
6703
67408
104
148
6424
67068
199
950
5818
63604
320
2351
4095
48435
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
4.3e-01
9.0e-01
1.8e+00
4.3e+00
2.0e+00
8.4e-01
4.9e-01
cases:2.95%
controls:1.95%
cases:3.04%
controls:1.25%
cases:1.19%
controls:0.19%
cases:0.65%
controls:0.01%
cases:1.58%
controls:0.22%
cases:3.31%
controls:1.45%
cases:7.25%
controls:4.55%
199
1312
6546
66065
205
846
6544
66568
80
127
6669
67287
44
6
6705
67408
103
149
6425
67067
199
935
5818
63619
320
2311
4095
48475
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
9.0e-02
7.7e-01
2.5e+00
4.4e+00
1.8e+00
1.1e+00
3.6e-01
cases:3.57%
controls:3.27%
cases:2.39%
controls:1.12%
cases:1.39%
controls:0.12%
cases:0.70%
controls:0.01%
cases:0.97%
controls:0.17%
cases:3.06%
controls:1.09%
cases:5.07%
controls:3.59%
241
2206
6504
65171
161
752
6588
66662
94
81
6655
67333
47
6
6702
67408
63
111
6465
67105
184
702
5833
63852
224
1825
4191
48961
Other specified pleural conditions
J94.8 [45567278]
J94.8 [45567278]
7.8e-01
1.5e+00
3.0e+00
1.0e+50
3.2e+00
1.9e+00
1.1e+00
cases:0.28%
controls:0.13%
cases:0.34%
controls:0.07%
cases:0.18%
controls:0.01%
cases:0.31%
controls:0.00%
cases:0.21%
controls:0.01%
cases:0.50%
controls:0.07%
cases:0.70%
controls:0.23%
19
87
6726
67290
23
49
6726
67365
12
6
6737
67408
21
0
6728
67414
14
6
6514
67210
30
47
5987
64507
31
118
4384
50668
Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
20444-6 [3028369]
20444-6 [3028369]
1.3e+00
2.0e+00
—
—
4.1e+00
1.7e+00
1.6e+00
cases:0.43%
controls:0.12%
cases:0.56%
controls:0.07%
—
—
—
—
cases:0.46%
controls:0.01%
cases:0.43%
controls:0.08%
cases:1.31%
controls:0.26%
29
83
6716
67294
38
50
6711
67364
—
—
30
5
6498
67211
26
50
5991
64504
58
134
4357
50652
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
49178-7 [3048929]
6.7e-01
1.4e+00
2.2e+00
—
2.8e+00
1.9e+00
1.8e+00
cases:0.77%
controls:0.40%
cases:0.59%
controls:0.14%
cases:0.15%
controls:0.02%
—
—
cases:0.20%
controls:0.01%
cases:0.75%
controls:0.12%
cases:2.17%
controls:0.38%
52
267
6693
67110
40
95
6709
67319
10
11
6739
67403
—
13
8
6515
67208
45
76
5972
64478
96
195
4319
50591
Wegener granulomatosis
M31.3 [45591818]
M31.3 [45591818]
—
1.2e+00
2.5e+00
1.0e+50
3.3e+00
2.5e+00
2.5e+00
—
—
cases:0.12%
controls:0.04%
cases:0.09%
controls:0.01%
cases:0.19%
controls:0.00%
cases:0.25%
controls:0.01%
cases:0.47%
controls:0.04%
cases:0.63%
controls:0.05%
—
8
24
6741
67390
6
5
6743
67409
13
0
6736
67414
16
6
6512
67210
28
26
5989
64528
28
27
4387
50759
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
2.9e-01
9.1e-01
2.0e+00
3.2e+00
1.9e+00
1.4e+00
9.9e-01
cases:17.70%
controls:13.88%
cases:16.88%
controls:7.56%
cases:10.48%
controls:1.48%
cases:1.97%
controls:0.08%
cases:9.51%
controls:1.54%
cases:24.75%
controls:7.83%
cases:39.80%
controls:19.73%
1194
9354
5551
58023
1139
5094
5610
62320
707
1001
6042
66413
133
54
6616
67360
621
1036
5907
66180
1489
5055
4528
59499
1757
10020
2658
40766
Instruction on medicine inhalation technique
ZX109 [2001311490]
ZX109 [2001311490]
1.3e+00
2.6e+00
—
1.0e+50
—
3.8e+00
2.9e+00
cases:0.27%
controls:0.07%
cases:0.21%
controls:0.01%
—
—
cases:0.21%
controls:0.00%
—
—
cases:0.63%
controls:0.01%
cases:0.95%
controls:0.05%
18
49
6727
67328
14
10
6735
67404
—
14
0
6735
67414
—
38
9
5979
64545
42
26
4373
50760
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
8095-2 [3007566]
7.1e-01
1.2e+00
2.9e+00
—
3.1e+00
1.9e+00
9.1e-01
cases:0.93%
controls:0.46%
cases:0.58%
controls:0.17%
cases:0.16%
controls:0.01%
—
—
cases:0.29%
controls:0.01%
cases:1.00%
controls:0.16%
cases:1.18%
controls:0.48%
63
312
6682
67065
39
115
6710
67299
11
6
6738
67408
—
19
9
6509
67207
60
101
5957
64453
52
243
4363
50543
Bone marrow Pathology biopsy report
33721-2 [3045142]
33721-2 [3045142]
1.3e+00
2.0e+00
2.0e+00
—
2.6e+00
1.6e+00
1.3e+00
cases:0.86%
controls:0.25%
cases:0.62%
controls:0.09%
cases:0.09%
controls:0.01%
—
—
cases:0.14%
controls:0.01%
cases:0.32%
controls:0.07%
cases:0.88%
controls:0.25%
58
166
6687
67211
42
58
6707
67356
6
8
6743
67406
—
9
7
6519
67209
19
42
5998
64512
39
128
4376
50658
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
3.0e-01
8.4e-01
1.9e+00
3.9e+00
1.8e+00
1.1e+00
8.2e-01
cases:16.58%
controls:12.81%
cases:14.89%
controls:7.00%
cases:7.19%
controls:1.09%
cases:2.76%
controls:0.06%
cases:6.89%
controls:1.17%
cases:18.36%
controls:7.23%
cases:33.61%
controls:18.26%
1118
8634
5627
58743
1005
4718
5744
62696
485
737
6264
66677
186
40
6563
67374
450
786
6078
66430
1105
4669
4912
59885
1484
9276
2931
41510
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
6.2e-01
1.5e+00
2.0e+00
3.4e+00
1.0e+00
1.2e+00
1.0e+00
cases:5.38%
controls:2.97%
cases:3.38%
controls:0.80%
cases:0.62%
controls:0.09%
cases:0.22%
controls:0.01%
cases:0.25%
controls:0.09%
cases:2.61%
controls:0.80%
cases:7.84%
controls:3.01%
363
2002
6382
65375
228
541
6521
66873
42
60
6707
67354
15
5
6734
67409
16
60
6512
67156
157
516
5860
64038
346
1527
4069
49259
Oxygen [Partial pressure] in Venous blood
2705-2 [3024354]
2705-2 [3024354]
3.4e-01
8.2e-01
2.1e+00
4.4e+00
2.0e+00
7.1e-01
3.1e-01
cases:2.24%
controls:1.60%
cases:2.18%
controls:0.97%
cases:0.92%
controls:0.11%
cases:0.61%
controls:0.01%
cases:1.03%
controls:0.15%
cases:2.26%
controls:1.12%
cases:5.32%
controls:3.96%
151
1081
6594
66296
147
656
6602
66758
62
77
6687
67337
41
5
6708
67409
67
99
6461
67117
136
724
5881
63830
235
2012
4180
48774
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
4.2e-01
8.3e-01
1.3e+00
4.6e+00
1.4e+00
1.3e+00
8.1e-01
cases:3.72%
controls:2.48%
cases:2.70%
controls:1.19%
cases:0.56%
controls:0.16%
cases:0.71%
controls:0.01%
cases:0.64%
controls:0.15%
cases:3.96%
controls:1.14%
cases:6.89%
controls:3.19%
251
1668
6494
65709
182
803
6567
66611
38
106
6711
67308
48
5
6701
67409
42
102
6486
67114
238
736
5779
63818
304
1621
4111
49165
certolizumab pegol; parenteral
L04AB05 [21603912]
L04AB05 [21603912]
2.5e+00
2.8e+00
—
—
—
2.5e+00
2.9e+00
cases:0.21%
controls:0.02%
cases:0.16%
controls:0.01%
—
—
—
—
—
—
cases:0.13%
controls:0.01%
cases:0.25%
controls:0.01%
14
12
6731
67365
11
7
6738
67407
—
—
—
8
7
6009
64547
11
7
4404
50779
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
6.6e-01
1.3e+00
1.6e+00
3.5e+00
1.5e+00
1.1e+00
9.3e-01
cases:25.32%
controls:14.86%
cases:24.00%
controls:7.77%
cases:6.83%
controls:1.43%
cases:1.81%
controls:0.05%
cases:6.07%
controls:1.44%
cases:19.89%
controls:7.95%
cases:32.32%
controls:15.92%
1708
10012
5037
57365
1620
5241
5129
62173
461
962
6288
66452
122
36
6627
67378
396
970
6132
66246
1197
5129
4820
59425
1427
8083
2988
42703
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
1.8e-01
7.4e-01
1.7e+00
4.1e+00
2.1e+00
1.0e+00
7.4e-01
cases:8.12%
controls:6.90%
cases:6.82%
controls:3.36%
cases:2.47%
controls:0.45%
cases:1.04%
controls:0.02%
cases:3.91%
controls:0.47%
cases:7.94%
controls:3.08%
cases:16.35%
controls:8.56%
548
4650
6197
62727
460
2263
6289
65151
167
305
6582
67109
70
12
6679
67402
255
317
6273
66899
478
1991
5539
62563
722
4345
3693
46441
Pleural effusion, not elsewhere classified
J90 [45605897]
J90 [45605897]
1.1e+00
1.7e+00
2.5e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:1.02%
controls:0.33%
cases:1.01%
controls:0.19%
cases:0.49%
controls:0.04%
—
—
cases:0.63%
controls:0.06%
cases:1.00%
controls:0.17%
cases:1.49%
controls:0.50%
69
220
6676
67157
68
126
6681
67288
33
28
6716
67386
—
41
38
6487
67178
60
112
5957
64442
66
252
4349
50534
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
3.9e-01
8.8e-01
1.8e+00
4.2e+00
2.0e+00
8.4e-01
5.0e-01
cases:2.97%
controls:2.03%
cases:3.07%
controls:1.30%
cases:1.24%
controls:0.20%
cases:0.68%
controls:0.01%
cases:1.58%
controls:0.23%
cases:3.32%
controls:1.46%
cases:7.50%
controls:4.68%
200
1371
6545
66006
207
874
6542
66540
84
135
6665
67279
46
7
6703
67407
103
152
6425
67064
200
945
5817
63609
331
2376
4084
48410
Primary pulmonary hypertension
I27.0 [45552787]
I27.0 [45552787]
1.7e+00
2.5e+00
2.1e+00
—
—
3.1e+00
3.2e+00
cases:0.12%
controls:0.02%
cases:0.15%
controls:0.01%
cases:0.07%
controls:0.01%
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.29%
controls:0.01%
8
14
6737
67363
10
8
6739
67406
5
6
6744
67408
—
—
12
6
6005
64548
13
6
4402
50780
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
3.5e-01
9.9e-01
1.8e+00
4.3e+00
1.4e+00
1.0e+00
7.3e-01
cases:5.34%
controls:3.81%
cases:3.70%
controls:1.41%
cases:1.01%
controls:0.18%
cases:0.73%
controls:0.01%
cases:0.63%
controls:0.15%
cases:3.76%
controls:1.38%
cases:8.77%
controls:4.43%
360
2566
6385
64811
250
952
6499
66462
68
119
6681
67295
49
7
6700
67407
41
103
6487
67113
226
889
5791
63665
387
2252
4028
48534
Biopsy of the lung with CT guidance
GD1CT [2001303738]
GD1CT [2001303738]
1.1e+00
2.4e+00
3.2e+00
1.0e+50
—
2.3e+00
1.6e+00
cases:0.43%
controls:0.15%
cases:0.41%
controls:0.04%
cases:0.21%
controls:0.01%
cases:0.10%
controls:0.00%
—
—
cases:0.42%
controls:0.04%
cases:0.66%
controls:0.14%
29
98
6716
67279
28
26
6721
67388
14
6
6735
67408
7
0
6742
67414
—
25
27
5992
64527
29
69
4386
50717
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
2.3e-01
7.4e-01
1.7e+00
4.5e+00
1.8e+00
8.7e-01
6.4e-01
cases:11.65%
controls:9.51%
cases:10.98%
controls:5.55%
cases:4.64%
controls:0.86%
cases:1.76%
controls:0.02%
cases:4.75%
controls:0.83%
cases:13.20%
controls:5.97%
cases:26.27%
controls:15.83%
786
6409
5959
60968
741
3742
6008
63672
313
577
6436
66837
119
14
6630
67400
310
561
6218
66655
794
3857
5223
60697
1160
8038
3255
42748
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
64084-7 [40766800]
1.0e+00
1.9e+00
—
—
3.0e+00
2.9e+00
1.6e+00
cases:0.46%
controls:0.17%
cases:0.52%
controls:0.07%
—
—
—
—
cases:0.20%
controls:0.01%
cases:0.58%
controls:0.03%
cases:0.84%
controls:0.16%
31
113
6714
67264
35
50
6714
67364
—
—
13
7
6515
67209
35
21
5982
64533
37
83
4378
50703
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
8.1e-01
1.3e+00
1.5e+00
—
3.2e+00
2.2e+00
1.3e+00
cases:1.33%
controls:0.60%
cases:0.95%
controls:0.27%
cases:0.24%
controls:0.05%
—
—
cases:0.89%
controls:0.04%
cases:1.88%
controls:0.20%
cases:2.65%
controls:0.72%
90
402
6655
66975
64
179
6685
67235
16
34
6733
67380
—
58
25
6470
67191
113
131
5904
64423
117
366
4298
50420
Diffuse lymphoma with large B cells
C83.31 [2000501224]
C83.31 [2000501224]
1.2e+00
1.8e+00
2.1e+00
—
2.1e+00
1.6e+00
1.6e+00
cases:0.56%
controls:0.17%
cases:0.73%
controls:0.12%
cases:0.39%
controls:0.05%
—
—
cases:0.34%
controls:0.04%
cases:0.73%
controls:0.15%
cases:1.00%
controls:0.21%
38
117
6707
67260
49
80
6700
67334
26
31
6723
67383
—
22
27
6506
67189
44
99
5973
64455
44
107
4371
50679
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
4.1e-01
9.1e-01
1.7e+00
3.0e+00
2.1e+00
1.3e+00
9.6e-01
cases:5.28%
controls:3.58%
cases:3.96%
controls:1.62%
cases:1.36%
controls:0.26%
cases:0.24%
controls:0.01%
cases:1.98%
controls:0.24%
cases:5.75%
controls:1.66%
cases:12.03%
controls:5.00%
356
2410
6389
64967
267
1095
6482
66319
92
173
6657
67241
16
8
6733
67406
129
158
6399
67058
346
1074
5671
63480
531
2537
3884
48249
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
9.2e-01
1.5e+00
2.3e+00
—
2.3e+00
1.9e+00
1.4e+00
cases:2.15%
controls:0.87%
cases:1.57%
controls:0.35%
cases:0.62%
controls:0.06%
—
—
cases:0.67%
controls:0.07%
cases:2.24%
controls:0.34%
cases:3.47%
controls:0.86%
145
584
6600
66793
106
239
6643
67175
42
42
6707
67372
—
44
45
6484
67171
135
222
5882
64332
153
438
4262
50348
Extractable nuclear Ab [Presence] in Serum by Immunoblot
57431-9 [40760543]
57431-9 [40760543]
1.5e+00
2.3e+00
—
—
—
4.3e+00
2.2e+00
cases:0.39%
controls:0.08%
cases:0.33%
controls:0.03%
—
—
—
—
—
—
cases:0.83%
controls:0.01%
cases:0.75%
controls:0.08%
26
56
6719
67321
22
23
6727
67391
—
—
—
50
7
5967
64547
33
42
4382
50744
acetylcysteine; inhalant, oral
R05CB01 [21603380]
R05CB01 [21603380]
7.9e-01
1.5e+00
3.3e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:0.76%
controls:0.34%
cases:0.59%
controls:0.13%
cases:0.19%
controls:0.01%
—
—
cases:0.21%
controls:0.03%
cases:0.58%
controls:0.14%
cases:1.59%
controls:0.50%
51
232
6694
67145
40
86
6709
67328
13
5
6736
67409
—
14
17
6514
67199
35
88
5982
64466
70
254
4345
50532
acetylcysteine
V03AB23 [21605248]
V03AB23 [21605248]
7.9e-01
1.5e+00
3.3e+00
—
2.1e+00
1.5e+00
1.2e+00
cases:0.76%
controls:0.34%
cases:0.59%
controls:0.13%
cases:0.19%
controls:0.01%
—
—
cases:0.21%
controls:0.03%
cases:0.58%
controls:0.14%
cases:1.59%
controls:0.50%
51
232
6694
67145
40
86
6709
67328
13
5
6736
67409
—
14
17
6514
67199
35
88
5982
64466
70
254
4345
50532
Wheezing
R06.2 [45548946]
R06.2 [45548946]
9.9e-01
2.1e+00
2.1e+00
—
2.7e+00
1.6e+00
9.4e-01
cases:0.80%
controls:0.30%
cases:0.70%
controls:0.09%
cases:0.10%
controls:0.01%
—
—
cases:0.18%
controls:0.01%
cases:0.53%
controls:0.11%
cases:0.84%
controls:0.33%
54
201
6691
67176
47
60
6702
67354
7
9
6742
67405
—
12
8
6516
67208
32
73
5985
64481
37
167
4378
50619
Pleural plaque without asbestos
J92.9 [45605898]
J92.9 [45605898]
1.1e+00
2.0e+00
2.3e+00
1.0e+50
—
2.9e+00
2.0e+00
cases:0.44%
controls:0.15%
cases:0.40%
controls:0.05%
cases:0.09%
controls:0.01%
cases:0.74%
controls:0.00%
—
—
cases:0.86%
controls:0.05%
cases:0.93%
controls:0.13%
30
99
6715
67278
27
35
6722
67379
6
6
6743
67408
50
0
6699
67414
—
52
32
5965
64522
41
64
4374
50722
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.2e-01
7.0e-01
1.7e+00
4.5e+00
1.7e+00
8.2e-01
6.5e-01
cases:10.63%
controls:8.73%
cases:9.44%
controls:4.94%
cases:3.90%
controls:0.74%
cases:1.59%
controls:0.02%
cases:4.03%
controls:0.72%
cases:11.22%
controls:5.27%
cases:23.87%
controls:14.11%
717
5879
6028
61498
637
3332
6112
64082
263
502
6486
66912
107
12
6642
67402
263
487
6265
66729
675
3405
5342
61149
1054
7164
3361
43622
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
3.3e-01
6.3e-01
1.8e+00
4.7e+00
1.6e+00
8.1e-01
4.3e-01
cases:9.62%
controls:7.10%
cases:6.79%
controls:3.74%
cases:3.04%
controls:0.52%
cases:0.95%
controls:0.01%
cases:2.71%
controls:0.54%
cases:8.29%
controls:3.85%
cases:15.97%
controls:11.02%
649
4781
6096
62596
458
2520
6291
64894
205
350
6544
67064
64
6
6685
67408
177
360
6351
66856
499
2486
5518
62068
705
5597
3710
45189
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
5.4e-01
1.3e+00
2.1e+00
3.0e+00
1.4e+00
9.3e-01
9.4e-01
cases:25.29%
controls:16.53%
cases:14.61%
controls:4.38%
cases:4.13%
controls:0.53%
cases:0.31%
controls:0.01%
cases:1.98%
controls:0.48%
cases:10.37%
controls:4.35%
cases:28.18%
controls:13.24%
1706
11137
5039
56240
986
2954
5763
64460
279
358
6470
67056
21
10
6728
67404
129
322
6399
66894
624
2805
5393
61749
1244
6722
3171
44064
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 [706163]
94500-6 [706163]
1.1e-01
7.6e-01
2.0e+00
4.8e+00
1.7e+00
5.8e-01
4.1e-01
cases:9.90%
controls:8.94%
cases:9.47%
controls:4.66%
cases:4.39%
controls:0.60%
cases:2.68%
controls:0.02%
cases:2.97%
controls:0.56%
cases:8.34%
controls:4.83%
cases:22.02%
controls:15.82%
668
6024
6077
61353
639
3141
6110
64273
296
403
6453
67011
181
15
6568
67399
194
377
6334
66839
502
3116
5515
61438
972
8032
3443
42754
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
2882-9 [3003434]
9.2e-01
1.4e+00
2.7e+00
1.0e+50
3.5e+00
1.1e+00
7.4e-01
cases:0.49%
controls:0.20%
cases:0.50%
controls:0.12%
cases:0.28%
controls:0.02%
cases:0.09%
controls:0.00%
cases:0.61%
controls:0.02%
cases:0.43%
controls:0.15%
cases:1.13%
controls:0.54%
33
132
6712
67245
34
82
6715
67332
19
13
6730
67401
6
0
6743
67414
40
13
6488
67203
26
97
5991
64457
50
276
4365
50510
Lobar pneumonia, unspecified
J18.1 [45562442]
J18.1 [45562442]
1.2e+00
2.5e+00
3.5e+00
1.0e+50
—
1.6e+00
1.5e+00
cases:0.21%
controls:0.06%
cases:0.18%
controls:0.01%
cases:0.24%
controls:0.01%
cases:0.13%
controls:0.00%
—
—
cases:0.13%
controls:0.03%
cases:0.36%
controls:0.08%
14
41
6731
67336
12
10
6737
67404
16
5
6733
67409
9
0
6740
67414
—
8
17
6009
64537
16
43
4399
50743
Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
31374-2 [3007080]
31374-2 [3007080]
5.6e-01
1.5e+00
1.9e+00
—
2.8e+00
2.0e+00
2.0e+00
cases:0.53%
controls:0.30%
cases:0.47%
controls:0.11%
cases:0.10%
controls:0.01%
—
—
cases:0.20%
controls:0.01%
cases:0.66%
controls:0.09%
cases:2.02%
controls:0.28%
36
205
6709
67172
32
73
6717
67341
7
10
6742
67404
—
13
8
6515
67208
40
57
5977
64497
89
143
4326
50643
Status asthmaticus
J46 [45591560]
J46 [45591560]
7.1e-01
1.6e+00
2.8e+00
1.0e+50
3.0e+00
1.2e+00
9.7e-01
cases:0.53%
controls:0.26%
cases:0.40%
controls:0.08%
cases:0.12%
controls:0.01%
cases:0.10%
controls:0.00%
cases:0.15%
controls:0.01%
cases:0.25%
controls:0.08%
cases:0.68%
controls:0.26%
36
178
6709
67199
27
56
6722
67358
8
5
6741
67409
7
0
6742
67414
10
5
6518
67211
15
49
6002
64505
30
131
4385
50655
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
2.2e-01
6.8e-01
1.8e+00
4.0e+00
1.8e+00
9.1e-01
7.6e-01
cases:7.16%
controls:5.85%
cases:5.48%
controls:2.86%
cases:2.39%
controls:0.39%
cases:0.90%
controls:0.02%
cases:2.44%
controls:0.40%
cases:6.75%
controls:2.83%
cases:15.22%
controls:7.74%
483
3939
6262
63438
370
1928
6379
65486
161
265
6588
67149
61
11
6688
67403
159
270
6369
66946
406
1827
5611
62727
672
3932
3743
46854
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
1.7e-01
6.5e-01
1.8e+00
4.4e+00
1.8e+00
8.3e-01
6.4e-01
cases:12.13%
controls:10.41%
cases:9.99%
controls:5.49%
cases:4.34%
controls:0.78%
cases:1.54%
controls:0.02%
cases:4.50%
controls:0.78%
cases:12.05%
controls:5.64%
cases:25.46%
controls:15.21%
818
7013
5927
60364
674
3702
6075
63712
293
527
6456
66887
104
13
6645
67401
294
523
6234
66693
725
3639
5292
60915
1124
7724
3291
43062
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
6.2e-01
1.1e+00
1.9e+00
2.8e+00
2.1e+00
1.1e+00
7.4e-01
cases:5.28%
controls:2.91%
cases:4.74%
controls:1.65%
cases:1.88%
controls:0.28%
cases:0.24%
controls:0.01%
cases:2.27%
controls:0.30%
cases:4.74%
controls:1.70%
cases:8.67%
controls:4.34%
356
1962
6389
65415
320
1111
6429
66303
127
192
6622
67222
16
10
6733
67404
148
200
6380
67016
285
1100
5732
63454
383
2206
4032
48580
Localized enlarged lymph nodes
R59.0 [45534459]
R59.0 [45534459]
1.0e+00
1.3e+00
2.3e+00
1.0e+50
3.1e+00
1.5e+00
9.7e-01
cases:0.71%
controls:0.25%
cases:0.33%
controls:0.09%
cases:0.15%
controls:0.01%
cases:0.13%
controls:0.00%
cases:0.17%
controls:0.01%
cases:0.32%
controls:0.07%
cases:0.52%
controls:0.20%
48
170
6697
67207
22
60
6727
67354
10
10
6739
67404
9
0
6740
67414
11
5
6517
67211
19
46
5998
64508
23
101
4392
50685
Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
47826-3 [3052649]
47826-3 [3052649]
1.2e+00
1.0e+00
2.9e+00
1.0e+50
3.3e+00
1.5e+00
1.2e+00
cases:0.37%
controls:0.11%
cases:0.18%
controls:0.07%
cases:0.19%
controls:0.01%
cases:0.09%
controls:0.00%
cases:0.29%
controls:0.01%
cases:0.30%
controls:0.07%
cases:0.75%
controls:0.22%
25
75
6720
67302
12
44
6737
67370
13
7
6736
67407
6
0
6743
67414
19
7
6509
67209
18
43
5999
64511
33
111
4382
50675
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.8e-01
7.9e-01
2.0e+00
4.6e+00
1.6e+00
6.7e-01
3.6e-01
cases:13.02%
controls:11.10%
cases:11.42%
controls:5.51%
cases:5.14%
controls:0.73%
cases:3.24%
controls:0.03%
cases:3.42%
controls:0.74%
cases:10.42%
controls:5.62%
cases:21.90%
controls:16.37%
878
7477
5867
59900
771
3717
5978
63697
347
492
6402
66922
219
22
6530
67392
223
500
6305
66716
627
3626
5390
60928
967
8315
3448
42471
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
16933-4 [3021879]
8.0e-01
1.2e+00
1.8e+00
—
3.0e+00
1.9e+00
1.4e+00
cases:2.27%
controls:1.03%
cases:1.50%
controls:0.45%
cases:0.19%
controls:0.03%
—
—
cases:0.63%
controls:0.03%
cases:2.68%
controls:0.39%
cases:4.39%
controls:1.15%
153
695
6592
66682
101
305
6648
67109
13
21
6736
67393
—
41
21
6487
67195
161
254
5856
64300
194
586
4221
50200
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
1.2e-01
6.7e-01
2.3e+00
3.5e+00
2.0e+00
1.0e+00
6.7e-01
cases:8.94%
controls:8.02%
cases:6.02%
controls:3.18%
cases:3.22%
controls:0.35%
cases:0.59%
controls:0.02%
cases:2.82%
controls:0.38%
cases:8.53%
controls:3.26%
cases:19.23%
controls:10.86%
603
5405
6142
61972
406
2141
6343
65273
217
233
6532
67181
40
12
6709
67402
184
258
6344
66958
513
2107
5504
62447
849
5514
3566
45272
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
-3.7e-02
7.6e-01
2.0e+00
4.6e+00
1.5e+00
7.4e-01
5.2e-01
cases:2.91%
controls:3.01%
cases:2.83%
controls:1.34%
cases:1.19%
controls:0.16%
cases:1.04%
controls:0.01%
cases:0.74%
controls:0.17%
cases:3.22%
controls:1.56%
cases:8.97%
controls:5.53%
196
2030
6549
65347
191
906
6558
66508
80
109
6669
67305
70
7
6679
67407
48
112
6480
67104
194
1009
5823
63545
396
2811
4019
47975
Mixed asthma
J45.8 [45548118]
J45.8 [45548118]
7.7e-01
1.7e+00
2.4e+00
—
1.8e+00
2.0e+00
1.3e+00
cases:0.68%
controls:0.32%
cases:0.65%
controls:0.12%
cases:0.24%
controls:0.02%
—
—
cases:0.14%
controls:0.02%
cases:0.80%
controls:0.11%
cases:1.16%
controls:0.31%
46
213
6699
67164
44
78
6705
67336
16
14
6733
67400
—
9
15
6519
67201
48
70
5969
64484
51
156
4364
50630
Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
34720-3 [3030558]
34720-3 [3030558]
1.6e+00
3.0e+00
1.0e+50
—
—
2.9e+00
2.6e+00
cases:0.25%
controls:0.05%
cases:0.53%
controls:0.03%
cases:0.24%
controls:0.00%
—
—
—
—
cases:0.47%
controls:0.02%
cases:0.93%
controls:0.07%
17
36
6728
67341
36
18
6713
67396
16
0
6733
67414
—
—
28
16
5989
64538
41
35
4374
50751
Lung ventilation SPECT
GD2SN [2001303746]
GD2SN [2001303746]
1.4e+00
3.2e+00
—
—
—
3.1e+00
2.4e+00
cases:0.24%
controls:0.06%
cases:0.22%
controls:0.01%
—
—
—
—
—
—
cases:0.27%
controls:0.01%
cases:0.39%
controls:0.04%
16
39
6729
67338
15
6
6734
67408
—
—
—
16
8
6001
64546
17
18
4398
50768
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.7e-01
8.3e-01
1.8e+00
3.7e+00
1.7e+00
9.9e-01
7.2e-01
cases:17.94%
controls:14.27%
cases:16.64%
controls:8.01%
cases:7.53%
controls:1.31%
cases:2.47%
controls:0.06%
cases:7.46%
controls:1.38%
cases:20.03%
controls:8.48%
cases:35.83%
controls:21.42%
1210
9613
5535
57764
1123
5401
5626
62013
508
884
6241
66530
167
42
6582
67372
487
930
6041
66286
1205
5474
4812
59080
1582
10880
2833
39906
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
517
716
7.72
307.65
1.2
1.1
30.62
7.07
u/ml
1.53
29
27
1175
1626
8.50
307.65
2.3
1.5
—
—
—
0
0
1655
2529
8.29
307.65
3.1
2.7
—
—
—
0
0
326
125
27.32
307.65
1.1
1.1
—
—
—
0
0
2713
9389
4.11
307.65
1.4
1.3
58.29
34.59
iu/ml
6.20
935
2764
4996
28390
3.73
307.65
13.2
6.2
60.38
58.52
%
22.85
4943
26921
5402
31791
4.19
307.65
13.7
6.1
0.21
0.20
e9/l
3.03
4975
27212
2278
8749
3.39
307.65
2.7
1.9
—
—
—
0
0
595
1003
6.40
307.65
1.4
1.2
56.93
45.57
u/ml
0.66
76
93
1501
4598
3.89
307.65
2.1
1.4
—
—
—
0
0
1184
1362
10.28
307.65
2.1
1.3
—
—
—
0
0
511
714
7.65
307.65
3.5
3.6
—
—
—
0
0
1067
1763
6.97
307.65
1.7
1.4
14.36
17.03
iu/ml
0.22
41
35
1139
3095
4.21
307.65
1.6
1.3
247.07
257.61
u/ml
0.13
1070
2838
386
393
10.34
307.65
2.0
1.4
—
—
—
0
0
408
436
9.88
307.65
2.0
1.4
—
—
—
0
0
812
1626
5.52
307.65
1.9
1.5
1.19
1.18
g/l
0.54
790
1547
950
1436
7.51
307.65
1.4
1.2
41.78
47.93
u/ml
0.19
47
67
5046
28525
3.84
307.65
13.6
6.2
2.71
2.85
%
4.69
4968
26502
1076
1183
10.59
307.65
2.0
1.3
—
—
—
0
0
807
1572
5.68
307.65
1.9
1.5
0.23
0.24
g/l
3.05
781
1496
891
1157
8.69
307.65
1.3
1.2
16.83
2.07
u/ml
2.13
74
75
929
1356
7.76
307.65
1.4
1.3
11.94
5.28
u/ml
1.81
177
210
889
1191
8.42
307.65
1.8
1.4
—
—
—
0
0
647
850
8.29
307.65
1.2
1.1
—
—
—
0
0
970
404
27.76
307.65
2.1
1.4
—
—
—
0
0
1058
2411
5.00
307.65
1.9
1.9
38.85
38.64
u/l
0.10
974
2071
823
974
9.46
307.65
1.8
1.4
—
—
—
0
0
718
1167
6.75
307.65
12.0
4.6
1242.41
1765.91
iu/ml
0.13
169
157
2108
8841
2.99
307.65
9.7
7.3
10.36
12.09
kpa
59.05
2042
8482
1743
2604
8.61
307.65
1.7
1.6
16.48
16.82
iu/ml
0.02
39
65
1317
1511
10.53
307.65
1.9
1.5
—
—
—
0
0
1287
2035
7.54
307.65
2.1
1.6
7.34
6.81
iu/ml
0.22
295
496
728
977
8.21
307.65
1.5
1.3
15.94
10.14
u/ml
0.62
24
20
688
235
32.40
307.65
1.1
1.1
—
—
—
0
0
1303
3481
4.38
307.65
2.3
1.9
1.13
1.38
g/l
4.37
1224
3145
874
1144
8.60
307.65
2.3
1.6
—
—
—
0
0
5057
28994
3.77
307.65
13.7
6.3
24.55
26.05
%
18.55
4986
27257
380
179
22.40
307.65
1.9
1.2
—
—
—
0
0
1321
1220
13.15
307.65
1.3
1.2
50.66
0.60
u/ml
—
30
7
742
824
9.97
307.65
2.5
1.4
—
—
—
0
0
2950
7095
6.50
307.65
1.6
1.3
563.59
492.54
titre
1.23
891
1531
537
561
10.29
307.65
1.2
1.1
68.57
38.93
u/ml
0.95
28
30
713
1186
6.59
307.65
1.3
1.3
192.50
121.67
titre
0.27
24
24
1681
4393
4.73
307.65
4.4
2.7
10.43
10.60
g/l
0.69
1618
4029
937
1351
7.87
307.65
1.4
1.2
6.64
5.15
u/ml
0.17
117
130
2866
12547
3.19
307.65
2.9
1.9
—
—
—
0
0
698
831
9.23
307.65
2.3
1.4
—
—
—
0
0
2388
9417
3.35
307.65
2.6
1.9
—
—
—
0
0
5361
31419
4.14
307.65
13.2
6.0
1.90
1.85
e9/l
0.64
4938
27109
5390
34682
3.51
307.65
16.8
9.3
4.69
4.31
e9/l
25.07
4945
29749
448
576
8.25
307.65
1.3
1.2
59.18
52.40
u/ml
0.15
36
28
5344
30801
4.23
307.65
13.0
5.9
0.67
0.62
e9/l
25.24
4859
25941
383
379
10.64
307.65
2.0
1.4
—
—
—
0
0
1184
1656
8.42
307.65
2.3
1.5
—
—
—
0
0
713
1188
6.58
307.65
1.3
1.2
288.44
304.00
titre
0.07
77
100
2082
8766
2.97
307.65
9.6
7.3
1.33
0.94
mmol/l
3.75
1792
7152
2110
8845
2.99
307.65
9.7
7.3
5.03
5.08
kpa
1.40
2042
8492
1146
1842
7.26
307.65
1.3
1.2
1.91
0.95
u/ml
0.94
90
163
846
1731
5.43
307.65
2.6
2.3
128.48
127.38
g/l
0.41
410
1381
2574
8704
4.12
307.65
1.4
1.3
25.91
12.17
u/ml
3.52
767
3165
5349
30926
4.22
307.65
13.0
6.0
0.04
0.04
e9/l
6.45
4866
26078
693
1485
5.07
305.36
1.9
2.0
11.61
12.71
mg/l
1.39
652
1368
412
542
8.02
295.85
2.1
1.5
—
—
—
0
0
1473
5567
3.09
286.69
6.6
4.0
0.59
0.74
%
1.95
610
1777
368
480
8.04
265.90
1.3
1.2
78.08
76.80
u/ml
0.02
12
20
383
525
7.66
265.14
1.4
1.3
7.50
6.67
g/l
2.22
266
378
3784
23302
2.38
264.50
4.4
3.4
1720.99
1759.57
ng/l
0.18
3448
20435
382
525
7.64
263.83
1.4
1.3
2.97
2.90
g/l
0.28
270
381
382
525
7.64
263.83
1.4
1.3
0.50
0.41
g/l
2.44
266
380
165
49
34.47
260.67
2.9
1.6
—
—
—
0
0
503
935
5.72
259.04
5.3
2.3
598.33
2184.62
u/ml
1.10
45
61
4896
34021
2.50
256.27
10.7
6.6
11.36
12.54
umol/l
7.60
4787
32440
481
892
5.72
248.17
1.7
1.6
0.88
0.85
g/l
0.19
350
698
1781
7990
2.66
247.22
10.4
7.6
93.79
95.40
%
19.01
1728
7708
1203
4511
3.02
233.56
11.4
9.2
24.66
24.24
mmol/l
3.86
1170
4400
4473
30685
2.29
227.87
10.7
6.9
1.20
1.21
mmol/l
4.72
4282
28228
291
347
8.71
226.11
4.1
3.8
—
—
—
0
0
377
609
6.49
223.77
2.0
1.6
—
—
—
0
0
317
429
7.70
221.57
1.3
1.1
—
—
—
0
0
385
646
6.25
220.03
2.0
1.6
—
—
—
0
0
3968
26321
2.19
213.94
23.3
12.5
0.00
0.00
e9/l
0.80
3367
21305
220
199
11.39
209.10
2.0
1.8
42129.51
19550.42
u/ml
0.23
35
26
300
412
7.57
206.91
1.3
1.2
49.88
63.67
u/ml
0.27
23
23
931
3236
3.17
204.61
2.4
1.9
1.99
2.37
ug/l
0.30
847
2839
5645
43799
2.57
202.03
10.5
4.5
18.34
13.86
mm/h
68.00
5533
40490
1223
4976
2.77
201.95
6.0
3.9
5.16
5.14
kpa
0.19
1184
4725
284
380
7.75
200.33
1.3
1.1
—
—
—
0
0
1293
5474
2.68
197.09
2.2
2.4
343.03
385.68
nmol/l
8.62
1234
5043
4727
34259
2.20
194.72
11.8
7.6
1.21
1.21
mmol/l
3.23
4118
29516
1983
10294
2.30
193.13
2.0
1.5
2.81
2.63
g/l
2.75
1453
5951
598
1655
3.86
186.88
1.6
1.5
50.12
4.73
iu/ml
0.92
124
347
313
512
6.36
183.17
2.2
2.1
1020.75
1103.68
e6/l
0.82
284
453
1065
4238
2.79
182.21
5.7
3.7
2.32
1.83
mmol/l
3.95
847
3105
256
359
7.37
173.13
1.3
1.1
—
—
—
0
0
252
348
7.48
172.77
1.3
1.1
—
—
—
0
0
258
367
7.26
172.26
1.3
1.1
—
—
—
0
0
258
367
7.26
172.26
1.3
1.1
—
—
—
0
0
777
2679
3.14
171.77
4.6
3.0
25.35
24.77
mmol/l
3.40
757
2635
2277
13000
2.12
171.10
2.4
1.7
1.55
1.48
mg/l
0.30
1904
10239
566
1603
3.76
170.70
4.6
3.0
88.63
89.08
%
0.77
553
1559
1509
7337
2.35
168.26
11.8
8.0
123.25
120.07
g/l
6.79
1481
7175
618
1895
3.48
165.19
5.4
3.3
7.69
7.95
kpa
3.82
603
1851
536
1514
3.75
162.09
3.7
2.7
15.78
16.06
%
1.08
525
1484
257
389
6.82
161.98
2.2
2.0
—
—
—
0
0
418
992
4.42
160.46
1.4
1.4
39.23
17.34
u/ml
—
10
20
253
381
6.85
160.22
2.1
2.0
16.11
16.72
%
0.29
247
367
300
543
5.73
158.07
1.6
1.6
—
—
—
0
0
300
543
5.73
158.07
1.6
1.6
—
—
—
0
0
300
543
5.73
158.07
1.6
1.6
—
—
—
0
0
383
860
4.66
157.60
1.4
1.4
152.56
154.62
au/ml
0.10
103
257
190
222
8.77
149.75
1.2
1.1
—
—
—
0
0
4156
30382
1.92
145.19
6.9
5.2
33.57
34.82
g/l
35.98
3927
28319
1067
4727
2.49
144.52
12.8
7.8
25.01
24.77
mmol/l
1.07
1056
4693
5728
47092
2.26
140.80
16.3
8.5
79.74
82.03
u/l
2.88
5632
44530
2943
19380
1.90
140.38
5.2
3.2
34.64
36.51
u/l
0.55
2821
18140
4394
32909
1.92
140.29
19.5
19.2
1.32
1.35
inr
2.83
3800
27823
2001
11612
2.02
138.32
6.6
3.2
0.81
0.81
mmol/l
1.80
1889
10866
200
285
7.20
133.17
1.4
1.1
—
—
—
0
0
2921
19475
1.87
131.54
5.0
3.6
0.40
0.47
e6/l
1.12
2294
14662
3486
24648
1.84
129.04
6.4
4.3
110.32
112.62
e6/l
0.04
2684
18053
212
340
6.40
126.25
2.3
2.2
101.26
114.14
e6/l
0.36
206
323
1024
4731
2.37
125.11
8.2
6.6
24.95
24.46
mmol/l
3.56
993
4536
1411
7440
2.13
124.78
3.9
3.3
4.65
4.79
e9/l
0.34
1285
6207
2199
13564
1.91
124.67
4.1
3.1
518.87
536.94
mosm/kgh2o
4.41
2014
11913
3236
22564
1.82
123.52
5.2
3.7
84.73
94.34
e6/l
0.09
2616
17571
3462
24680
1.81
122.30
5.2
3.7
—
1.76
—
0
6
2052
12474
1.92
120.91
3.1
2.7
11.56
12.22
umol/l
4.20
1933
11547
268
565
4.89
118.75
1.4
1.2
—
—
—
0
0
465
1461
3.34
118.70
6.8
4.3
8.25
8.45
kpa
1.62
456
1427
1326
6967
2.12
117.64
11.3
6.9
10.84
11.10
mmol/l
0.62
1275
6628
169
230
7.51
117.20
3.6
1.8
43.01
61.26
ug/l
2.64
169
222
521
1766
3.11
117.20
3.4
2.3
3.83
3.63
g/l
2.11
508
1677
1844
10933
1.94
116.39
3.0
2.8
20.95
21.76
%
1.75
1736
10105
459
1453
3.31
115.70
6.8
4.3
2.73
2.64
mmol/l
0.27
354
983
459
1454
3.31
115.57
6.9
4.3
5.02
4.98
kpa
0.44
450
1421
4821
38294
1.85
115.57
9.3
5.3
6.84
6.86
mmol/l
0.29
4681
36568
1943
11749
1.91
115.39
3.0
2.7
2.23
2.25
g/l
1.12
1814
10794
1278
6669
2.12
115.19
2.4
2.6
66.15
65.90
g/l
0.52
1202
6032
1577
8908
2.00
114.38
4.8
4.2
263.33
246.82
u/l
3.58
1510
8423
2441
15957
1.82
112.53
3.9
2.9
4.64
4.55
e6/l
0.11
2274
14542
204
358
5.84
110.86
1.5
1.3
1.16
2.18
u/ml
0.91
132
211
292
706
4.27
108.98
1.3
1.2
5.85
3.45
u/ml
0.57
134
227
148
188
8.02
108.88
2.1
1.9
1.86
1.71
ratio
0.34
139
177
554
2033
2.88
107.98
1.7
1.7
—
—
—
0
0
1197
6259
2.10
106.54
4.3
3.2
225.45
237.53
ng/l
0.42
1127
5783
978
4809
2.20
101.56
2.1
1.8
—
—
—
0
0
1042
5261
2.15
101.19
1.9
1.7
—
—
—
0
0
153
220
7.09
100.99
45.5
25.4
153.81
105.05
ug/l
8.82
121
180
368
1106
3.46
100.54
2.3
1.9
1.64
1.72
mmol/l
0.69
362
1075
1705
10283
1.87
99.72
12.1
7.0
103.81
104.35
mmol/l
4.46
1705
10278
188
338
5.69
99.57
2.1
2.2
471.37
511.80
e6/l
0.38
145
275
3000
21347
1.72
99.49
3.6
2.2
148.59
225.36
u/l
7.96
2858
20081
1604
9495
1.90
99.38
8.1
6.0
1.05
1.04
mmol/l
0.69
1508
8796
313
852
3.80
99.18
1.2
1.2
341.75
283.96
u/ml
1.48
199
509
185
335
5.65
97.23
2.3
2.3
216.85
238.65
e6/l
0.52
160
291
471
1677
2.94
96.77
3.6
2.2
90.10
89.42
%
0.28
460
1615
179
316
5.79
96.64
1.6
1.8
—
—
—
0
0
179
316
5.79
96.64
1.6
1.8
—
—
—
0
0
179
316
5.79
96.64
1.6
1.8
—
—
—
0
0
892
4320
2.22
95.83
15.0
9.6
16.02
15.87
%
0.82
862
4178
274
696
4.06
95.64
1.3
1.2
5.28
4.40
u/ml
0.27
167
305
177
316
5.72
94.43
1.7
1.8
—
—
—
0
0
1226
6733
2.00
94.31
12.0
7.3
1.45
1.36
mmol/l
1.39
1197
6592
119
138
8.76
94.26
1.4
1.7
2120.00
3803.33
titre
1.14
12
24
207
427
4.97
94.02
2.3
2.3
37.14
26.07
iu/ml
0.40
23
69
150
228
6.70
94.02
1.7
2.0
—
—
—
0
0
150
228
6.70
94.02
1.7
2.0
—
—
—
0
0
3135
22853
1.68
92.90
4.4
3.6
2.34
2.35
mmol/l
2.88
2917
20523
440
1544
2.98
92.72
3.8
2.4
211.29
208.53
%
0.24
421
1473
2496
17135
1.71
92.55
4.9
3.0
360.57
359.02
umol/l
0.29
2235
14818
149
230
6.60
92.03
1.7
2.0
—
—
—
0
0
254
629
4.15
91.75
1.3
1.1
118.20
114.04
%
1.03
244
555
137
195
7.15
91.26
48.0
36.7
8.00
7.22
ug/l
2.82
124
174
4069
32055
1.65
86.60
5.5
4.2
0.00
0.00
estimate
1.34
1191
6832
1533
9336
1.82
84.98
3.5
2.4
1.93
1.77
%
6.87
1374
8268
4099
32455
1.65
84.55
5.5
4.2
4.79
4.67
estimate
0.02
1215
7063
4117
32657
1.64
84.08
5.6
4.3
0.01
0.21
estimate
0.71
1141
6552
3562
27338
1.62
82.43
3.2
2.4
77.90
79.09
nmol/l
1.78
3306
24176
2048
13664
1.71
82.16
5.4
4.3
418.13
482.23
ng/l
0.32
1831
11714
209
490
4.37
81.10
1.2
1.2
96.82
94.93
%
0.42
203
455
2330
16165
1.67
80.22
6.7
4.3
84.42
84.53
%
0.07
2289
15817
1166
6659
1.90
78.56
2.4
2.2
0.21
0.20
g/l
1.82
1079
6187
245
661
3.81
78.53
1.2
1.1
—
—
—
0
0
85
80
10.74
78.46
1.2
1.2
43.62
43.34
mg/l
0.01
56
73
162
320
5.16
77.35
1.2
1.2
88.69
81.38
0.84
13
21
165
336
5.01
76.07
2.0
1.5
5.96
6.48
u/l
0.36
150
284
1296
7726
1.83
76.01
5.1
3.8
5.86
5.80
kpa
1.25
1259
7532
1266
7508
1.84
75.46
5.1
3.8
2.15
1.75
mmol/l
3.09
1115
6518
1003
5526
1.95
74.98
5.1
4.2
1.22
1.22
mmol/l
3.38
916
4759
189
436
4.43
74.86
1.3
1.2
158.14
141.74
titre
0.13
43
69
189
436
4.43
74.86
1.3
1.2
120.00
117.50
titre
0.03
12
12
4881
40989
1.65
74.14
6.8
5.3
604.36
1958.25
e6/l
2.76
79
684
3656
28666
1.58
74.03
3.1
2.5
—
—
—
0
0
927
4998
1.99
73.71
14.9
9.3
92.49
93.89
%
9.59
921
4980
388
1444
2.79
73.11
1.5
1.3
—
—
—
0
0
388
1444
2.79
73.11
1.5
1.3
—
—
—
0
0
1237
7356
1.83
72.82
3.5
2.5
72.14
67.73
e9/l
3.31
860
5466
2565
18636
1.60
71.09
2.7
2.4
3.06
2.92
mg/l
2.10
2281
15997
1683
11037
1.69
70.00
2.9
2.0
29.90
29.98
s
0.22
1642
10722
153
318
4.90
68.87
2.5
2.5
37.95
37.67
%
0.05
87
174
206
542
3.89
68.42
1.1
1.1
1.78
2.87
iu/ml
—
9
18
881
4843
1.94
65.71
15.5
9.4
0.60
0.63
%
1.37
872
4810
3356
26234
1.54
65.68
5.7
4.4
92.01
81.98
ng/l
0.07
2771
20548
595
2834
2.20
65.50
2.8
3.3
71.10
79.29
mg/l
0.13
455
2434
594
2830
2.20
65.34
2.8
3.3
42.86
54.28
mg/l
1.08
452
2427
901
5007
1.92
65.01
15.2
9.1
1.34
1.30
%
0.76
892
4976
811
4360
1.97
64.50
5.0
3.8
24.36
24.10
mmol/l
1.42
805
4306
72
72
10.09
63.70
1.2
1.1
—
—
—
0
0
153
340
4.58
63.53
2.4
2.2
0.57
0.64
e9/l
0.77
137
321
80
93
8.69
63.24
1.1
1.0
—
—
—
0
0
725
3791
2.02
62.29
1.7
1.5
—
—
—
0
0
3398
26833
1.52
62.10
3.8
3.2
194.17
153.82
ug/l
8.17
3154
24607
1160
7064
1.77
62.08
5.0
3.8
—
—
—
0
0
1666
11221
1.64
61.21
4.6
3.4
1.81
1.96
e6/l
0.34
863
5792
107
180
6.02
60.73
2.0
1.9
30.72
29.49
%
0.28
101
166
538
2543
2.21
60.21
2.7
3.2
1.84
4.96
ratio
1.60
258
1521
239
757
3.23
59.83
1.1
1.1
1.57
1.55
g/l
0.24
213
683
94
147
6.47
57.36
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
553
2693
2.14
57.33
3.8
2.9
0.32
0.34
iu/ml
0.88
315
1471
657
3475
1.98
54.33
5.9
4.9
1.72
1.57
%
4.44
630
3295
5119
44737
1.55
53.78
43.2
24.0
14.32
13.87
%
84.78
5101
44115
317
1255
2.60
52.72
1.3
1.3
—
—
—
0
0
543
2720
2.08
52.14
3.2
2.2
342.29
716.62
ug/l
2.73
516
2599
489
2391
2.12
50.00
2.4
2.3
0.05
0.05
g/l
0.05
447
2144
1729
12236
1.55
49.81
4.3
3.3
0.95
1.12
e6/l
1.27
941
6825
693
3853
1.89
49.20
2.2
1.6
1.61
1.57
g/l
0.51
597
3305
338
1425
2.44
49.19
1.3
1.3
—
—
—
0
0
472
2296
2.13
48.89
2.5
2.3
0.00
0.00
g/l
1.04
419
2002
298
1192
2.57
48.50
1.1
1.1
3.95
3.95
0.00
17
104
54
53
10.26
48.38
1.1
1.0
—
—
—
0
0
306
1245
2.53
48.06
4.1
3.7
1.60
1.61
%
0.02
286
1088
516
2645
2.03
46.40
7.1
4.2
25.00
24.76
mmol/l
1.15
485
2395
2172
16324
1.48
46.32
5.3
3.8
0.11
0.29
estimate
0.85
1022
5286
1021
6468
1.68
46.16
4.0
3.2
4.46
4.46
kpa
0.01
986
6288
1142
7451
1.64
46.01
3.1
2.7
10.27
9.43
umol/l
0.50
1000
6568
2630
20565
1.45
45.46
3.1
2.7
65.44
64.61
u/l
0.05
2460
19002
543
2857
1.98
45.32
2.6
2.4
0.63
1.01
g/l
2.02
478
2434
44
36
12.29
44.40
1.0
1.1
5.50
1.80
u/ml
—
5
5
542
2870
1.96
44.39
2.4
2.3
10.51
10.22
g/l
0.79
506
2517
437
2144
2.11
44.19
2.6
2.4
0.00
0.00
g/l
-0.00
419
1996
605
3330
1.90
44.13
2.4
2.3
3.91
3.73
g/l
1.75
572
3011
341
1515
2.32
44.06
1.8
1.6
—
—
—
0
0
587
3204
1.91
43.92
6.4
5.0
0.85
0.87
%
0.52
560
3034
605
3337
1.89
43.83
2.4
2.3
4.13
4.18
g/l
0.99
575
3016
605
3337
1.89
43.83
2.4
2.3
7.84
7.42
g/l
6.96
574
3012
573
3109
1.92
43.64
2.4
2.4
3.11
2.91
g/l
4.88
542
2789
433
2161
2.07
41.80
7.9
5.8
1.39
1.35
mmol/l
0.47
395
1924
338
1536
2.26
41.39
1.2
1.2
119.58
117.72
titre
0.03
48
123
104
240
4.38
41.26
1.2
1.2
—
—
—
0
0
2373
18460
1.43
41.01
5.6
4.4
0.00
0.00
estimate
1.73
1085
6124
1870
13944
1.47
40.34
3.0
3.2
2.48
2.46
mmol/l
8.15
1704
12436
104
246
4.28
39.98
1.2
1.2
1.07
1.07
ratio
0.14
91
190
178
615
2.94
38.42
1.1
1.1
3.24
3.31
0.02
11
76
472
2513
1.94
37.91
4.6
3.9
1.40
1.41
mmol/l
0.06
465
2469
384
1901
2.08
37.84
1.6
1.4
—
—
—
0
0
326
1533
2.18
36.69
1.2
1.2
908.46
985.78
titre
0.10
13
45
84
183
4.63
35.84
1.1
1.1
22.15
5.16
u/ml
0.58
13
19
2098
16361
1.41
34.25
4.3
3.2
0.03
0.07
1.06
47
529
6009
55893
1.57
34.21
38.6
19.4
26.52
27.54
mg/l
1.83
5729
47494
315
1516
2.13
33.41
8.0
6.7
11.63
11.31
mmol/l
0.95
289
1359
315
1516
2.13
33.41
8.1
6.7
103.81
105.01
mmol/l
4.78
289
1360
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
86
202
4.30
33.41
1.3
2.0
201.19
173.19
%
1.41
80
191
42
12
35.20
32.73
1.0
1.0
14.73
14.19
mg/l
—
23
7
370
1911
1.99
32.40
4.3
3.6
2.61
1.88
index
1.22
216
987
356
1831
2.00
31.54
1.6
1.6
—
—
—
0
0
366
1906
1.97
31.29
3.4
2.9
1.81
1.74
mg/l
0.72
340
1684
1559
11692
1.43
31.24
1.3
1.3
1.21
1.72
u/ml
1.84
397
2935
428
2360
1.87
30.80
1.4
1.3
—
—
—
0
0
157
577
2.76
30.30
1.7
1.8
4.28
4.57
mg/l
0.30
148
551
208
883
2.40
29.83
1.2
1.3
200.44
204.15
miu/ml
0.04
34
315
69
149
4.67
29.81
2.4
2.6
1.79
2.07
ratio
0.49
61
135
276
1322
2.13
29.64
1.7
1.5
—
—
—
0
0
2854
23830
1.34
28.89
5.6
4.3
0.95
0.37
estimate
0.40
1054
5602
1931
15237
1.37
28.17
4.8
4.0
0.14
0.47
0.55
14
187
62
130
4.80
27.76
1.0
1.2
90.51
82.13
%
1.08
39
67
225
1033
2.22
26.90
1.8
1.9
4.23
4.62
mmol/24h
1.07
204
886
4044
35699
1.32
26.78
4.7
3.4
65.73
55.12
u/l
6.08
3806
32861
56
112
5.03
26.50
1.5
1.2
—
—
—
0
0
197
861
2.33
26.48
1.5
1.4
6.63
6.32
mmol/l
0.68
181
803
160
637
2.55
26.38
1.7
1.4
13.75
13.09
u/l
0.54
153
613
328
1745
1.92
26.33
1.8
1.6
13613.41
14805.69
e6/l
0.16
234
1210
185
791
2.38
26.15
1.7
1.5
58.16
61.51
%
0.53
111
518
722
4798
1.56
25.90
4.8
3.3
126.40
127.82
g/l
0.94
700
4652
2491
20635
1.32
25.72
1.9
1.8
19.31
19.97
nmol/l
1.39
2181
17396
61
136
4.52
25.38
1.1
1.4
91.63
81.57
%
1.07
41
74
45
78
5.80
24.87
1.7
1.5
92.81
88.69
au/ml
—
8
7
198
891
2.26
24.87
3.4
2.4
0.88
0.35
mmol/l
1.15
191
856
256
1281
2.04
24.50
1.5
1.5
32.93
31.35
g/l
1.14
222
1151
195
879
2.25
24.40
10.9
14.9
7.56
7.39
mmol/l
0.24
173
734
68
174
3.94
23.66
1.0
1.1
98.02
92.57
%
0.93
62
126
148
600
2.50
23.53
1.9
1.4
37.01
27.61
%
2.17
85
384
49
97
5.08
23.48
1.2
1.4
10991.67
5340.00
u/ml
—
6
12
164
698
2.38
23.45
1.1
1.1
7.44
20.60
au/ml
2.12
14
123
125
468
2.70
23.36
1.9
1.9
8.06
8.19
mmol/l
0.13
125
468
59
137
4.34
23.35
1.7
1.5
8.58
9.70
ug/l
1.11
59
137
311
1692
1.88
23.32
1.9
1.7
—
—
—
0
0
902
6417
1.47
23.25
2.5
2.2
187.82
158.07
ug/g
1.40
748
5064
193
884
2.22
23.25
1.4
1.3
455.86
367.97
u/l
0.70
180
838
160
680
2.38
22.96
1.3
1.3
14.90
12.99
u/l
0.52
144
623
212
1014
2.13
22.91
7.5
6.2
12.09
12.25
mg/l
0.22
197
937
553
3560
1.60
22.64
4.7
3.5
25.58
25.09
mmol/l
2.30
526
3445
1670
13275
1.34
22.24
1.9
1.8
1184.35
1153.17
nmol/l
0.62
1275
9975
91
300
3.06
21.49
1.7
1.4
4.00
3.69
%
0.09
21
70
217
1077
2.05
21.28
1.2
1.3
—
—
—
0
0
44
87
5.08
21.14
1.3
1.2
122.18
1032.99
ng/l
0.48
28
58
854
6134
1.45
20.80
3.0
2.5
36.71
47.27
u/l
0.71
765
5165
118
456
2.62
20.76
1.3
1.2
—
—
—
0
0
752
5280
1.48
20.60
1.7
1.7
1.67
1.56
%
2.91
637
4453
168
766
2.22
20.51
1.5
1.4
—
—
—
0
0
50
114
4.41
20.29
2.3
1.9
7.17
9.18
mg/l
1.57
43
94
171
789
2.20
20.28
4.3
3.5
57.08
58.54
%
0.38
153
657
50
115
4.37
20.07
1.6
1.5
—
—
—
0
0
455
2878
1.62
20.00
2.7
2.0
—
—
—
0
0
767
5474
1.45
19.25
4.7
4.0
100.81
97.18
ng/l
0.39
676
4630
589
3998
1.52
18.99
4.0
2.8
0.63
0.62
%
0.36
589
3980
272
1527
1.81
18.49
2.6
2.4
32.42
33.75
umol/l
0.41
257
1350
149
679
2.22
18.26
1.2
1.2
66.77
65.59
u/l
0.07
133
591
1754
14411
1.29
17.69
1.9
1.8
40575104.72
27465278.92
pmol/l
0.34
1427
11735
96
364
2.66
17.61
1.6
1.4
—
—
—
0
0
96
364
2.66
17.61
1.6
1.4
—
—
—
0
0
3281
29086
1.24
17.18
3.7
2.9
—
—
estimate
—
0
0
265
1510
1.79
17.16
1.3
1.3
—
—
—
0
0
333
2036
1.67
16.74
1.4
1.5
284.02
261.93
ug/g
0.49
207
1251
86
320
2.71
16.39
4.2
3.3
1.07
1.37
%
0.90
86
320
566
3936
1.48
16.17
5.2
4.2
44.22
46.56
%
1.42
559
3875
481
3246
1.52
15.90
2.5
2.2
0.09
0.29
estimate
0.31
156
890
112
481
2.35
15.83
1.3
1.2
98.16
100.68
pmol/l
0.26
112
481
63
207
3.06
15.08
2.8
1.5
1.97
1.91
umol/l
0.21
58
187
309
1915
1.64
14.76
1.4
1.3
—
—
—
0
0
4628
42921
1.24
14.69
4.5
4.2
15.02
15.02
pmol/l
0.07
4240
38710
200
1106
1.83
14.35
1.5
1.5
4330.42
2934.39
e6/l
0.28
127
785
400
2670
1.53
13.92
2.3
1.8
—
—
—
0
0
292
1816
1.63
13.77
3.3
3.3
0.87
0.82
nmol/l
0.95
233
1451
102
455
2.26
13.28
1.3
1.1
—
—
—
0
0
108
494
2.21
13.23
1.1
1.1
1.31
1.01
u/ml
0.21
68
268
696
5206
1.37
13.17
3.7
2.8
55.17
61.54
ml/min/173m2
5.01
362
2266
135
676
2.02
13.07
1.1
1.1
1.15
1.78
u/ml
0.54
83
381
25
46
5.45
13.04
1.0
1.0
—
—
—
0
0
2641
23329
1.21
12.98
4.8
4.2
11.57
9.38
mg/mmol
1.29
1720
14815
3361
30415
1.20
12.73
2.4
2.3
92.11
94.00
pmol/l
1.49
1888
16399
176
979
1.82
12.45
1.5
1.5
163302.61
53880.00
e6/l
1.37
89
562
2629
23293
1.21
12.33
3.9
3.5
7.03
7.32
mmol/l
3.46
2191
19348
187
1074
1.76
11.90
1.6
1.9
22.70
24.22
ug/l
0.15
182
1050
88
388
2.28
11.82
1.1
1.2
112.30
96.12
u/l
0.39
77
320
95
433
2.21
11.79
1.1
1.1
2.50
2.28
u/ml
0.08
57
228
35
93
3.78
11.70
1.0
1.3
89.08
76.45
%
0.58
12
33
27
59
4.59
11.63
1.3
1.7
—
—
—
0
0
85
377
2.27
11.28
1.1
1.2
50.08
26.47
u/l
1.05
73
307
249
1567
1.61
11.26
4.6
2.6
62.97
61.31
%
0.56
249
1561
132
693
1.92
11.22
5.1
3.5
14.17
12.42
index
1.12
99
374
2563
22797
1.20
11.21
4.0
3.5
63.33
51.88
mg/l
1.61
1747
14957
6019
58003
1.29
11.11
40.5
23.9
139.05
139.62
mmol/l
50.34
5973
56865
83
367
2.28
11.10
1.2
1.1
31.15
28.40
u/l
0.16
75
322
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
34
93
3.67
10.93
1.1
1.2
75.82
80.43
%
0.26
11
30
89
408
2.20
10.92
1.1
1.1
1.19
3.07
u/ml
1.45
48
187
70
290
2.43
10.85
6.2
3.7
68.54
65.59
mg/l
0.11
52
200
83
372
2.25
10.77
1.2
1.1
90.03
85.16
u/l
0.20
75
329
21
22
9.57
10.72
1.3
1.2
0.93
1.13
iu/ml
0.29
14
11
111
558
2.01
10.71
1.1
1.1
3.06
3.14
u/ml
0.02
63
284
62
246
2.53
10.54
1.2
1.1
10.19
21.02
u/ml
—
8
95
66
270
2.46
10.53
1.3
1.3
3.86
3.36
mmol/l
0.55
59
245
6020
58082
1.28
10.51
40.9
24.1
4.02
4.00
mmol/l
5.23
5966
56864
128
686
1.88
10.26
2.8
3.3
—
—
—
0
0
37
112
3.32
10.23
2.6
3.4
6.70
8.19
mg/l
0.53
28
91
80
362
2.22
10.17
1.1
1.1
0.22
0.21
u/ml
0.05
43
148
20
22
9.11
9.99
1.6
1.3
2.19
2.15
mg/l
0.01
12
14
20
22
9.11
9.99
1.5
1.3
0.71
0.88
mg/l
0.12
11
13
20
22
9.11
9.99
1.6
1.3
0.98
1.32
mg/l
—
9
13
20
22
9.11
9.99
1.5
1.3
1.93
1.18
mg/l
—
9
15
20
22
9.11
9.99
1.5
1.3
4.75
2.11
mg/l
—
9
11
20
22
9.11
9.99
1.6
1.3
1.33
3.12
mg/l
0.60
13
15
20
22
9.11
9.99
1.6
1.3
3.99
1.08
mg/l
—
8
14
20
22
9.11
9.99
1.6
1.3
1.62
2.73
mg/l
0.29
11
13
20
22
9.11
9.99
1.6
1.3
2.08
0.64
mg/l
0.52
11
13
611
7879
0.75
9.87
9.9
8.2
—
—
—
0
0
812
6468
1.29
9.86
1.5
1.4
—
—
—
0
0
20
23
8.72
9.76
1.6
1.3
0.41
1.97
mg/l
—
8
15
29
77
3.78
9.75
1.2
1.4
260878.65
119703.98
nmol/l
0.20
23
66
83
389
2.15
9.69
1.4
1.5
8.20
7.07
u/l
0.32
60
310
45
159
2.84
9.61
1.7
1.6
0.32
0.39
ug/l
0.75
38
97
105
548
1.93
9.17
1.1
1.1
0.69
1.07
u/ml
0.44
54
249
16
14
11.45
9.05
1.3
1.3
0.57
0.13
iu/ml
—
10
7
295
2030
1.47
8.95
1.7
1.6
0.38
0.32
mg/l
0.84
139
908
45
166
2.72
8.90
1.2
1.2
1.81
1.48
mmol/l
1.03
23
108
5573
53520
1.21
8.88
33.8
19.5
73.12
74.04
ml/min/173m2
2.64
5352
50101
49
190
2.59
8.79
1.1
1.1
14.30
2.01
u/ml
1.11
11
23
39
135
2.90
8.67
1.3
1.5
3.82
8.16
%
1.74
17
70
71
328
2.18
8.64
1.4
1.4
64.69
68.73
%
0.36
48
271
54
222
2.44
8.60
1.1
1.1
—
—
—
0
0
95
494
1.94
8.42
1.6
1.4
—
—
—
0
0
46
177
2.61
8.40
5.7
8.0
6.05
5.96
kpa
0.17
38
154
816
6637
1.26
8.31
2.7
2.4
11.21
7.09
ug/l
4.62
719
5757
17
20
8.52
8.29
1.2
1.1
—
—
—
0
0
67
310
2.17
8.15
1.0
1.1
9.57
10.73
iu/ml
—
9
84
110
607
1.83
8.14
1.3
1.3
—
—
—
0
0
18
38
4.75
8.10
1.9
2.0
1.19
1.36
mg/l
0.32
13
31
214
1408
1.54
8.09
1.5
1.4
63.21
61.67
mmol/l
0.24
189
1137
95
502
1.90
8.05
1.6
1.3
—
—
—
0
0
421
3146
1.36
8.03
2.9
3.4
4.20
4.40
pmol/l
3.14
370
2769
30
94
3.20
7.92
2.2
2.8
130.38
110.68
au/ml
—
5
15
71
341
2.09
7.87
1.7
1.4
—
—
—
0
0
71
341
2.09
7.87
1.7
1.4
—
—
—
0
0
1817
16072
1.18
7.81
3.2
2.6
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
19
45
4.23
7.46
1.2
1.2
2037.00
2690.97
ng/l
0.31
12
33
5996
58211
1.23
7.43
23.9
13.1
24.74
25.54
u/l
3.23
5938
56187
360
2658
1.37
7.42
1.1
1.1
0.88
1.21
u/ml
—
5
29
26
78
3.34
7.36
1.2
1.2
0.04
0.53
u/ml
—
8
16
68
330
2.07
7.36
1.4
1.2
—
—
—
0
0
926
7757
1.22
7.17
3.4
4.2
14.28
29.72
ug/l
1.88
781
6465
37
139
2.67
7.13
1.3
1.3
—
—
—
0
0
24
70
3.44
7.10
1.3
1.0
10.15
14.04
iu/ml
0.22
13
27
83
442
1.89
6.93
1.1
1.1
—
—
—
0
0
23
67
3.44
6.83
1.7
1.6
—
—
—
0
0
66
327
2.03
6.79
1.4
1.2
—
—
—
0
0
322
2379
1.37
6.65
2.9
3.2
341.74
465.53
mg/l
0.76
168
1066
5378
51839
1.17
6.55
5.8
5.3
2.07
2.02
mu/l
1.14
4976
47093
24
74
3.25
6.54
1.0
1.7
—
—
—
0
0
47
207
2.28
6.51
1.3
1.4
26.03
23.03
%
0.25
32
173
38
154
2.48
6.33
5.4
8.1
5.71
5.41
kpa
0.34
38
154
13
16
8.14
6.32
1.8
1.3
—
—
—
0
0
50
231
2.17
6.20
5.6
6.9
24.68
24.70
mmol/l
0.01
42
208
26
88
2.96
6.10
1.4
1.4
69.58
73.47
%
0.23
19
74
95
551
1.73
6.06
2.2
2.2
583.83
652.52
ml
0.98
65
349
122
760
1.62
5.95
1.4
1.3
271.97
276.86
mosm/kgh2o
1.45
103
564
175
1183
1.49
5.93
1.1
1.1
18.28
7.82
eliau/ml
0.67
12
95
5527
53525
1.16
5.76
7.9
7.3
40.91
40.32
mmol/mol
4.84
5180
49338
75
416
1.81
5.59
1.0
1.0
296.69
286.30
mg/l
0.60
68
373
42
189
2.23
5.58
1.3
1.2
—
—
—
0
0
260
3488
0.74
5.53
2.2
2.1
3.73
3.45
ratio
0.50
216
2797
31
122
2.55
5.52
1.3
1.3
232.67
313.27
u/l
0.10
21
86
127
815
1.57
5.50
1.7
1.4
—
—
—
0
0
6049
59056
1.19
5.49
44.9
26.1
88.45
84.30
umol/l
9.54
6007
58225
84
486
1.74
5.44
3.2
2.8
32.76
33.46
mg/l
0.06
70
368
127
818
1.56
5.42
1.7
1.4
—
—
—
0
0
215
1541
1.41
5.39
1.3
1.2
—
—
—
0
0
33
136
2.43
5.35
1.2
1.2
0.46
1.84
mmol/l
1.43
21
94
148
994
1.50
5.23
2.4
2.3
0.91
1.20
g/24h
1.05
101
579
125
814
1.55
5.11
1.7
1.4
—
—
—
0
0
211
1529
1.39
4.99
1.3
1.2
—
—
—
0
0
175
2459
0.70
4.99
2.0
1.8
3.31
3.39
mmol/l
0.36
131
1769
106
669
1.59
4.97
1.7
1.3
95989.94
143053.24
e6/l
0.38
68
442
31
129
2.41
4.95
1.3
1.2
—
—
—
0
0
11
16
6.88
4.94
1.1
1.0
—
—
—
0
0
64
357
1.80
4.75
2.2
1.9
—
—
—
0
0
188
1351
1.40
4.70
1.2
1.3
40.35
38.00
u/l
0.07
169
1160
47
239
1.97
4.62
3.3
2.4
4.67
4.86
kpa
0.89
47
239
749
6413
1.19
4.59
2.6
2.2
0.01
0.01
estimate
0.20
185
1190
47
240
1.96
4.57
3.3
2.4
9.22
10.16
kpa
1.85
47
240
49
255
1.93
4.52
1.3
1.3
—
—
—
0
0
13
27
4.82
4.49
6.2
11.0
108.69
105.41
g/l
0.36
13
27
54
292
1.86
4.44
1.3
1.3
80.30
421.86
ug/l
1.30
23
145
46
236
1.96
4.43
2.7
2.6
0.61
0.61
mmol/l
0.02
46
236
15
45
3.34
4.32
1.3
1.4
0.82
0.88
ml/s/173m2
—
8
30
126
855
1.48
4.31
1.7
1.4
—
—
—
0
0
47
246
1.92
4.28
4.5
1.7
211.30
105.59
umol/l
0.71
27
145
127
867
1.47
4.22
1.7
1.4
—
—
—
0
0
125
851
1.48
4.21
1.7
1.4
—
—
—
0
0
675
7858
0.84
4.21
5.2
5.4
32.61
33.16
%
0.62
486
5042
14
35
4.01
4.09
1.5
1.1
—
—
—
0
0
20
75
2.67
3.98
2.3
1.5
44.15
44.08
umol/l
0.00
20
75
708
6109
1.18
3.97
3.5
2.7
0.46
0.49
e6/l
0.11
686
5902
18
64
2.82
3.95
1.0
1.1
—
—
—
0
0
14
43
3.26
3.90
1.1
1.1
—
—
—
0
0
22
88
2.50
3.87
1.2
1.2
23.08
19.90
u/l
0.26
13
63
21
84
2.50
3.70
1.0
1.0
14.95
7.90
u/ml
0.44
13
48
13
34
3.83
3.68
2.2
1.8
—
—
—
0
0
18
67
2.69
3.65
3.8
2.6
0.67
1.27
mg/l
2.68
11
52
6065
59540
1.15
3.62
51.8
29.4
7.78
6.90
e9/l
73.39
5974
57899
6064
59530
1.15
3.61
51.6
29.3
92.64
91.72
fl
39.12
6028
58732
6064
59533
1.15
3.60
51.7
29.4
4.34
4.41
e12/l
18.36
5968
57903
6064
59534
1.15
3.59
53.5
30.0
39.63
39.78
%
1.49
6028
58707
6063
59525
1.15
3.58
51.9
29.4
244.20
240.67
e9/l
3.61
5985
58130
6064
59543
1.15
3.54
52.2
29.6
130.99
133.25
g/l
24.61
6032
58771
259
2044
1.28
3.53
1.4
1.3
—
—
—
0
0
14
46
3.05
3.52
1.2
1.3
—
—
—
0
0
66
409
1.62
3.45
1.9
1.7
—
—
—
0
0
21
89
2.36
3.31
1.3
1.9
103.52
39.04
pmol/l
0.57
16
70
44
247
1.79
3.30
1.5
1.4
24.38
18.83
%
0.55
38
226
57
909
0.62
3.20
1.1
1.2
0.62
0.63
ratio
0.06
12
153
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
88
604
1.46
2.96
1.2
1.4
—
—
—
0
0
41
234
1.76
2.95
1.3
1.2
33.26
40.42
g/l
2.37
19
110
81
548
1.48
2.93
2.0
1.9
3970.43
3665.23
u/l
0.03
26
208
49
295
1.67
2.92
2.3
1.4
20.54
21.45
umol/l
0.07
44
271
25
121
2.07
2.92
1.4
1.3
—
—
—
0
0
25
121
2.07
2.92
1.2
1.2
—
—
—
0
0
8
17
4.71
2.91
1.3
1.0
—
—
—
0
0
23
108
2.13
2.89
1.1
1.1
1233.33
890.00
titre
—
6
30
86
592
1.46
2.87
1.8
2.0
1.33
1.33
u/field
0.01
42
317
68
446
1.53
2.86
1.4
1.3
1.09
1.13
promille
0.08
54
354
40
229
1.75
2.86
1.1
1.1
1426.49
1601.49
miu/ml
0.40
40
229
54
336
1.61
2.84
1.6
1.8
1.67
2.82
u/field
0.72
42
228
58
368
1.58
2.82
2.3
2.5
23.36
35.21
umol/l
—
5
36
19
85
2.24
2.69
1.5
1.3
102.38
113.47
ug/l
—
10
51
12
40
3.00
2.69
1.0
1.0
—
—
—
0
0
10
29
3.45
2.68
1.1
1.0
—
—
—
0
0
432
3712
1.17
2.63
2.4
2.5
33.02
22.56
au/ml
0.87
32
288
30
162
1.86
2.61
1.5
1.5
0.40
0.34
mmol/l
—
6
35
397
3391
1.18
2.60
1.3
1.3
58.16
58.68
au/ml
0.01
17
231
70
1012
0.69
2.52
1.2
1.2
1.53
1.52
g/l
0.08
70
1012
21
101
2.08
2.52
10.6
13.7
5.49
5.03
mmol/l
0.53
21
101
48
301
1.60
2.49
1.1
1.6
6.35
11.01
umol/l
1.29
35
211
147
1135
1.30
2.48
1.4
1.4
33.95
29.40
iu/l
0.78
114
965
7
16
4.38
2.47
2.7
4.9
—
—
—
0
0
346
2938
1.19
2.45
1.2
1.2
129.59
131.63
u/ml
0.03
105
1024
54
350
1.55
2.44
1.5
1.3
1.20
1.18
nmol/l
0.04
41
248
29
159
1.83
2.43
1.2
1.3
0.34
0.30
g/l
1.45
21
124
5539
54361
1.09
2.38
6.0
5.8
6.09
6.09
mmol/l
0.07
5040
49075
5
8
6.25
2.37
1.0
1.0
—
—
—
0
0
26
139
1.87
2.35
1.6
1.2
16.92
15.92
umol/l
0.46
20
124
11
39
2.82
2.34
1.1
1.1
—
—
—
0
0
85
610
1.40
2.33
1.5
1.6
13.55
26.92
u/ml
2.57
11
124
15
65
2.31
2.31
1.0
1.0
—
—
—
0
0
23
119
1.94
2.29
4.8
7.5
11.00
10.17
%
1.14
23
119
74
520
1.43
2.28
1.0
1.1
14.09
3.12
eliau/ml
0.76
21
173
118
897
1.32
2.26
3.0
2.1
28.99
24.65
mg/l
0.39
55
310
1539
14411
1.09
2.21
5.4
4.6
1.02
1.12
kg/l
0.50
1140
9906
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
240
1993
1.21
2.19
1.6
1.6
38.50
24.16
u/ml
0.45
30
365
8
24
3.34
2.18
1.3
1.6
—
—
—
0
0
14
62
2.26
2.07
1.1
1.1
—
—
—
0
0
6
15
4.00
2.04
1.0
1.1
0.01
0.04
u/ml
—
6
15
8
26
3.08
2.01
2.1
5.6
—
—
—
0
0
51
343
1.49
2.00
3.2
3.0
227.49
206.18
u/l
0.98
51
336
39
247
1.58
2.00
1.3
1.1
—
—
—
0
0
136
1074
1.27
1.99
1.4
1.4
10.46
10.23
u/l
0.07
109
856
29
171
1.70
1.96
1.1
1.2
19.00
28.70
%
—
7
23
27
156
1.73
1.95
1.1
1.2
—
—
—
0
0
97
735
1.32
1.94
1.4
1.3
0.19
0.21
nmol/l
0.43
66
604
24
135
1.78
1.90
1.2
1.2
0.82
77.26
mg/l
0.80
15
97
194
1604
1.22
1.90
3.2
3.3
207.86
843.99
u/ml
1.87
173
1462
60
840
0.71
1.89
1.5
1.5
—
—
—
0
0
45
301
1.50
1.84
1.3
1.3
—
—
—
0
0
5
12
4.17
1.82
1.0
1.1
—
—
—
0
0
5
12
4.17
1.82
1.0
1.0
1.00
1.00
u/field
—
5
12
29
175
1.66
1.82
1.3
1.3
36.96
35.93
%
0.05
24
120
104
806
1.29
1.80
1.2
1.3
305.47
284.04
pmol/l
0.27
89
661
2085
21827
0.94
1.78
4.4
5.0
22.07
22.32
%
0.29
986
11796
38
248
1.54
1.75
1.3
1.2
0.57
0.53
ratio
0.20
20
148
16
83
1.93
1.64
1.9
1.2
22.65
20.58
mmol/l
0.76
11
66
40
270
1.48
1.60
1.2
1.2
60.67
64.32
%
—
6
38
10
43
2.33
1.58
1.0
1.1
99.20
93.77
titre
—
10
43
101
798
1.27
1.55
1.5
1.5
—
—
—
0
0
6
21
2.86
1.50
2.3
2.3
2.30
3.01
mg/l
—
6
21
123
1001
1.23
1.47
1.3
1.8
298.38
293.81
mu/l
0.06
109
923
35
511
0.68
1.46
1.1
1.0
370.17
321.01
ng/l
0.37
24
343
19
110
1.73
1.42
1.3
1.2
—
—
—
0
0
39
270
1.45
1.41
6.3
5.1
48.83
55.63
u/ml
—
6
43
103
827
1.25
1.41
3.4
3.8
25.98
34.81
u/ml
0.96
98
802
36
514
0.70
1.35
1.1
1.0
38.97
42.53
ng/l
0.17
25
340
69
530
1.30
1.35
1.4
1.4
124.00
323.65
titre
—
5
52
16
272
0.59
1.33
1.3
1.5
—
—
—
0
0
36
512
0.70
1.33
1.1
1.0
822.17
705.79
ng/l
1.01
23
335
6
24
2.50
1.30
2.8
2.3
4.33
4.45
mmol/l
—
6
24
26
169
1.54
1.28
2.3
2.4
4.09
251.28
ug/l
0.82
26
169
103
839
1.23
1.26
1.4
1.3
9.01
2.77
nmol/l
0.33
96
805
30
206
1.46
1.17
1.0
1.1
—
—
—
0
0
6
127
0.47
1.16
1.5
1.6
55.10
51.80
ug/l
—
6
127
5236
51670
1.05
1.15
4.8
4.6
1.33
1.27
mmol/l
8.95
4683
46488
16
260
0.61
1.15
1.1
1.1
1298.80
276.48
ng/l
—
5
70
14
235
0.59
1.14
1.6
1.5
1.80
1.12
ratio
—
7
149
14
235
0.59
1.14
1.6
1.5
0.95
0.95
ratio
—
7
149
14
235
0.59
1.14
1.6
1.5
1.46
1.24
ratio
—
7
149
43
318
1.35
1.12
1.1
1.1
—
—
—
0
0
14
233
0.60
1.11
1.6
1.5
—
—
—
0
0
83
1015
0.82
1.07
1.9
1.9
—
—
—
0
0
38
278
1.37
1.07
1.0
1.1
—
—
—
0
0
12
67
1.79
1.04
1.0
1.1
—
—
—
0
0
25
170
1.47
1.04
1.1
1.3
250.91
27.03
g/l
0.48
20
139
45
340
1.33
1.04
1.1
1.1
299.60
300.74
mg/l
0.01
40
295
60
472
1.27
1.04
1.3
1.2
2.29
2.24
mmol/l
0.09
55
442
11
191
0.58
1.03
1.7
1.6
—
—
—
0
0
9
46
1.96
1.03
1.0
1.2
—
—
—
0
0
103
862
1.20
1.02
1.4
1.3
0.14
0.28
nmol/l
—
9
60
99
828
1.20
0.99
1.1
1.1
61.65
280.12
iu/ml
0.52
20
157
69
850
0.81
0.98
1.6
1.9
—
—
—
0
0
332
3639
0.91
0.97
4.6
3.7
1.02
1.02
ratio
0.66
313
3302
22
148
1.49
0.97
1.3
1.2
262.00
284.83
pmol/l
0.11
12
109
25
173
1.45
0.97
1.6
1.4
15.79
16.97
pmol/l
0.32
16
137
7
36
1.95
0.97
3.6
4.5
—
0.00
estimate
—
0
8
27
190
1.42
0.96
1.1
1.3
119.97
134.73
nmol/l
0.24
20
139
190
1679
1.14
0.96
2.4
2.3
125.07
100.87
ug/min
0.42
115
968
13
77
1.69
0.95
1.2
1.0
17.24
43.69
iu/ml
2.53
13
77
6
27
2.22
0.93
1.0
1.0
—
—
—
0
0
21
142
1.48
0.92
1.2
1.1
—
—
—
0
0
137
1188
1.16
0.91
1.8
1.6
1.07
0.84
nmol/l
2.39
111
994
46
358
1.29
0.89
2.4
2.1
66.00
184.56
ug/min
—
7
95
166
1463
1.14
0.89
1.3
1.3
683.94
567.40
mg/l
0.32
154
1386
12
71
1.69
0.88
1.7
2.9
0.50
0.37
u/field
0.23
12
71
46
359
1.28
0.88
1.2
1.1
52.04
44.78
mg/l
0.47
36
300
297
2714
1.10
0.85
3.2
3.4
9027.19
1639.90
u/ml
0.39
248
2345
146
1284
1.14
0.82
1.2
1.2
3.86
3.84
mmol/l
0.07
136
1207
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
81
683
1.19
0.79
1.4
1.3
1.58
1.48
nmol/l
0.37
73
603
89
759
1.17
0.77
1.1
1.1
—
—
—
0
0
23
166
1.39
0.75
1.2
1.4
23.22
12.31
mm/h
1.56
23
166
5591
55446
1.04
0.73
6.4
6.4
2.44
2.54
mmol/l
12.01
5085
50728
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
11
171
0.64
0.72
1.8
1.8
—
—
—
0
0
141
1254
1.13
0.70
1.2
1.4
15.29
28.83
e6/l
0.68
93
931
142
1266
1.12
0.69
1.3
1.4
229.75
1062.17
e6/l
3.51
104
1001
40
319
1.26
0.68
1.0
1.1
—
—
—
0
0
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
63
530
1.19
0.66
1.1
1.1
—
25.21
—
0
9
5
28
1.79
0.66
1.4
1.5
1.46
3.49
nmol/l
—
5
28
5
29
1.72
0.64
1.2
1.7
—
—
—
0
0
18
130
1.39
0.61
1.5
1.2
—
—
—
0
0
39
316
1.24
0.60
2.1
1.7
37.77
39.56
g/l
1.12
39
316
37
298
1.24
0.60
1.3
1.5
—
—
—
0
0
26
200
1.30
0.60
1.3
1.2
10.10
11.95
pmol/l
—
10
77
24
183
1.31
0.59
1.1
1.1
—
—
—
0
0
13
89
1.46
0.58
2.0
1.7
—
—
—
0
0
73
841
0.87
0.57
4.5
4.6
317.24
344.12
umol/l
0.83
58
723
106
943
1.13
0.56
3.4
2.4
4.13
4.10
mmol/l
0.33
106
931
106
943
1.13
0.56
3.4
2.4
105.51
105.76
mmol/l
0.23
106
931
32
256
1.25
0.56
1.1
1.1
1.14
1.17
u/l
0.16
17
122
104
926
1.12
0.55
3.4
2.4
1.19
1.20
mmol/l
0.47
104
914
13
90
1.45
0.55
1.9
1.7
—
—
—
0
0
248
2311
1.08
0.53
1.6
1.8
—
—
—
0
0
31
382
0.81
0.52
1.0
1.1
5.18
13.35
nmol/l
—
7
81
1550
15881
0.97
0.51
3.2
3.5
0.73
0.82
ug/l
3.52
1122
11334
12
83
1.45
0.51
2.1
3.1
37.66
88.17
pmol/l
2.32
12
78
32
260
1.23
0.51
1.5
2.1
539.71
3748.35
e6/l
0.55
17
181
13
92
1.41
0.50
1.0
1.1
—
—
—
0
0
34
279
1.22
0.49
1.0
1.1
—
—
—
0
0
254
2377
1.07
0.49
1.1
1.1
—
—
—
0
0
560
5366
1.05
0.48
2.7
2.3
12.37
12.66
nmol/l
0.39
490
4725
5463
54275
1.03
0.48
5.7
5.5
4.33
4.42
mmol/l
9.55
4968
49839
5420
53847
1.03
0.47
5.6
5.4
1.39
1.43
mmol/l
6.88
4892
49067
19
146
1.30
0.47
1.4
1.3
56.29
72.74
mu/l
0.34
14
108
7
49
1.43
0.46
1.1
5.1
—
—
—
0
0
22
174
1.27
0.44
1.5
1.4
103.68
436.13
nmol/24h
1.16
22
174
8
60
1.33
0.40
1.8
1.1
1.69
1.78
umol/24h
—
8
60
2747
27111
1.02
0.39
5.4
6.1
3.20
3.65
ug/l
0.32
2423
24305
5
35
1.43
0.39
13.4
9.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
8.23
—
0
19
5
37
1.35
0.37
2.2
1.8
—
—
—
0
0
19
153
1.24
0.35
1.0
1.1
—
—
—
0
0
31
265
1.17
0.33
1.5
1.7
11.05
7.89
nmol/l
0.17
25
224
120
1117
1.08
0.32
1.4
1.3
—
—
—
0
0
62
560
1.11
0.31
1.2
1.2
7.26
7.70
mmol/l
0.65
54
470
147
1381
1.07
0.31
1.8
1.8
10.87
8.59
iu/l
0.10
53
506
23
193
1.19
0.30
1.2
1.2
—
—
—
0
0
24
204
1.18
0.28
1.3
1.5
14.98
14.05
g/l
0.18
17
158
17
140
1.21
0.27
1.0
1.1
—
—
—
0
0
41
459
0.89
0.27
1.8
1.8
117.79
118.36
ng/l
0.01
41
459
151
1429
1.06
0.26
1.5
1.7
—
30.85
—
0
5
30
262
1.15
0.26
1.2
1.4
—
—
—
0
0
18
150
1.20
0.26
1.4
1.1
—
—
—
0
0
29
331
0.88
0.26
1.4
1.4
145.96
190.08
pmol/l
0.72
29
331
220
2106
1.05
0.26
1.6
1.7
—
—
—
0
0
52
472
1.10
0.26
1.1
1.1
—
—
—
0
0
4405
44295
0.98
0.25
45.0
25.5
329.29
331.59
g/l
51.61
4385
43998
149
1414
1.05
0.25
2.1
1.7
23.40
4.71
mg/l
6.15
132
1079
34
302
1.13
0.24
4.1
7.0
8.41
221.36
ug/l
1.20
21
194
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
47
427
1.10
0.23
3.8
5.7
101.33
48.96
u/ml
0.52
15
136
17
143
1.19
0.23
2.2
2.0
—
—
—
0
0
5
39
1.28
0.23
1.4
1.1
6.34
6.19
mmol/l
—
5
39
19
162
1.17
0.22
1.1
1.1
—
—
—
0
0
7
92
0.76
0.22
1.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
1.38
—
0
10
12
98
1.22
0.21
1.0
1.1
—
—
—
0
0
5
43
1.16
0.21
1.2
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
32.98
—
0
13
0
13
0.00
0.21
0.0
8.1
—
—
—
0
0
14
117
1.20
0.20
1.4
1.1
0.85
0.69
umol/24h
—
7
59
13
155
0.84
0.20
1.3
1.3
1.18
1.17
mmol/l
0.16
13
155
27
240
1.13
0.20
1.3
1.3
138.22
162.13
mmol/24h
1.00
27
240
14
165
0.85
0.19
1.9
2.5
1.32
1.23
ug/l
0.08
14
156
15
174
0.86
0.17
1.0
1.1
—
—
—
0
0
2370
23522
1.01
0.17
2.1
2.0
1.39
1.32
mmol/l
4.58
1917
19371
19
167
1.14
0.16
1.0
1.1
—
—
—
0
0
8
68
1.18
0.16
1.0
1.0
—
—
—
0
0
18
159
1.13
0.15
1.1
1.1
—
—
—
0
0
36
389
0.93
0.14
1.2
1.4
28.68
30.36
u/l
0.13
30
321
137
1420
0.96
0.14
5.9
3.8
28.68
30.08
mg/l
0.19
104
1011
16
141
1.14
0.13
2.3
2.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
297
1.08
0.12
1.1
1.1
—
—
—
0
0
41
386
1.06
0.11
2.1
1.7
93.78
91.41
umol/l
0.12
41
386
10
86
1.16
0.11
1.0
1.1
—
—
—
0
0
6
54
1.11
0.09
1.0
1.2
7.83
11.28
u/l
—
6
54
24
224
1.07
0.08
1.3
1.9
23763.50
16124.71
e6/l
—
6
124
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
7
84
0.83
0.07
1.0
1.2
—
—
—
0
0
22
207
1.06
0.06
23.0
19.3
1430.50
1383.09
nmol/l
0.12
22
200
541
5368
1.01
0.06
1.5
1.4
—
—
—
0
0
41
425
0.96
0.05
1.9
1.4
0.18
0.27
nmol/l
1.32
30
307
41
399
1.03
0.03
2.3
2.3
—
—
—
0
0
125
1236
1.01
0.03
2.1
1.9
193.58
201.40
pmol/l
0.44
113
1154
14
147
0.95
0.01
2.1
2.3
7.63
8.02
mmol/l
—
9
92
11
113
0.97
0.00
2.4
1.7
0.33
1.77
u/ml
—
5
21
20
196
1.02
0.00
17.8
14.5
831.85
815.57
nmol/l
0.05
20
186
25
254
0.98
0.00
1.4
1.3
6.05
6.14
mmol/l
0.14
25
239
7
71
0.99
0.00
1.0
1.1
—
—
—
0
0
235
2350
1.00
-0.00
3.3
4.0
59.23
83.82
u/ml
0.88
227
2254
6
61
0.98
-0.00
2.2
2.0
14.33
18.63
umol/l
—
6
61
0
5
0.00
-0.00
0.0
1.0
—
17.00
—
0
5
0
6
0.00
-0.00
0.0
6.8
—
0.27
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
5.8
—
14.00
—
0
5
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: ILD_ENDPOINTS – Interstitial lung disease endpoints
GWS hits: 15
This endpoint is excluded (different definition than used in FinnGen).